Cancer of Pituitary

Synonym
Cancer of Pituitary
Pituitary Cancer
Cancer of the Pituitary
Pituitary Tumors
Pituitary Carcinoma
Pituitary Adenoma

Excerpt	Reference
"While pituitary tumors are not as rare as was once thought, it is difficult to assess how many are of clinical significance."	( May, PB, 1977)
"We conclude that pituitary tumors are present in the great majority of patient with Cushing's disease, even in the absence of demonstrable tomographic changes in the sella turcica, and that selective removal corrects hypercortisolism with little morbidity."	( Brooks, RM; Cofoid, PB; Fitzgerald, PA; Forsham, PH; Tyrrell, JB; Wilson, CB, 1978)
"TSH-secreting pituitary adenomas are treated with surgery and, if necessary, adjuvant pituitary radiotherapy."	( Davis, DH; Freeman, SL; Gharib, H; Horvath, E; Scheithauer, BW; Wynne, AG, 1992)
"Nonfunctioning pituitary tumors are mostly of gonadotroph cell origin and may be associated with significant disconnection hyperprolactinaemia."	( Bevan, JS; Burke, CW; Scanlon, MF; Webster, J, 1992)
"Spontaneous pituitary adenomas are common in certain strains of the laboratory rat."	( Helminski, M; Petter, H; Solecki, R, 1989)
"Pituitary carcinoma is defined as a malignant pituitary tumour associated with blood- or lymph-borne metastases."	( Anderson, PJ; Gabrilove, JL; Halmi, NS, 1986)
"Pituitary adenomas are known to occur spontaneously in several rat strains, especially during aging."	( Chedid, A; Chejfec, G; Evans, EE; Hoversland, RC; Jurin, RR; McCune, SA, 1988)
"Pituitary adenomas are usually classified according to the nature of their proper hormonal production."	( Buntrock, P; Decker, T; Gottschalk, J; Hufnagl, P; Knappe, G; Rohde, W, 1985)
"Growth of pituitary tumors is controlled with the administration of dopamine agonists such as bromocriptine and prospective studies have suggested that these drugs are now the preferred method of treatment for primary lesions and recurrences."	( Blackwell, RE; Dollar, JR, 1986)
"The majority of pituitary adenomas are prolactin (PRL)-secreting, but it is still uncertain whether their pathogenesis results from a central nervous system (CNS) disturbance or autonomous lactotroph growth and function."	( Barden, N; Daigle, M; Di Paolo, T, 1985)
"A case of pituitary carcinoma is here presented, together with a review of the 25 cases so far reported in the literature."	( Bussolati, G; Gatti, G; Limone, P; Papotti, M; Riva, C, 1984)
"Prolactin-secreting pituitary adenoma is a common cause of gynecologic problems that include oligomenorrhea, infertility, amenorrhea and galactorrhea."	( Jaffe, RB; Martin, MC; Schriock, ED, 1983)
"Prolactin-secreting pituitary adenomas are an importance cause of male and female infertility."	( Barziliai, S; Glaser, B; Nesher, Y, 1994)
"Occult pituitary adenomas are identified at autopsy in 3% to 27% of unselected asymptomatic patients."	( Doppman, JL; Hall, WA; Luciano, MG; Oldfield, EH; Patronas, NJ, 1994)
"The pathogenesis of pituitary tumors is still controversial."	( Constantinescu, I, 1993)
"Pituitary adenomas are common intracranial neoplasms, for which surgery and radiation are usually not curative."	( Davidson, BL; During, MJ; Flamm, ES; Freese, A; Gennarelli, TA; Kaplitt, MG; Snyder, PJ, 1996)
"If no visible pituitary adenoma is present or if the oCRH test is equivocal, bilateral simultaneous inferior petrosal sinus sampling with oCRH administration is necessary to distinguish between a pituitary and an ectopic source."	( Chrousos, GP; Cizza, G, 1997)
"1."	( Franzin, A; Giovanelli, M; Losa, M; Mangili, F; Mortini, P; Terreni, MR, 1998)
"Pituitary tumors are mostly benign lesions, although 5-35% are locally invasive."	( Besser, GM; Grossman, AB; Kaltsas, GA; Monson, JP; Mukherjee, JJ; Plowman, PN, 1998)
"Pituitary tumors are commonly encountered, and result from clonal expansion of a single mutated cell."	( Heaney, AP; Horwitz, GA; Melmed, S; Singson, R; Wang, Z, 1999)
"Pituitary tumors are common monoclonal neoplasms which cause considerable morbidity and mortality."	( Heaney, AP; Melmed, S, 2000)
"Pituitary adenomas are members of the family of neuroendocrine cells and tumors which have secretory granules containing chromogranins/secretogranins and other proteins."	( Chretien, M; Davis, DH; Jin, L; Kulig, E; Lloyd, RV; Qian, X; Scheithauer, BW; Seidah, NG; Young, WF, 1999)
"Pituitary adenomas are usually sporadic, although rare familial cases have been described."	( Alesse, E; Asteria, C; Beck-Peccoz, P; Bosman, C; Daniele, P; Di Stefano, D; Esposito, V; Ferrante, L; Ferretti, E; Gallucci, M; Gulino, A; Jaffrain Rea, ML; Tamburrano, G; Tiberti, C, 2001)
"Although pituitary adenomas are regarded as benign tumors, some of them behave aggressively with malignant behavior of invasion and metastasis."	( Asano, K; Miura, H; Nakano, T; Suzuki, S; Takahashi, T; Tanaka, M, 2001)
"However, most pituitary tumors are not associated with underlying hyperplasia."	( Ezzat, S, 2001)
"Pituitary tumors are frequently encountered intracranial neoplasms."	( Arafah, BM; Nasrallah, MP, 2001)
"A CRH-producing pituitary adenoma is a new type of Cushing's syndrome."	( Fujimoto, N; Fushimi, H; Inoue, T; Itatani, H; Kusaka, K; Ohashi, A; Okamoto, D; Sakaguchi, K; Tsujimura, T; Yamada, Y, 2002)
"About half of the pituitary adenomas are prolactinomas which are unique in a sense that medical therapy causes rapid tumor shrinkage and symptomatic improvement."	( Brabant, G; Bremer, M; Cuarezma, JS; Karstens, JH; Lenarz, T; Samii, M; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A, 2002)
"Pituitary adenomas are rare in young patients."	( Gomes, MC; Knoepfelmacher, M; Melo, ME; Mendonca, BB, 2004)
"Pituitary adenomas are neuroendocrine tumors that produce different endocrine and metabolic alterations, including hyperprolactinemia, acromegaly and Cushing's disease."	( Arzt, E; Echenique, C; Giacomini, D; Holsboer, F; Paez-Pereda, M; Stalla, GK, 2005)
"Because pituitary tumors are almost always benign, there has been little interest in their cytokeratin profile."	( Coons, SW; Estrada, SI; Gamez, R; White, WL, 2005)
"Pituitary carcinomas are extremely rare."	( Kars, M; Pereira, AM; Roelfsema, F; Romijn, JA, 2006)
"Pituitary tumors are common intracranial neoplasms that often result in endocrine dysfunction due to hormone overproduction or deficiencies from mass effects."	( Ertel, J; Kleinschmidt-Demasters, BK; Lillehei, K; Matsuoka, I; Nielsen-Preiss, S; Shorts-Cary, L; Wierman, ME; Xu, M, 2007)
"Prolactin-secreting pituitary adenomas are one of the most common causes of infertility in women."	( Bowsher, T; Chatfield, J; Loskutoff, N; O'Neill, K; Ramey, J; Zhang, L, 2006)
"Pituitary adenomas are clinically diagnosed based on radiologic studies and/or secondary effects of hormone production."	( Jarzembowski, J; Lloyd, R; McKeever, P, 2007)
"Apoplexy of a pituitary adenoma is a rare and under-diagnosed clinical occurrence."	( Benvenuti, L; Carnesecchi, S; Chibbaro, S; Faggionato, F; Gagliardi, R, 2007)
"Pituitary adenoma is a rare neoplasm in childhood, with prolactin and adrenocorticotropic hormone (ACTH)-secreting adenomas predominating in this age group."	( Kim, SK; Lee, SJ; Min, HS; Park, SH, 2007)
"Pituitary carcinomas are very rare tumors, nearly always presenting as widely invasive masses, although the hallmark of these lesions is the finding of distant metastases."	( De Tommasi, A; De Tommasi, C; Guastamacchia, E; Losa, M; Luzzi, S; Resta, F; Sabbà, C; Tafaro, E; Terreni, MR; Triggiani, V, 2007)
"If a pituitary adenoma is present, the possibility of a coincidental aneurysm should always be considered."	( Hayashi, S; Inoue, Y; Matsumoto, Y; Okawara, M; Okawara, S; Yamaguchi, H, 2007)
"Pituitary tumors are common and usually grow insidiously over many years."	( Heaney, AP, 2007)
"Conversely, pituitary tumors are hypomethylated, particularly in females where MAGE-A3 expression is nearly thrice higher than in males."	( Asa, SL; Ezzat, S; Zhu, X, 2008)
"Aggressive pituitary adenomas are notoriously difficult to manage due to their size, invasiveness, speed of growth and high frequency of recurrence."	( Buchfelder, M, 2009)
"Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors."	( Lebrun, JJ, 2009)
"The pituitary tumors are gonadotropin-positive and the ovarian tumors are sex cord (less differentiated) and granulosa cell tumors (differentiated and estrogen secreting)."	( Andersson, LC; Cheng, G; Fan, X; Gabbi, C; Gustafsson, JA; Kim, HJ; Warner, M, 2010)
"Pituitary carcinomas are rare and neurosurgically challenging lesions, as they commonly relapse after surgical removal."	( Back, W; Bode, H; Brockmann, MA; Hammes, HP; Lammert, A; Seiz, M; Thomé, C, 2010)
"Whereas most pituitary adenomas are removable via the transsphenoidal approach, certain cases, such as dumbbell-shaped or suprasellar adenomas and recurrent and/or fibrous tumors, remain difficult to treat."	( Cappabianca, P; Cavallo, LM; Corriero, OV; Di Maio, S; Esposito, F; Stagno, V, 2011)
"Pituitary carcinomas are rare and largely unresponsive to current treatment options."	( Borson-Chazot, F; Ducray, F; Favrel, V; Honnorat, J; Jouanneau, E; Raverot, G; Trouillas, J; Wierinckx, A, 2012)
"Pituitary tumors are common intracranial neoplasms, yet few germline abnormalities have been implicated in their pathogenesis."	( Asa, SL; Ezzat, S; Mayr, T; Tateno, T; Ullrich, A; Zheng, L, 2011)
"Pituitary adenomas are rare benign tumours in children with macroadenomas observed mainly in boys."	( Cottier, JP; François, P; Gilbert-Dussardier, B; Girard, JJ; Jan, M; Lecomte, P; Richard, S; Trouillas, J; Tudorancea, A, 2012)
"Pituitary carcinomas are rare, accounting for about 0."	( Brue, T; Castinetti, F; Dufour, H; Figarella-Branger, D; Jouanneau, E; Morange, I; Raverot, G; Trouillas, J, 2012)
"Pituitary tumors are a common form of endocrine neoplasia."	( El Mahdy, MM; Hewedi, IH; Osman, WM, 2011)
"Pituitary tumors are classified into typical adenomas, atypical adenomas or carcinomas."	( Alves, M; Bastos, M; Belo, F; Carvalheiro, M; Paiva, I; Rebelo, O, 2011)
"Gonadotroph pituitary adenomas are common, but the overwhelming majority are classified as nonfunctioning adenomas."	( Chamoun, R; Couldwell, WT; Layfield, L, 2013)
"Pituitary adenomas are the most common tumors of the sellar region, but the occurrence of spherical amyloid deposits in a pituitary adenoma is rare."	( Gonzalez-Toledo, E; Ishaq, S; Levine, SN; Nanda, A; Wilson, JD, 2013)
"Pituitary tumors are often detected only after death or at late stages of the disease when they are macroadenomas with a low surgical cure rate."	( Dierckx, RA; Elsinga, PH; Ishiwata, K; Kwizera, C; Marosi, K; Nyakas, CJ; Pruim, J; Ramakrishnan, NK; Rybczynska, AA; Sijbesma, JW; van Waarde, A; Visser, AK, 2013)
"Pituitary adenomas are often encased in a histological pseudocapsule that separates the tumor from the normal gland."	( Carrau, RL; de Lara, D; Ditzel Filho, L; Ebner, FH; Otto, BA; Prevedello, DM, 2013)
"The prevalence of pituitary adenoma is of 1/1000 and has been fora long time underestimated."	( Beckers, A; Daly, A; Vroonen, L, 2013)
"Pituitary adenomas are common intracranial neoplasms that generate symptoms as a result of either mass effect or the increased production of pituitary hormones."	( Bernays, R; Leske, H; Magagna-Poveda, A; Rushing, EJ; Schmid, C, 2013)
"Pituitary carcinoma is a rare disease with a challenge in both diagnosis and treatment."	( Ma, W; Wang, R; Xiao, J; Zhong, D; Zhu, Z, 2015)
"Pituitary carcinoma is extremely rare and difficult to diagnose early."	( Jiang, S; Yin, S; Zhong, C; Zhou, P, 2014)
"In general, pituitary tumors are benign with low mitotic activity."	( Hui, G; Li, H; Li, J; Wu, J; Zhang, C; Zhang, S; Zhang, T; Zhao, B, 2015)
"Pituitary tumors are amongst the most common intracranial neoplasms and are generally benign."	( Eloy, JA; Liu, JK; Patel, J, 2015)
"Pituitary adenoma is a common intracranial tumor in neurosurgery."	( Guo, X; Li, S; Liang, S; Liu, A; Xue, J; Zhang, Z, 2015)
"Aggressive pituitary tumors are rare but difficult to manage, as there is no effective chemotherapy to restrict their growth and cause their shrinkage."	( Auger, C; Chanal, M; Chevallier, P; Fonteneau, G; Honnorat, J; Jouanneau, E; Lucia, K; Monteserin Garcia, JL; Rachwan, A; Raverot, G; Raverot, V; Theodoropoulou, M; Trouillas, J, 2016)
"Pituitary adenomas are benign intracranial neoplasms that are frequently well-controlled with standard treatments that include surgical resection, radiotherapy, and agents that modulate hormonal excess."	( DeAngelis, LM; Lin, AL; Sum, MW, 2016)
"Pituitary tumors are the most frequent intracranial tumor and classically considered as benign."	( Lasolle, H; Raverot, G, 2016)
"Pituitary adenomas are the commonest intracranial tumor, but metastases are rare (0."	( Arnal, AV; Donovan, LE; Odia, Y; Wang, SH, 2016)
"Although pituitary adenomas are considered benign lesions, a small group may show clinically aggressive behavior, sometimes independently from the classic markers of aggressiveness, including the Ki67 labeling index or p53 expression."	( Abbritti, RV; Angileri, FF; Baldari, S; Barresi, V; Cannavò, S; Conti, A; Esposito, F; Ferraù, F; Germanò, A; Priola, SM; Tomasello, F, 2017)
"Pituitary adenomas are classified as typical or atypical, invasive or noninvasive, and aggressive or nonaggressive based on pathological features, radiological findings, and clinical behavior."	( Bao, X; Dai, C; Deng, K; Feng, M; Lian, W; Liu, X; Ma, S; Ma, W; Sun, B; Wang, R; Wang, Y; Xing, B; Yao, Y; Zhong, D, 2016)
"Pituitary adenomas are a group of tumors arising from the pituitary gland: they may be subdivided in functional or non-functional, depending on their hormonal activity."	( Agostinelli, E; Altissimi, G; Artico, M; Bardella, L; Giangaspero, F; Minni, A; Parnigotto, PP; Pastore, FS; Spoletini, M; Taurone, S; Tombolini, M; Wierzbicki, V, 2017)
"Pituitary tumors are the most common primary intracranial neoplasms."	( Asad, AS; Candolfi, M; Gottardo, MF; Imsen, M; Jaita, G; Pidre, ML; Romanowski, V; Seilicovich, A; Zuccato, C, 2018)
"Pituitary adenoma is a common intracranial neoplasm that is observed in approximately 10% of unselected individuals at autopsy."	( Chack, AC; Dennison, KL; Harenda, QE; Hickman, MP; Shull, JD, 2018)
"Pituitary tumors are generally intracranial neoplasms with high incidence and mortality rates."	( Ding, J; He, C; Jiang, Y; Li, S; Teng, L; Wu, H; Xiong, Y; Yang, J; Zhou, F, 2018)
"Pituitary adenoma is the most common tumor with a high recurrence rate due to a hormone-dependent JAK/signal transducer and activator of transcriptions (STAT) signaling."	( Arisan, ED; Ayhan-Sahin, B; Coker-Gurkan, A; Keceloglu, G; Obakan-Yerlikaya, P; Palavan-Unsal, N, 2019)
"Tumor recurrence in pituitary adenomas is as high as 20% after surgery."	( Cho, SS; Lee, JYK, 2019)
"Double pituitary adenomas are a rare occurrence."	( Alvarado, M; Carlo-Chevere, VJ; Collazo-Gutiérrez, N; de Jesús, O; González, L; Ramírez, M; Villamil-Jarauta, M, 2019)
"Nonfunctioning pituitary adenoma is a common intracranial tumor."	( Feng, S; Han, S; Jiang, W; Lu, Y; Ma, E; Sun, X, 2020)
"Pituitary adenomas are commonly benign tumours and should benefit from the least invasive approach."	( Baussart, B; Declerck, A; Gaillard, S, 2021)
"Pituitary adenomas are common benign tumors of the pituitary gland with an overall estimated prevalence of 16."	( Mathur, M, 2020)
"Pituitary adenoma is a tumor that can cause hormonal secretion problems, including hypocortisolism."	( Hidayati, HB; Qonita, NN, 2021)
"Pituitary tumors are generally benign, although in rare cases aggressive pituitary tumors (APTs) and carcinomas present important diagnostic and therapeutic challenges and are associated with a high mortality rate."	( Ilie, MD; Jouanneau, E; Lasolle, H; Raverot, G; Vasiljevic, A, 2022)
"Pituitary adenoma is a clinical syndrome in which excessive production of pituitary corticotropin (ACTH)."	( Lin, Y; Meng, L; Qu, X; Wang, W; Yang, J, 2023)
"Pituitary adenoma is the second most common primary brain tumor."	( Gao, L; Guo, X; Lian, W; Ma, W; Pang, H; Wang, Y; Wang, Z; Xing, B; Zhang, D, 2022)
"Pituitary adenoma is the second most common primary brain tumor."	( Gao, L; Guo, X; Lian, W; Ma, W; Pang, H; Wang, Y; Wang, Z; Xing, B; Zhang, D, 2022)
"Pituitary adenoma is the second most common primary brain tumor."	( Gao, L; Guo, X; Lian, W; Ma, W; Pang, H; Wang, Y; Wang, Z; Xing, B; Zhang, D, 2022)
"Pituitary tumors are defined as refractory when resistance to optimal standard therapies including surgery, radiotherapy, and medical treatment is documented."	( Greenman, Y; Kolitz, T, 2023)
"Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell lineage and include functioning tumors, characterized by the secretion of pituitary hormones, and nonfunctioning tumors."	( Miller, KK; Tritos, NA, 2023)
"Pituitary adenomas are classified as either macroadenomas (≥10 mm) (48% of tumors) or microadenomas (<10 mm)."	( Miller, KK; Tritos, NA, 2023)
"Refractory pituitary adenomas are those that have progressed following standard of care treatments."	( Geer, EB, 2023)
"Pituitary carcinomas are thus clinically defined by the presence of craniospinal or distant metastases, typically developing several years after the first presentation."	( Tóth, M, 2023)

Excerpt	Reference
"Twenty unselected pituitary adenomas have been examined for proliferative indices (PIs), and anterior pituitary hormone expression."	( Carboni, P; Detta, A; Hitchcock, ER; Postans, R, 1992)
"Prolactin-secreting pituitary adenomas have only recently been recognised as distinct entities, but probably represent the most frequent type of secreting pituitary adenomas."	( Hall, R; McGregor, A; Scanlon, MF, 1982)
"Two groups of pituitary adenomas have been identified with high and low basal inositol phosphoinositide turnover."	( Jones, TH; Justice, SK; Kennedy, RL; Price, A, 1993)
"Pituitary adenomas have long been recognized as a common finding in geriatric rats (> 18 months old)."	( DeCubellis, J; Donnelly, T; Kiupel, M; Mayer, J; Sato, A, 2011)
"Some pituitary adenomas have the characteristics of invasive growth make them unable to be removed completely by surgery leading to easy relapse."	( Guo, X; Li, S; Liang, S; Liu, A; Xue, J; Zhang, Z, 2015)
"Pituitary adenomas have relatively high expression of vascular endothelial growth factor; therefore, bevacizumab, an antiangiogenic agent, has been used in a small number of aggressive or malignant pituitary tumors after recurrence."	( Hoostal, S; Lou, E; Peterson, RA; SantaCruz, KS; Touma, W; Wiernik, A, 2017)
"For the future, pituitary adenoma has to remain the "reasonable obsession" of efficient and optimistic therapists…."	( Bertagna, X, 2018)
"Although pituitary tumors have a high risk for spontaneous hemorrhage, the use of aspirin is not a risk for hemorrhage."	( Blackburn, SL; Ciavarra, B; Guttenberg, KB; Kole, MJ; Li, W; McIntyre, T; Yao, W, 2023)

Excerpt	Reference
"Clinically manifest pituitary adenomas affect approximately 1 in 1100 people and can be complicated by syndromes of hormone excess as well as visual field defects and hypopituitarism from mass effect in larger tumors."	( Miller, KK; Tritos, NA, 2023)

Excerpt	Reference
"Prolactin-secreting pituitary tumors can be induced in rats or mice by administration of estrogens; thyroid stimulating hormone-secreting tumors will occur in some mice after thyroid ablation by radioactive iodine."	( Russfield, AB, 1975)
"In the presence of a pituitary adenoma or in patients with hyperprolactinemia and amenorrhea and galactorrhea, bromocryptine treatment may cure sterility without pituitary complication during pregnancy."	( Claustrat, B; Gagnaire, JC; Hugues, B; Mornex, R; Orgiazzi, J, 1978)
"Hyperprolactinaemia, with and without pituitary tumors, causing amenorrhea and galactorrhea in females, and loss of libido and impotence in males, can be treated effectively by neurosurgical procedures in tumor cases, or by medical inhibition of hPRL-secretion with bromocryptin."	( Werder, VK, 1976)
"Four infertile women with pituitary adenoma were treated with human pituitary gonadotropins (HPG) in order to enable them to become pregnant."	( Gemzell, C, 1975)
"Levels of cAMP in DES-induced pituitary tumors were also high compared with levels in controls or in glands from estrogen-treated rats."	( De Nicola, AF; Pignataro, O; Piroli, G, 1992)
"TSH-secreting pituitary adenomas are treated with surgery and, if necessary, adjuvant pituitary radiotherapy."	( Davis, DH; Freeman, SL; Gharib, H; Horvath, E; Scheithauer, BW; Wynne, AG, 1992)
"A man with a prolactin secreting pituitary carcinoma was treated by surgery and radiotherapy."	( MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD, 1992)
"A patient with invasive basophilic pituitary adenoma is described, in whom the hypercortisolaemia and clinical features persisted despite two attempts to reduce the tumour mass by transfrontal pituitary surgery and external beam radiotherapy."	( Dash, RJ; Kak, VK; Khandekar, S, 1990)
"The management of non-functioning pituitary adenomas with bromocriptine is controversial, and surgical treatment is usually prescribed when the visual field is affected."	( Acosta, D; Astorga, R; García-Luna, PP; Leal-Cerro, A; Mazuelos, C; Montero, C; Pereira, JL; Trujillo, F, 1989)
"Significant shrinkage of pituitary tumors occurred in 7 previously untreated and 2 previously treated patients."	( Barkan, AL; Beitins, IZ; Hopwood, NJ; Kelch, RP, 1988)
"189 patients with secretory pituitary adenomas underwent medical therapy for the hypersecretory state."	( Corenblum, B, 1985)
"Growth of pituitary tumors is controlled with the administration of dopamine agonists such as bromocriptine and prospective studies have suggested that these drugs are now the preferred method of treatment for primary lesions and recurrences."	( Blackwell, RE; Dollar, JR, 1986)
"In addition, pituitary tumors were found in 29 of the 58 rats treated with the carcinogen alone, compared to only 3 of the 20 rats in the control groups."	( Ohshima, M; Ward, JM, 1986)
"MtT/W15 transplantable pituitary tumors from rats treated for 3 weeks with DES showed significant reduction in the extent of [3H]thymidine incorporation compared with tumor cells from untreated rats (2231 +/- 182 vs 172 +/- 17 dpm/10(5) cells; n = 3)."	( Coleman, K; Lloyd, RV; Schmidt, K; Wilson, BS, 1986)
"Ten patients with prolactin-secreting pituitary adenomas (prolactinoma) and visual dysfunction were treated primarily with bromocriptine."	( Bosley, TM; Moster, ML; Savino, PJ; Schatz, NJ; Sergott, RC; Snyder, PJ, 1985)
"An enhanced development of pituitary tumors was observed in virgin female mice of the C57 Leaden strain following repeated oral administration of synthetic progestins."	( Poel, WE, 1966)
"This puts the medical treatment of pituitary tumors on a sound scientific footing."	( Besser, GM; Wass, JA, 1983)
"Unlike other reported cases with pituitary tumors and rhinorrhea, our patient never had previous radiotherapy or surgery."	( Heffernan, LP; Holness, RO; Shlossberg, AH, 1984)
"We report a nonfunctioning pituitary adenoma, which remarkably regressed during and following bromocriptine therapy."	( Ichihara, K; Kageyama, N; Katoh, T; Kuwayama, A; Sasaki, F; Takahashi, T, 1984)
"Twenty-six cases of women with pituitary adenoma and seven cases of women with functional hyperprolactinemia were studied to evaluate the effects of neurosurgery and Bromocriptine treatment."	( Kageyama, N; Kimura, T; Kuwayama, A; Narita, O; Suzuki, M; Tomoda, Y, 1980)
"The effect on the size of the pituitary tumors was quantitated by planimetry of computed tomographic scans before and during treatment."	( Andersen, T; Karle, A; Wollesen, F, 1982)
"However, two cases with pituitary adenoma following long-term high dosage estrogen therapy was found."	( Gehring, WG; Kannengiesser, U; Niesert, S; Reitmann, I; Völker, W; von zur Mühlen, A, 1981)
"However, 2 cases with pituitary adenoma following long-term high dosage estrogen therapy were found."	( Gehring, WG; Kannengiesser, U; Niesert, S; Reitmann, I; Völker, W; von zur Mühlen, A, 1981)
"and Group III rats were implanted with pituitary tumors (MtT) secreting growth hormone while Group I received no further treatment after MNU."	( Ando, Y; Fujimoto, N; Ito, A; Kanin, GN; Kawamoto, K; Okamoto, T; Watanabe, H; Yamada, K, 1995)
"Sera and pituitary tumors were sampled on each treatment schedule."	( Arita, K; Eguchi, K; Ito, A; Kawamoto, K; Kurisu, K; Uozumi, T, 1995)
"Transsphenoidal removal of pituitary adenomas has become the accepted treatment for Cushing's disease."	( Carpenter, PC; Kane, LA; Laws, ER; Leinung, MC; Scheithauer, BW; Zimmerman, D, 1995)
"After adequate treatment of pituitary adenoma these are no contraindications for pregnancy, once fertility has returned."	( Kuntschen, F, 1995)
"65 consecutive women with pituitary adenomas who had not been previously treated with surgery or radiation were monitored during 111 pregnancies."	( Kleinberg, D; Kupersmith, MJ; Rosenberg, C, 1994)
"A significant shrinkage of pituitary adenoma was observed at the second CT scan performed in 7 of the 9 subjects treated for 6 months with bromocriptine-LAR."	( Ajossa, S; Cagnacci, A; Depau, GF; Guerriero, S; Mais, V; Melis, GB; Murgia, C; Paoletti, AM; Serra, GG, 1994)
"Most pituitary adenomas remain asymptomatic and do not require treatment."	( Doppman, JL; Hall, WA; Luciano, MG; Oldfield, EH; Patronas, NJ, 1994)
"Large prolactin-secreting pituitary adenomas with suprasellar extension are often complicated by visual field defects, for which surgical decompression is the accepted treatment."	( Crawford, PJ; Dewar, JH; Hall, K; Kendall-Taylor, P; Mbanya, JC; Mendelow, AD, 1993)
"Rats with GH3 pituitary tumors were treated with E2 in vivo and a GH3 pituitary cell line maintained in vitro were also analyzed for PKC activity after estrogen treatment."	( Lloyd, RV; Maeda, T, 1993)
"Six human pituitary adenoma cultures, characterized for estrogen and progesterone (Pg) receptors, were treated with 17 beta-estradiol (17 beta-E2), Pg and tamoxifen (TAM) at different concentrations, alone and in combination, for 2, 4 and 8 days."	( Bevilacqua, MG; Cantore, G; Carapella, CM; Caronti, B; Fraioli, B; Jaffrain-Rea, ML; Palladini, G; Petrangeli, E; Tamburrano, G, 1993)
"We conclude that calculating pituitary adenoma volume from MR data using the Softvu computer program is a highly reproducible technique, but that Nal-Glu GnRH is not an effective treatment for reducing gonadotroph adenoma size."	( Goncalves, RJ; Grossman, RI; McGrath, GA; Molitch, ME; Pavlou, SN; Rivier, J; Snyder, PJ; Udupa, JK; Vale, WW, 1993)
"Two established pituitary adenoma cell lines, AtT-20 and GH4C1, were treated with hypericin in tissue culture for defined periods following passage."	( Chen, ZH; Couldwell, WT; Gopalakrishna, R; Hamilton, HB; Hinton, DR; Law, RE; Su, YZ; Weiss, MH, 1996)
"Medical treatment of other pituitary adenomas is much more disappointing."	( Chanson, P, 1996)
"Eight patients with pituitary tumors were treated isocentrically with a combination of sagittal and transverse rotational arcs."	( Meinass, HJ; Rennicke, P; Rittmann, KL; Schulte, RW, 1996)
"If no visible pituitary adenoma is present or if the oCRH test is equivocal, bilateral simultaneous inferior petrosal sinus sampling with oCRH administration is necessary to distinguish between a pituitary and an ectopic source."	( Chrousos, GP; Cizza, G, 1997)
"41 cases of pituitary adenoma in pregnancy and their treatment before conception and outcomes of pregnancy were analyzed."	( Cheng, W; Zhang, Z, 1996)
"The causal linkage between the pituitary adenoma apoplexy and Gd-DTPA-administration is unclear."	( Klingmüller, D; Kristof, RA; Schramm, J; Springer, W; Wichers, M, 1997)
"In clinically nonfunctioning pituitary adenomas (NFPA), the efficacy of quinagolide treatment is controversial."	( Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Merola, B; Salvatore, M; Varrella, P, 1998)
"Hypopituitarism was the consequence of pituitary tumors treated surgically and/or with radiotherapy."	( al-Shoumer, KA; Chrisoulidou, A; Johnston, DG; Kousta, E; Lawrence, NJ; McCarthy, MI; Parker, KH, 1998)
"In patients with pituitary adenomas, the percent suppression of GH and alpha-subunit levels after 6-12 months of octreotide treatment (0."	( Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Marzullo, P; Pivonello, R; Salvatore, M; Varrella, P, 1999)
"PA is not a rare pituitary adenoma complication and its prognosis may be poor; baseline hormone levels showed a wide range of abnormalities of pituitary function; surgical treatment was required in the majority of patients and the prognosis was relatively good; on the contrary, the treatment with DXM only had high levels of mortality."	( da Motta, LA; da Motta, LD; de Lacerda, CM; de Mello, PA; Filho, MF; Neto, AP, 1999)
"The outcome of patients with pituitary adenomas who were treated surgically with or without postoperative radiotherapy was analyzed."	( Oruçkaptan, HH; Ozcan, OE; Ozgen, T; Senmevsim, O, 2000)
"While pituitary tumors can be induced in rats by the administration of estrogen, susceptibility to such tumors is highly strain dependent."	( Ying, C, 2000)
"The history of pituitary adenoma treatment shows, as in medicine in general, a succession of movements and counter movements."	( Landolt, AM, 1999)
"The use of antiestrogen therapy in pituitary adenomas, however, has not been explored."	( Alden, TD; Kaptain, GJ; Laws, ER; Lopes, MB; Simmons, NE; Vance, ML, 1999)
"Treatment of primary cultures of pituitary adenomas with phorbol 12-myristrate 13-acetate (PMA) resulted in an increase in pancreastatin (PST) secretion in most pituitary adenomas and increased PC1 mRNA and protein expression in gonadotroph adenomas, but not in other types of adenomas."	( Chretien, M; Davis, DH; Jin, L; Kulig, E; Lloyd, RV; Qian, X; Scheithauer, BW; Seidah, NG; Young, WF, 1999)
"To optimize and reduce the toxicity of pituitary adenoma irradiation, we evaluated the feasibility and effectiveness of fractionated stereotactic radiotherapy (FSR) in 51 patients with functional adenoma; 12 of them had Cushing's disease."	( Bazin, A; Bernard, MH; Caron, J; Colin, P; Delemer, B; Longuebray, A; Nakib, I; Peruzzi, P; Petel, F; Redon, C; Rousseaux, P; Scavarda, D; Scherpereel, B, 2002)
"It is still difficult to differentiate pituitary adenoma remnants from postradiotherapy fibrosis by computed tomography (CT) or magnetic resonance imaging (MRI), especially in patients with clinically nonfunctioning pituitary adenomas (NFA), lacking circulating markers to follow disease progression or cure."	( Colao, A; Ferone, D; Lastoria, S; Lombardi, G, 2002)
"About half of the pituitary adenomas are prolactinomas which are unique in a sense that medical therapy causes rapid tumor shrinkage and symptomatic improvement."	( Brabant, G; Bremer, M; Cuarezma, JS; Karstens, JH; Lenarz, T; Samii, M; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A, 2002)
"To study the regulation of 7B2 in human pituitary tumors, we used a cell line derived from a human pituitary adenoma (HP75) that has been shown to express 7B2, PC1, PC2, and TGFbeta receptors to analyze the effects of TGFbeta1 and the histone deacetylase inhibitor (HDACI) sodium butyrate (NaB) treatment on 7B2 mRNA expression along with the neuroendocrine-specific proconvertases 1/3 (PC1) and PC2 mRNA and protein expression."	( Bayliss, JM; Hidehiro, O; Jin, L; Kobayashi, I; Lloyd, RV; Ruebel, KH, 2003)
"The detection of recurrent pituitary adenoma by magnetic resonance imaging (MRI) is rendered uncertain by the tissue remodelling that follows surgery or radiotherapy."	( Corvilain, B; David, P; Devriendt, D; Dumarey, N; Goldman, S; Heureux, M; Levivier, M; Massager, N; Tang, BN; Wikler, D, 2006)
"Radiotherapy for pituitary adenomas frequently leads to GH deficiency (GHD)."	( Biermasz, NR; Corssmit, EP; Frolich, M; Iranmanesh, A; Pereira, AM; Roelfsema, F; Romijn, JA; Smit, JW; van der Klaauw, AA; van Thiel, SW; Veldhuis, JD, 2006)
"Human pituitary adenoma cells and rat pituitary cell line (GH3) were cultured and treated in vitro with octreotide and the broad-spectrum SST agonist SOM230 (pasireotide)."	( Ciccarelli, E; Czirják, S; Gaia, D; Góth, MI; Grossman, AB; Hanson, MR; Hanzély, Z; Hubina, E; Jordan, S; Khalaf, S; Korbonits, M; Losa, M; Nagy, GM; Nanzer, AM; Papotti, M; Terreni, MR, 2006)
"We have used PET in pituitary tumors for in vivo characterization with respect to metabolism, 11C-L-methionine and 18F-fluorodeoxyglucose, receptor properties, 11C-N-methylspiperone and 11C-raclopride, and monoamine oxidase B enzyme content, 11C-L-deprenyl; further, for diagnosing and outlining the tumors in differential diagnostic perspectives and in the follow-up of treatment."	( Muhr, C, 2006)
"In contrast to other pituitary tumors that are mainly treated by surgery, medical treatment with dopamine agonists is the principal therapeutic option in prolactinomas."	( Christ, ER; Jenni, S; Seiler, R; Stettler, C, 2006)
"All olfactory neuroblastoma and 2 pituitary adenoma received radiotherapy after operation."	( Han, DM; Wei, YX, 2008)
"Three cases of patients with pituitary adenomas who underwent temozolomide treatment are presented."	( Cusimano, MD; Kovacs, K; Mason, W; Mohammed, S; Smyth, H, 2009)
"However, nonfunctioning pituitary adenomas (NFAs) are still orphans of medical therapy."	( Ambrosio, MR; Buratto, M; Degli Uberti, EC; Filieri, C; Lapparelli, M; Minoia, M; Scanarini, M; Tagliati, F; Zatelli, MC, 2010)
"To investigate the anti-pituitary adenoma effect of secalonic acid D (SAD) extracting from marine microorganisms, we used MTT colorimetric method to evaluate the proliferation of GH3 cells treated by SAD, the time- and dose-dependent effects and the value of IC50 were recorded."	( Liao, G; Mao, Z; She, Z; Wang, H; Xiao, W; Zhou, J; Zhu, Y, 2010)
"Eight patients, five with pituitary carcinomas (three prolactin (PRL) and two ACTH) and three with aggressive pituitary tumors (one PRL and two ACTH), all treated with temozolomide administered orally for four to 24 cycles, were included in our French multicenter study."	( Assaker, R; Bernier, M; Borson-Chazot, F; Brue, T; Caron, P; Chabre, O; Chanson, P; Cornélius, A; Cortet-Rudelli, C; de Fraipont, F; Dufour, H; Figarella-Branger, D; François, P; Gaillard, S; Jouanneau, E; Muller, M; Passagia, JG; Raverot, G; Salenave, S; Sturm, N; Trouillas, J, 2010)
"Seven patients with aggressive pituitary tumors have been treated with temozolomide."	( Bush, ZM; Cunningham, T; Jane, JA; Laws, ER; Longtine, JA; Lopes, MB; Schiff, D; Thorner, MO; Vance, ML, 2010)
"Adrenocorticotropic hormone-secreting pituitary adenomas predominantly express sst(5), followed by sst(2) and sst(1), suggesting that pasireotide may be effective in the treatment of Cushing's disease."	( Pedroncelli, AM, 2010)
"Whereas most pituitary adenomas are removable via the transsphenoidal approach, certain cases, such as dumbbell-shaped or suprasellar adenomas and recurrent and/or fibrous tumors, remain difficult to treat."	( Cappabianca, P; Cavallo, LM; Corriero, OV; Di Maio, S; Esposito, F; Stagno, V, 2011)
"Among pituitary adenomas, thyrotropinomas were previously considered as extremely rare and resistant to therapy."	( Azzoug, S; Bertagna, X; Billaud, L; Latrech, H; Le Marois, E; Raffin-Sanson, ML; Rousseau, A, 2010)
"Patients with successful surgery for pituitary adenomas show also in comparison with other chronically ill patients an increased risk for deficits in certain aspects of cognitive function, including attention and working memory, supporting the relevance of the brain lesion and its treatment for these dysfunctions."	( Besemer, B; Gallwitz, B; Häring, HU; Klingberg, S; Leyhe, T; Müssig, K; Saur, R, 2011)
"Mean tumor size of all 16 pituitary adenomas before treatment was 7."	( Astner, ST; Grosu, AL; Jacob, V; Kopp, C; Molls, M; Poullos, N; Theodorou, M, 2012)
"Treatment of prolactin-secreting pituitary adenomas by dopamine agonists is highly effective and currently is used as basic treatment in most cases, however, literature sources practically do not contain data about possible complications of this therapy."	( Astaf'eva, LI; Kadashev, BA; Kalinin, PL; Kutin, MA, 2011)
"Many pituitary adenoma patients, particularly those with macroprolactinomas, tend to have anemia and may need rhEPO therapy."	( Fan, B; Gu, X; Li, T; Xiao, Z; Yang, J, 2012)
"Prolactinoma is the most common pituitary adenoma, and dopamine agonists( BRC, and CAB) is the primary therapy."	( Bilge, A; Kurtulmus, N; Yarman, S, 2012)
"Patients undergoing pituitary adenoma or Rathke cleft cyst (RCC) removal are often administered perioperative glucocorticoids regardless of lesion size and preoperative adrenocorticotropic hormone/cortisol levels."	( Barnett, P; Chaloner, C; Cohan, P; Eisenberg, A; Kelly, DF; McLaughlin, N, 2013)
"Fifteen patients with TSH-secreting pituitary adenomas (8 men and 7 women), who previously underwent incomplete surgical resection and/or adjuvant radiotherapy (n = 12) and failure of octreotide treatment (n = 15), followed between 2007 and 2010 in Beijing Tiantan Hospital were included in this study."	( Liang, D; Zhang, CF; Zhong, LY, 2012)
"Invasive pituitary adenomas (PAs) are often refractory to standard therapy and salvage treatment with temozolomide (TMZ)."	( Bao, X; Cai, F; Dai, C; Feng, M; Guo, K; Li, G; Lian, W; Liu, X; Ma, S; Ma, W; Wang, J; Wang, R; Xiao, J; Xing, B; Yang, Y; Yao, Y; Zhang, B; Zhang, H, 2013)
"Invasive pituitary adenomas (PAs) are generally refractory to conventional therapy and salvage treatment with temozolomide (TMZ)."	( Bao, X; Cai, F; Dai, C; Deng, K; Feng, M; Guo, K; Jiao, Y; Junji, W; Lian, W; Liu, X; Ma, S; Wang, R; Wei, Z; Xing, B; Yang, Y; Yao, Y; Zhang, B, 2013)
"The Japan Society of Hypothalamic and Pituitary Tumors study suggests that MSH6, one of mismatch repair pathway enzyme, fulfills a contributory role to the efficacy of TMZ treatment for pituitary carcinomas and atypical adenomas."	( Hirohata, T; Hoya, K; Ide, F; Ishii, Y; Matsuno, A; Miyamoto, S; Mizutani, A; Murakami, M; Nagashima, H; Nishido, H; Okinaga, H; Osamura, RY; Son, JH; Sugaya, M; Tahara, S; Teramoto, A; Yamada, S; Yamada, SM, 2014)
"One patient with slowly progressive pituitary carcinoma has stable disease 40 months after completing the planned 4 cycles of treatment."	( Aldridge, M; Bomanji, J; Fersht, N; Maclean, J; Short, S, 2014)
"Two patients with prostate cancer and pituitary tumors were treated with leuprolide and radiation therapy."	( Babbo, A; Bajramovic, S; Chandler, JP; Garnett, J; Kalapurakal, GT; Kalapurakal, JA; Liu, B, 2014)
"Two large pituitary tumors disappeared on MRI following long-term dopamine agonist therapy."	( Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G, 2014)
"Aggressive pituitary adenomas, defined from a clinical perspective, have earlier and more frequent recurrences and can be resistant to conventional treatments."	( Cusimano, MD; Di Ieva, A; Kovacs, K; Rotondo, F; Syro, LV, 2014)
"22 patients with pituitary adenomas were treated with transsphenoidal microsurgery and were included in this study."	( Elbelt, U; Klene, W; Sandow, N; Strasburger, CJ; Vajkoczy, P, 2015)
"Aggressive pituitary adenomas (PAs) are clinically challenging for endocrinologists and neurosurgeons due to their locally invasive nature and resistance to standard treatment (surgery, medical or radiotherapy)."	( Bertorelle, R; Boscaro, M; Ceccato, F; D'Avella, D; Denaro, L; Emanuelli, E; Gardiman, MP; Lombardi, G; Manara, R; Milanese, L; Occhi, G; Scanarini, M; Scaroni, C; Zagonel, V, 2015)
"Locally aggressive pituitary tumors (LAPT) and pituitary carcinomas respond poorly to conventional therapy and cytotoxic drugs."	( Andersen, M; Bengtsson, D; Berinder, K; Burman, P; Feldt Rasmussen, U; Hoybye, C; Johannsson, G; Maiter, D; Petersson, M; Ragnarsson, O; Rasmussen, ÅK; Schrøder, HD; van der Lely, AJ, 2015)
"However, some pituitary tumors exhibit clinically aggressive behavior that is characterized by tumor recurrence and continued progression despite repeated treatments with conventional surgical, radiation and medical therapies."	( Eloy, JA; Liu, JK; Patel, J, 2015)
"A primary hypoxia pituitary adenoma cell model was established and treated with DDR1 inhibitor nilotinib."	( Guo, X; Li, S; Liang, S; Liu, A; Xue, J; Zhang, Z, 2015)
"METHODS Forty patients with pituitary adenomas were treated with either binostril or mononostril endoscopic surgery."	( Ayyad, A; Conrad, J; Giese, A; Konerding, MA; Müller-Forell, W; Oertel, J; Omran, W; Weber, MM; Wüster, C, 2016)
"Aggressive pituitary tumors are rare but difficult to manage, as there is no effective chemotherapy to restrict their growth and cause their shrinkage."	( Auger, C; Chanal, M; Chevallier, P; Fonteneau, G; Honnorat, J; Jouanneau, E; Lucia, K; Monteserin Garcia, JL; Rachwan, A; Raverot, G; Raverot, V; Theodoropoulou, M; Trouillas, J, 2016)
"When neurosurgery for pituitary adenoma is contraindicated, radiotherapy is candidate as the second line of therapy."	( Stigliano, A; Toscano, V, 2016)
"Clinically nonfunctioning pituitary adenoma (NFPA) remains the only pituitary tumor subtype for which no effective medical therapy is available or recommended."	( Cooper, O; Gertych, A; Greenman, Y; Jonas-Kimchi, T; Melmed, S; Ram, Z; Robenshtok, E; Sagiv, N; Shimon, I; Stern, N; Yaish, I; Yuan, X, 2016)
"Descriptions of aggressive pituitary tumors and pituitary carcinomas have increased notably over the last decade following the first report on the successful treatment of pituitary carcinomas using temozolomide."	( Lasolle, H; Raverot, G, 2016)
"TMZ has an accepted role in treating pituitary carcinoma and adenomas if radiation and surgery have failed to control tumour growth."	( Halevy, C; Whitelaw, BC, 2017)
"BRC-treated pituitary adenoma cells mainly underwent autophagic cell death rather than apoptosis."	( Chen, Z; Geng, X; Li, J; Li, M; Li, Z; Ma, L; Sun, Q; Wang, Q, 2017)
"The optimal treatment of pituitary carcinomas (PC) is unknown."	( Hoostal, S; Lou, E; Peterson, RA; SantaCruz, KS; Touma, W; Wiernik, A, 2017)
"Because growth hormone-secreting pituitary adenoma (GH-PA) patients have a high incidence of diabetes frequently treated with metformin, we assessed the antitumor effect of metformin on GH-PA."	( An, J; Duan, L; He, J; Hu, J; Li, S; Pei, X; Shen, R; Yang, H; Zang, Z; Zhang, W; Zhang, Y; Zheng, X; Zhou, Z; Zhu, F, 2017)
"We use mouse pituitary adenoma cells (TtT/GF and AtT20 cells) as the experiment model and treated them with varying concentrations of triptolide."	( Chen, J; Lei, T; Li, R; Shu, K; Sun, W; Wang, J; Zhang, H; Zhang, Z, 2018)
"Aggressive pituitary adenomas and pituitary carcinomas are rare and demand multiple treatment strategies."	( Chen, C; Hu, Y; Jiang, S; Wang, M; Yin, S; Zhang, S; Zhou, P, 2017)
"We treated 3 patients with giant pituitary adenoma and 1 patient with pituicytoma."	( Kuga, D; Ogawa, K; Ozawa, H; Toda, M; Yoshida, K, 2019)
"Aggressive prolactin (PRL)-secreting pituitary adenomas that are resistant to conventional therapy with dopamine agonists, surgery, and radiation pose a therapeutic challenge."	( Bergsneider, M; Heaney, AP; Sergey, M; Wang, MB; Way, JS; Yong, WH; Zhang, D; Zhang, X, 2019)
"In very rare patients with a pituitary adenoma, particularly a macroadenoma that has not been surgically treated before pregnancy, or if a surgical remnant persists, or when acromegaly is revealed during pregnancy, tumor volume may increase and cause symptoms through a mass effect."	( Caron, P; Chanson, P; Vialon, M, 2019)
"Some functional pituitary tumors respond to drug therapy while other nonfunctional tumors require surgical intervention."	( Arguello, M; Levy, S; Macki, M; Rao, SD, 2019)
"Compared to other pituitary adenomas, secreting and non-secreting, where pituitary surgery is the recommended first-line treatment, men with prolactinomas will usually respond to medical treatment with no need for any additional treatment."	( Duskin-Bitan, H; Shimon, I, 2020)
"Treatment of hypothalamic/pituitary tumors in HBV carriers requires extensive care to avoid HBV reactivation as steroid therapy is required after surgery for hypothalamic/pituitary tumors."	( Kogure, T; Niizuma, K; Ogawa, Y; Tominaga, T, 2020)
"Aggressive pituitary adenomas (APAs) and pituitary carcinomas (PCs) are challenging for their invasive nature, resistance to treatment and recurrences."	( Barbot, M; Bellu, L; Ceccato, F; Gardiman, MP; Lizzul, L; Lombardi, G; Losa, M; Mazza, E; Regazzo, D; Scaroni, C, 2020)
"Aggressive pituitary adenomas (APAs) are, by definition, resistant to optimal multimodality therapy."	( Ahuja, CK; Bhansali, A; Das, L; Dhandapani, S; Dutta, P; Gupta, K; Gupta, N; Radotra, BD; Rai, A; Sood, R; Sreedharanunni, S; Tripathi, M; Vaiphei, K; Walia, R, 2021)
"Aggressive pituitary adenomas (APAs) are pituitary tumors that are refractory to standard treatments and carry a poor prognosis."	( Bhabhra, R; Forbes, JA; Golnik, K; Hagen, M; Lin, AL; Mahammedi, A; Manzoor, S; Pater, L; Rothman, Y; Sengupta, S; Shah, S, 2022)
"Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with regard to clinical presentation, proliferative markers, clinical course, and response to therapy."	( Burman, P; Casar-Borota, O; Dekkers, OM; Perez-Rivas, LG, 2023)
"Twenty-five patients with a pituitary adenoma were administered 12."	( Hasegawa, M; Hayakawa, M; Hirose, Y; Lee, JKY; Mine, Y; Murayama, K; Muto, J; Nishiyama, Y, 2023)
"Refractory pituitary adenomas are those that have progressed following standard of care treatments."	( Geer, EB, 2023)
"For patients with pituitary adenomas with an intact hypothalamus-pituitary-adrenal axis before surgery, whether routine steroid therapy is needed is still controversial."	( Liang, B; Lin, F; Qin, M; Su, Y; Zhang, X, 2023)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	3345 (42.98)	23.3326
1990's	1624 (20.87)	12.5806
2000's	1211 (15.56)	18.1394
2010's	1164 (14.96)	28.8240
2020's	438 (5.63)	9.53

Drug	Relationship Strength	Studies	Trials
dinitrochlorobenzene	low	1	0
gamma-aminobutyric acid	medium	10	1
aminolevulinic acid	medium	5	1
acetic acid	low	1	0
acetone	low	1	0
adenine	low	2	0
allantoin	low	1	0
ammonium hydroxide	low	2	0
quinacrine	low	1	0
benzene	low	2	0
bromide	low	1	0
butyric acid	low	5	0
cadaverine	low	5	0
carbon monoxide	low	1	0
carnitine	low	1	0
methane	low	1	0
choline	low	12	0
chlorine	low	19	0
salicylic acid	low	9	0
gallic acid	low	2	0
octanoic acid	low	1	0
hydrogen sulfide	low	2	0
3-hydroxybutyric acid	low	2	0
bupropion	low	1	0
n(1)-methylnicotinamide	low	1	0
guaiacol	low	1	0
3,4-dihydroxyphenylacetic acid	low	3	0
creatine	low	5	0
cytosine	low	4	0
lactic acid	medium	2	1
dimethyl sulfoxide	low	3	0
formaldehyde	low	5	0
hexachlorocyclohexane	low	1	0
glycine	low	7	0
glycerol	low	6	0
dalteparin	low	1	0
histamine	low	2	0
hydrogen	low	5	0
imidazole	low	1	0
indoleacetic acid	low	1	0
iodine	low	28	0
dihydroxyphenylalanine	low	22	0
racemethionine	low	1	0
methanol	low	3	0
phytic acid	low	2	0
inositol	low	14	0
melatonin	low	30	0
nickel	low	3	0
niacinamide	medium	7	1
niacin	medium	2	1
nitrites	low	2	0
nitrous oxide	medium	3	2
orotic acid	low	1	0
palmitic acid	low	1	0
phosphoenolpyruvate	low	1	0
phosphorylethanolamine	low	1	0
putrescine	low	6	0
pyridoxal phosphate	low	1	0
pyridoxine	low	1	0
sulfites	low	1	0
spermidine	low	7	0
spermine	low	7	0
succinic acid	low	3	0
taurine	low	1	0
uric acid	low	2	0
urea	low	11	0
gallopamil	low	6	0
sk&f-38393	low	2	0
vanilmandelic acid	low	1	0
1,2-dimethylhydrazine	low	2	0
1,2-dioctanoylglycerol	low	3	0
1-anilino-8-naphthalenesulfonate	low	3	0
edelfosine	low	1	0
pd 173074	low	1	0
14,15-epoxy-5,8,11-eicosatrienoic acid	low	1	0
2,4-dinitrophenol	low	2	0
amitrole	low	2	0
3-aminobenzamide	low	1	0
3-methylcholanthrene	low	5	0
ro 5-4864	low	2	0
4-aminopyridine	low	3	0
homovanillic acid	low	1	0
phenytoin	low	6	0
5,8,11,14-eicosatetraynoic acid	low	2	0
hydroxyindoleacetic acid	low	4	0
2,2'-azobis(2-amidinopropane)	low	1	0
acetazolamide	low	3	0
tyrphostin a23	low	1	0
alprenolol	low	1	0
amantadine	low	1	0
aminoglutethimide	low	5	0
theophylline	low	14	0
amiodarone	low	4	0
dan 2163	low	5	0
amobarbital	low	1	0
anastrozole	low	2	0
antipyrine	low	1	0
aristolochic acid i	low	1	0
aspirin	low	5	0
atrazine	low	2	0
azathioprine	low	2	0
baclofen	low	1	0
bay-k-8644	low	33	0
benserazide	low	2	0
benzamide	medium	1	1
benzo(a)pyrene	low	1	0
bisbenzimidazole	low	1	0
bisindolylmaleimide i	low	3	0
bromopride	low	1	0
bupivacaine	low	1	0
busulfan	low	2	0
caffeine	low	4	0
verapamil	low	22	0
calmidazolium	low	3	0
carbamazepine	low	6	0
carmustine	medium	4	1
carbonyl cyanide m-chlorophenyl hydrazone	low	2	0
cgp 12177	low	1	0
chelerythrine	low	2	0
chloral hydrate	low	1	0
chlorambucil	low	1	0
chlordiazepoxide	low	7	0
chloroquine	low	6	0
chlorpromazine	low	35	0
chlorpropamide	low	3	0
chlorzoxazone	low	1	0
ciclopirox	low	1	0
ciglitazone	low	1	0
cilostazol	low	2	0
cimetidine	low	10	0
ciprofloxacin	low	1	0
citalopram	low	1	0
clebopride	low	1	0
clofibrate	low	5	0
clonazepam	low	1	0
clonidine	medium	6	1
clotrimazole	low	1	0
cyproheptadine	low	31	0
dantrolene	low	1	0
dapi	low	1	0
dapsone	low	1	0
deferoxamine	low	1	0
amphetamine	low	1	0
eflornithine	low	1	0
diazepam	low	7	0
diazoxide	low	4	0
pentetic acid	medium	69	5
dipyridamole	low	2	0
disulfiram	low	2	0
valproic acid	medium	22	3
racemetirosine	low	5	0
domperidone	medium	45	2
donepezil	low	1	0
doxazosin	low	1	0
doxepin	low	1	0
e 4031	low	2	0
9-(2-hydroxy-3-nonyl)adenine	low	1	0
erythrosine	low	7	0
ether	low	1	0
etilefrine	low	1	0
carbonyl cyanide p-trifluoromethoxyphenylhydrazone	low	2	0
fenfluramine	low	1	0
fenofibrate	low	2	0
fentanyl	medium	8	2
fenthion	low	1	0
fluconazole	low	2	0
fluphenazine	low	2	0
fluorouracil	low	8	0
flurbiprofen	low	1	0
fluspirilene	low	1	0
flutamide	low	2	0
furosemide	low	4	0
gentamicin	low	1	0
glutaral	low	2	0
glyburide	low	3	0
go 6976	low	1	0
gossypol	low	1	0
guaifenesin	low	2	0
guanethidine	low	1	0
guanfacine	low	1	0
1-(5-isoquinolinesulfonyl)-2-methylpiperazine	low	2	0
haloperidol	low	25	0
halothane	low	4	0
hexestrol	low	1	0
hexobarbital	low	7	0
hydralazine	low	1	0
hydrochlorothiazide	low	1	0
p-hydroxyamphetamine	low	1	0
hydroxychloroquine	low	2	0
hypericin	low	3	0
lidocaine	medium	7	2
ifosfamide	low	2	0
imipramine	low	2	0
indomethacin	low	11	0
iodamide	low	1	0
iohexol	low	2	0
iopanoic acid	low	4	0
iothalamic acid	low	6	0
iodipamide	low	1	0
iproniazid	low	1	0
1-methyl-3-isobutylxanthine	low	31	0
isoflurane	medium	1	1
isoniazid	low	1	0
2-propanol	low	5	0
isoproterenol	low	29	0
isradipine	low	5	0
ketamine	medium	2	1
ketanserin	medium	2	1
ketoconazole	medium	32	2
khellin	low	1	0
lamotrigine	low	3	0
lavendustin a	low	1	0
letrozole	low	3	0
linopirdine	low	1	0
lomustine	low	3	0
lorazepam	low	2	0
losartan	low	1	0
ly 171883	low	1	0
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	low	4	0
mechlorethamine	low	1	0
vitamin k 3	low	1	0
meperidine	low	1	0
mephenesin	low	1	0
metformin	low	11	0
methadone	low	2	0
nocodazole	low	1	0
methylphenidate	low	2	0
metoclopramide	medium	73	1
metronidazole	low	1	0
metyrapone	medium	88	3
miconazole	low	1	0
midazolam	low	3	0
minoxidil	low	1	0
mirtazapine	low	1	0
mitotane	medium	18	1
modafinil	medium	1	1
monodansylcadaverine	low	4	0
muscimol	low	1	0
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide	low	1	0
n-bromoacetamide	low	1	0
ethylmaleimide	low	2	0
fenamic acid	low	1	0
apnea	low	1	0
activins	low	28	0
naphazoline	low	2	0
nicardipine	low	4	0
nifedipine	low	32	0
nimodipine	low	12	0
nisoldipine	low	3	0
nitrendipine	low	3	0
nomifensine	medium	41	1
ofloxacin	low	1	0
oxotremorine	low	7	0
pamidronate	low	1	0
papaverine	medium	1	1
pargyline	low	1	0
pd 98059	low	8	0
pentobarbital	low	1	0
perphenazine	low	10	0
phenobarbital	low	2	0
phenolsulfonphthalein	low	1	0
phenoxybenzamine	low	1	0
phloretin	low	2	0
pindolol	low	1	0
pioglitazone	low	2	0
pirenzepine	low	2	0
piribedil	low	1	0
potassium chloride	low	22	0
prazosin	low	1	0
proadifen	low	1	0
procaine	low	1	0
procarbazine	low	1	0
propidium	low	1	0
propofol	medium	19	9
propranolol	low	11	0
pyrimethamine	low	1	0
pf 5901	low	1	0
riluzole	low	1	0
risperidone	low	10	0
ritanserin	medium	1	1
rolipram	low	2	0
ropinirole	medium	2	1
saccharin	low	1	0
dpi 201-106	low	1	0
sevoflurane	medium	5	2
sodium fluoride	low	7	0
spiperone	low	31	0
stearic acid	low	2	0
vorinostat	low	1	0
succinylcholine	low	1	0
sulpiride	medium	35	1
sumatriptan	low	5	0
suramin	low	1	0
temozolomide	medium	131	1
tetracaine	low	1	0
tetraethylammonium	low	12	0
thalidomide	low	2	0
2,4-thiazolidinedione	low	2	0
thiethylperazine	low	1	0
thioridazine	low	2	0
thiotepa	low	2	0
thiram	low	1	0
thymeleatoxin	low	1	0
ticlopidine	low	1	0
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate	low	2	0
tolbutamide	low	2	0
trazodone	low	1	0
triazolam	low	1	0
trichlormethiazide	low	1	0
trifluoperazine	low	16	0
troglitazone	low	1	0
urethane	low	2	0
w 7	low	2	0
wb 4101	low	1	0
pirinixic acid	low	1	0
hydrocortisone acetate	low	2	0
mitomycin	low	3	0
corticosterone	low	52	0
prednisolone	low	18	0
estriol	low	9	0
reserpine	low	14	0
phentolamine	medium	5	1
sorbitol	low	5	0
thymidine	low	35	0
3,3',5-triiodothyroacetic acid	low	2	0
hydroxyproline	low	5	0
thyroxine	medium	309	3
dextroamphetamine	medium	4	1
carbachol	low	15	0
norethindrone acetate	low	2	0
spironolactone	low	5	0
aldosterone	medium	45	2
lynestrenol	low	2	0
tetrahydrocortisol	low	1	0
prednisone	low	26	0
estrone	low	26	0
androsterone	low	1	0
etiocholanolone	low	2	0
dehydroepiandrosterone	low	15	0
dichlororibofuranosylbenzimidazole	low	1	0
penicillin g	low	1	0
idoxuridine	low	2	0
pilocarpine	low	1	0
triiodothyronine	medium	254	4
diethylnitrosamine	low	1	0
isoflurophate	low	1	0
biguanides	low	1	0
alanine	low	4	0
serine	low	4	0
benz(a)anthracene	low	2	0
chloramphenicol	low	1	0
aspartic acid	low	7	0
glutamine	low	4	0
lysine	low	17	0
cyanides	low	1	0
physostigmine	low	1	0
sucrose	low	1	0
ethinyl estradiol	low	25	0
testosterone propionate	low	1	0
tubocurarine	low	1	0
9,10-dimethyl-1,2-benzanthracene	low	5	0
apomorphine	low	16	0
aminopyrine	low	8	0
tetrabenazine	low	2	0
adenosine diphosphate	low	3	0
2,3,4,6-tetrachlorophenol	low	1	0
uridine	low	8	0
kanamycin a	low	1	0
bromodeoxyuridine	low	21	0
galactose	medium	8	1
carbostyril	low	8	0
phenylephrine	low	1	0
levodopa	medium	80	1
edetic acid	low	9	0
p-dimethylaminoazobenzene	low	1	0
phenylethyl alcohol	low	1	0
tyrosine	low	14	0
cysteamine	low	4	0
adenosine monophosphate	low	2	0
methicillin	low	1	0
methylene blue	low	3	0
zoxazolamine	low	2	0
leucine	medium	17	1
ethyl methanesulfonate	low	2	0
aniline	low	1	0
2-aminoisobutyric acid	low	2	0
androstenedione	low	13	0
cytidine monophosphate	low	1	0
cytidine diphosphate	low	1	0
lactose	low	1	0
methionine	low	31	0
phenylalanine	low	6	0
desoxycorticosterone	low	28	0
colchicine	low	9	0
cytidine	low	5	0
cytidine triphosphate	low	1	0
cycloheximide	low	36	0
egtazic acid	low	25	0
barbituric acid	low	1	0
norethindrone	low	8	0
norethynodrel	low	3	0
17-alpha-hydroxyprogesterone	low	2	0
ampicillin	low	2	0
mannitol	low	1	0
cytarabine	low	5	0
ornithine	low	2	0
asparagine	low	3	0
histidine	low	1	0
medroxyprogesterone acetate	low	2	0
valine	low	4	0
threonine	low	4	0
mestranol	low	3	0
dichlorodiphenyldichloroethane	low	4	0
cordycepin	low	1	0
tryptophan	low	9	0
arginine	medium	50	1
methyl chloride	low	1	0
trichloroacetic acid	low	2	0
triamcinolone acetonide	low	19	0
phencyclidine	low	1	0
dimethyl sulfate	low	1	0
tromethamine	low	1	0
triparanol	low	1	0
trichloroethylene	low	1	0
tetrabromobisphenol a	low	1	0
bisphenol a	low	4	0
methylprednisolone	low	8	0
rotenone	low	1	0
fluorene	low	1	0
2,4,6-trimethylaniline	low	1	0
decalin	low	1	0
quinoxalines	low	2	0
phenidone	low	1	0
xanthenes	low	1	0
phenothiazine	low	2	0
4-butyrolactone	low	1	0
pyrrolidonecarboxylic acid	low	9	0
4-bromophenacyl bromide	low	1	0
ethylbenzene	low	1	0
styrene	low	1	0
pyridostigmine bromide	medium	4	1
n,n,n',n'-tetramethyl-4,4'-methylenedianiline	low	1	0
isethionic acid	low	1	0
vinyl acetate	low	1	0
pyrroles	low	4	0
thiophenes	low	2	0
ergotamine	low	2	0
estradiol dipropionate	low	3	0
diethylhexyl phthalate	low	2	0
1,4-naphthoquinone	low	1	0
meglumine	medium	20	4
dextrothyroxine	low	1	0
sodium cyanide	low	1	0
tetraphenylborate	low	1	0
pregnenolone	low	4	0
3-o-methylglucose	low	1	0
ditiocarb	low	2	0
potassium cyanide	low	1	0
catechin	low	2	0
perylene	low	3	0
benz(c)acridine	low	2	0
quinazolines	medium	8	1
acridines	low	3	0
indazoles	low	3	0
cyclopentane	low	4	0
isoxazoles	low	3	0
oxazoles	low	3	0
thiazoles	low	10	0
pyrazines	medium	3	2
ethynodiol diacetate	low	1	0
hydrazine	low	2	0
chlormadinone acetate	low	2	0
dexamethasone 21-phosphate	low	2	0
testosterone enanthate	low	1	0
azacitidine	low	11	0
aminoimidazole carboxamide	low	3	0
methysergide	low	3	0
citrulline	low	3	0
betamethasone	low	2	0
cyproterone acetate	low	4	0
nandrolone	low	1	0
2-aminopurine	low	1	0
hydantoins	low	1	0
fluorobenzenes	low	1	0
emetine	low	1	0
reticulin	low	6	0
bicuculline	low	2	0
alpha-aminopyridine	low	6	0
thiazolidines	low	1	0
cyanogen bromide	low	1	0
echothiophate iodide	low	1	0
hematoxylin	low	7	0
podophyllotoxin	low	2	0
medroxyprogesterone	low	7	0
dihydrotestosterone	medium	22	2
azomycin	low	1	0
methoxyhydroxyphenylglycol	low	1	0
myristic acid	low	1	0
eosine yellowish-(ys)	low	8	0
lithium carbonate	low	1	0

Protein Targets (3,905)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	167	0	0	167
thioredoxin reductase	180	0	0	180
ATAD5 protein, partial	130	0	0	130
GLS protein	134	0	0	134
TDP1 protein	333	0	0	333
regulator of G-protein signaling 4	129	0	0	129
67.9K protein	85	0	0	85
Parkin	39	0	0	39
bromodomain adjacent to zinc finger domain 2B	68	0	0	68
IDH1	97	0	0	97
euchromatic histone-lysine N-methyltransferase 2	301	0	0	301
nuclear factor erythroid 2-related factor 2 isoform 2	84	0	0	85
huntingtin isoform 2	37	0	0	37
ras-related protein Rab-9A	49	0	0	49
serine/threonine-protein kinase mTOR isoform 1	61	0	0	61
urokinase-type plasminogen activator precursor	61	0	0	61
plasminogen precursor	61	0	0	61
urokinase plasminogen activator surface receptor precursor	61	0	0	61
survival motor neuron protein isoform d	116	0	0	116
D(1A) dopamine receptor	34	4	0	38
Ataxin-2	139	0	0	139
ATP-dependent phosphofructokinase	140	0	0	140
Chain B, pheromone binding protein	0	0	1	1
Chain A, pheromone binding protein	0	0	1	1
Chain A, JmjC domain-containing histone demethylation protein 3A	75	0	0	75
Chain A, RNA-directed RNA polymerase NS5	0	2	0	2
acid sphingomyelinase	17	0	0	17
USP1 protein, partial	152	0	0	152
vitamin D3 receptor isoform VDRA	120	0	0	120
importin subunit beta-1 isoform 1	35	0	0	35
flap endonuclease 1	73	0	0	73
serine/threonine-protein kinase PLK1	25	0	0	25
snurportin-1	35	0	0	35
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	55	0	0	55
GTP-binding nuclear protein Ran isoform 1	21	0	0	21
DNA polymerase eta isoform 1	25	0	0	25
DNA polymerase iota isoform a (long)	102	0	0	102
geminin	281	0	0	281
DNA polymerase kappa isoform 1	83	0	0	83
fibroblast growth factor 22 isoform 1 precursor	0	0	0	3
Mitogen-activated protein kinase 13	0	3	9	12
Beta-lactamase	0	11	0	11
Transthyretin	0	5	6	13
Fatty acid-binding protein, intestinal	0	4	2	6
Fatty acid-binding protein, adipocyte	0	8	5	13
Cyclin-A2	0	9	0	10
Cannabinoid receptor 1	0	9	3	12
Cyclin-dependent kinase 2	0	18	27	47
Choline O-acetyltransferase	0	3	0	3
Mitogen-activated protein kinase 12	0	3	10	13
Guanine nucleotide-binding protein G	29	0	0	29
Fatty acid-binding protein 5	0	4	2	6
Fatty acid-binding protein 5	0	0	3	3
Mitogen-activated protein kinase 11	0	3	24	27
Mitogen-activated protein kinase 14	0	13	28	41
glucocerebrosidase	43	0	0	43
Alpha-mannosidase	0	2	0	2
alpha-galactosidase	28	0	0	28
Trehalase	0	1	0	1
lysosomal alpha-glucosidase preproprotein	32	0	0	32
Trehalase	0	1	0	1
Maltase-glucoamylase, intestinal	0	4	0	4
Trehalase	0	1	0	1
Lysosomal acid glucosylceramidase	0	2	1	3
Alpha-galactosidase A	0	1	0	1
Alpha-glucosidase MAL62	0	1	0	1
Lactase-phlorizin hydrolase	0	1	0	1
Lysosomal alpha-glucosidase	0	3	0	3
Beta-glucosidase A	0	1	0	1
Sucrase-isomaltase, intestinal	0	2	0	2
Alpha-1B adrenergic receptor	0	101	9	110
Sucrase-isomaltase, intestinal	0	3	0	3
Alpha-1D adrenergic receptor	0	55	9	66
Beta-glucosidase	0	1	0	1
Protein-lysine 6-oxidase	0	4	0	4
Alpha-mannosidase 2	0	1	0	1
Glycogen debranching enzyme	0	1	0	1
Glycogen debranching enzyme	0	1	0	1
Alpha-glucosidase MAL32	0	2	0	2
Alpha-1A adrenergic receptor	0	109	11	120
Oligo-1,6-glucosidase IMA1	0	1	0	1
Alpha-glucosidase MAL12	0	3	0	3
Oxysterols receptor LXR-beta	0	2	2	4
Spike glycoprotein	132	4	13	149
Alpha-amylase	0	1	0	1
Trehalose synthase/amylase TreS	0	1	0	1
Lactase-phlorizin hydrolase	0	1	0	1
Oxysterols receptor LXR-alpha	0	2	2	4
Neutral alpha-glucosidase AB	0	2	0	2
Ceramide glucosyltransferase	0	1	0	1
Lysosomal acid glucosylceramidase	0	1	0	1
Probable maltase-glucoamylase 2	0	2	0	2
Beta-glucosidase	0	1	0	1
Lysosomal alpha-glucosidase	0	2	0	2
Cytosolic beta-glucosidase	0	1	0	1
Non-lysosomal glucosylceramidase	0	1	0	1
Putative alpha-glucosidase	0	1	0	1
Chain A, Cruzipain	57	0	0	57
Platelet-activating factor receptor	1	4	0	6
Inositol monophosphatase 1	59	0	0	59
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	1	0	1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
Chain A, Phosphodiesterase 9A	0	1	0	1
Chain A, Class I phosphodiesterase PDEB1	0	1	0	1
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	1	0	1
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera	0	1	0	1
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera	0	1	0	1
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	1	0	1
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	1	0	1
glp-1 receptor, partial	86	0	0	86
thyroid stimulating hormone receptor	135	0	0	135
estrogen-related nuclear receptor alpha	282	0	0	282
Phosphodiesterase	0	5	0	5
mitogen-activated protein kinase 1	95	0	0	95
cytochrome P450 3A4 isoform 1	156	0	0	156
histone acetyltransferase KAT2A isoform 1	112	0	0	112
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	10	0	10
Gamma-aminobutyric acid receptor subunit pi	156	28	6	190
Monocarboxylate transporter 4	0	2	0	2
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	6	0	6
cGMP-specific 3',5'-cyclic phosphodiesterase	0	11	0	12
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	0	2	0	2
Renin	0	9	3	12
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	6	0	6
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	4	0	5
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	4	0	5
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	4	0	6
Gamma-aminobutyric acid receptor subunit beta-1	156	28	6	190
Gamma-aminobutyric acid receptor subunit delta	156	28	6	190
Gamma-aminobutyric acid receptor subunit gamma-2	156	28	8	192
Gamma-aminobutyric acid receptor subunit alpha-5	156	28	6	190
Gamma-aminobutyric acid receptor subunit alpha-3	156	28	6	190
Gamma-aminobutyric acid receptor subunit gamma-1	156	29	6	191
Gamma-aminobutyric acid receptor subunit alpha-2	156	28	6	190
Adenosine receptor A1	2	20	2	31
Gamma-aminobutyric acid receptor subunit alpha-4	156	28	6	190
Gamma-aminobutyric acid receptor subunit gamma-3	156	28	6	190
Adenosine receptor A3	0	6	0	6
Adenosine receptor A2a	0	25	7	37
Adenosine receptor A2b	0	2	1	8
Adenosine receptor A2b	0	8	2	12
Gamma-aminobutyric acid receptor subunit alpha-6	156	28	6	190
Adenosine receptor A1	0	24	6	38
Adenosine receptor A2a	0	21	4	34
Sodium-dependent serotonin transporter	0	25	2	28
Adenosine receptor A2a	0	3	0	3
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	4	0	5
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	8	0	9
Gamma-aminobutyric acid receptor subunit alpha-1	156	29	8	193
Gamma-aminobutyric acid receptor subunit beta-3	156	28	6	190
Gamma-aminobutyric acid receptor subunit beta-2	156	28	8	192
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	6	0	6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	8	0	9
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	3	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	13	1	15
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	17	1	19
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	14	0	15
Voltage-dependent L-type calcium channel subunit alpha-1C	0	41	1	43
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	5	0	5
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	11	0	12
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	15	0	16
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	3	0	3
Phosphodiesterase	0	1	0	1
GABA theta subunit	156	28	6	190
Phosphodiesterase	0	3	0	3
Gamma-aminobutyric acid receptor subunit epsilon	156	28	6	190
cAMP-specific 3',5'-cyclic phosphodiesterase 7B	0	3	0	3
Solute carrier family 22 member 1	0	6	0	10
Solute carrier family 22 member 2	0	20	0	28
Solute carrier family 22 member 1	0	43	0	59
Solute carrier family 22 member 2	0	3	0	5
Solute carrier family 22 member 3	0	13	0	15
Solute carrier family 22 member 3	0	3	0	5
POU domain, class 2, transcription factor 2	0	0	0	3
Sodium-dependent serotonin transporter	0	90	3	94
Solute carrier family 22 member 1	0	19	0	25
Solute carrier family 22 member 2	0	17	0	21
phosphopantetheinyl transferase	130	0	0	130
Chain A, Beta-lactamase	88	0	0	88
Epoxide hydrolase 1	0	0	0	5
Nitric oxide synthase, brain	0	8	1	10
Serine/threonine-protein kinase mTOR	0	16	16	32
Cytochrome P450 144	0	0	7	7
Glutaminyl-peptide cyclotransferase	0	7	0	7
Glutamate receptor ionotropic, NMDA 1	0	22	6	36
Glutamate receptor ionotropic, NMDA 2A	0	20	4	32
Glutamate receptor ionotropic, NMDA 2B	0	23	5	36
Glutamate receptor ionotropic, NMDA 2C	0	20	4	33
Dynamin-1	0	2	0	2
Glutamate receptor ionotropic, NMDA 2D	0	20	4	32
Glutamate receptor ionotropic, NMDA 3B	0	20	4	32
Glutamate receptor ionotropic, NMDA 3A	0	20	4	32
Luciferase	109	0	0	109
hypoxia-inducible factor 1 alpha subunit	100	0	0	100
RAR-related orphan receptor gamma	233	0	0	233
SMAD family member 2	96	0	0	96
SMAD family member 3	96	0	0	96
GLI family zinc finger 3	241	0	0	241
AR protein	316	0	0	316
caspase 7, apoptosis-related cysteine protease	59	0	0	59
estrogen receptor 2 (ER beta)	157	0	0	157
nuclear receptor subfamily 1, group I, member 3	206	0	0	206
retinoic acid nuclear receptor alpha variant 1	237	0	0	237
retinoid X nuclear receptor alpha	208	0	0	208
pregnane X nuclear receptor	221	0	0	221
estrogen nuclear receptor alpha	355	0	0	355
vitamin D (1,25- dihydroxyvitamin D3) receptor	167	0	0	167
caspase-3	59	0	0	59
aryl hydrocarbon receptor	123	0	0	123
thyroid stimulating hormone receptor	112	0	0	112
thyrotropin-releasing hormone receptor	29	0	0	29
v-jun sarcoma virus 17 oncogene homolog (avian)	135	0	0	135
Histone H2A.x	104	0	0	104
thyroid hormone receptor beta isoform a	95	0	0	95
histone deacetylase 9 isoform 3	24	0	0	24
nuclear factor erythroid 2-related factor 2 isoform 1	240	0	0	240
Voltage-dependent calcium channel gamma-2 subunit	143	0	0	143
Papain	0	2	0	2
DNA topoisomerase 1	0	6	2	11
Indoleamine 2,3-dioxygenase 1	0	12	1	14
Glutamate receptor 2	147	3	3	155
Carbon monoxide dehydrogenase small chain	0	0	1	1
Amine oxidase [flavin-containing] A	0	39	0	39
Amine oxidase [flavin-containing] B	0	32	3	35
Dual specificity protein phosphatase 1	0	2	0	2
M-phase inducer phosphatase 2	0	2	0	2
RAC-alpha serine/threonine-protein kinase	0	10	26	36
Alpha-synuclein	33	18	1	52
Dual specificity mitogen-activated protein kinase kinase 1	0	11	25	36
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	5	1	6
Genome polyprotein	0	3	0	3
Dual specificity protein phosphatase 6	0	2	0	2
Histone-lysine N-methyltransferase EHMT2	0	7	0	7
Histone-lysine N-methyltransferase EHMT1	0	4	0	4
acetylcholinesterase	107	0	0	107
pregnane X receptor	51	0	0	51
Microtubule-associated protein tau	141	0	0	141
progesterone receptor	179	0	0	179
glucocorticoid receptor [Homo sapiens]	258	0	0	258
farnesoid X nuclear receptor	163	0	0	163
G	144	0	0	144
arylsulfatase A	113	0	0	113
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	174	0	0	174
activating transcription factor 6	122	0	0	122
nuclear receptor subfamily 1, group I, member 2	37	0	0	37
chromobox protein homolog 1	193	0	0	193
lamin isoform A-delta10	225	0	0	225
Interferon beta	198	0	0	198
HLA class I histocompatibility antigen, B alpha chain	144	0	0	144
Glucocorticoid receptor	2	53	6	71
Sex hormone-binding globulin	0	1	22	23
Glycine receptor subunit alpha-1	0	48	0	48
Corticosteroid-binding globulin	0	17	0	17
Adenosine receptor A3	0	59	3	63
Replicase polyprotein 1ab	0	33	14	47
Androgen receptor	0	74	1	76
Glycine receptor subunit beta	0	48	0	48
Glycine receptor subunit alpha-2	0	48	0	48
Glycine receptor subunit alpha-3	0	48	0	48
Mitogen-activated protein kinase 3	0	8	25	34
Sodium-dependent dopamine transporter	0	69	2	71
TAR DNA-binding protein 43	71	0	0	71
Inositol hexakisphosphate kinase 1	144	0	0	144
cytochrome P450 2C9, partial	144	0	0	144
Chain A, HADH2 protein	89	0	0	89
Chain B, HADH2 protein	89	0	0	89
Chain A, 2-oxoglutarate Oxygenase	94	0	0	94
Chain A, Amine oxidase [flavin-containing] B	0	0	1	1
aldehyde dehydrogenase 1 family, member A1	189	0	0	189
cytochrome P450 2D6 isoform 1	83	0	0	83
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	75	0	0	75
Alpha-2A adrenergic receptor	0	98	8	112
Alpha-2B adrenergic receptor	0	88	5	99
Alpha-2C adrenergic receptor	0	78	9	93
Alpha-2B adrenergic receptor	0	38	6	45
Alpha-2C adrenergic receptor	0	38	6	45
Alpha-2A adrenergic receptor	0	38	6	45
Nischarin	0	7	0	7
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Methyltransferase Wbdd	0	1	0	1
15-lipoxygenase, partial	65	0	0	65
NFKB1 protein, partial	49	0	0	49
Thrombopoietin	44	0	0	44
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	65	0	0	65
EWS/FLI fusion protein	157	0	0	158
cellular tumor antigen p53 isoform a	69	0	0	69
cytochrome P450 2C19 precursor	78	0	0	78
cytochrome P450 2C9 precursor	70	0	0	70
M-phase phosphoprotein 8	68	0	0	68
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	11	12	24
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	0	2	0	2
Serine/threonine-protein kinase PLK4	0	7	25	32
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	2	10	12
Polyunsaturated fatty acid lipoxygenase ALOX15B	69	1	0	70
Bromodomain-containing protein 4	0	2	0	2
5-hydroxytryptamine receptor 4	0	84	2	86
Integrin beta-3	50	5	1	56
Cytochrome P450 1A2	0	33	2	38
Integrin alpha-IIb	50	3	1	54
Neuronal acetylcholine receptor subunit alpha-4	12	11	2	26
Serine/threonine-protein kinase pim-1	0	4	26	30
Neuronal acetylcholine receptor subunit beta-2	12	11	2	26
Casein kinase II subunit alpha'	0	4	25	29
Proteinase-activated receptor 1	0	1	1	3
Bromodomain-containing protein 2	0	3	0	3
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	6	1	8
5-hydroxytryptamine receptor 2A	0	99	6	111
5-hydroxytryptamine receptor 2C	0	101	5	107
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Type-1 angiotensin II receptor	0	5	3	8
5-hydroxytryptamine receptor 2B	0	102	3	107
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	14	14	29
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	10	12	24
Serine/threonine-protein kinase mTOR	0	1	0	1
Histamine H2 receptor	116	7	3	132
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	12	12	25
Glycogen synthase kinase-3 beta	0	16	27	43
Serine/threonine-protein kinase PLK1	0	12	19	31
Casein kinase II subunit beta	0	4	0	4
Casein kinase II subunit alpha	0	5	10	15
DNA-dependent protein kinase catalytic subunit	0	13	1	14
Mu-type opioid receptor	0	25	7	33
Serine-protein kinase ATM	0	7	0	7
Serine/threonine-protein kinase ATR	0	5	11	16
Bromodomain-containing protein 3	0	1	0	1
Serine/threonine-protein kinase pim-3	0	2	10	12
Phosphoinositide 3-kinase regulatory subunit 5	0	4	0	4
Serine/threonine-protein kinase PLK3	0	9	10	19
Serine/threonine-protein kinase PLK2	0	7	9	16
Proton-coupled amino acid transporter 1	0	12	0	13
Phosphatidylinositol 4-kinase alpha	0	8	0	9
Xanthine dehydrogenase/oxidase	0	7	0	7
Phosphatidylinositol 4-kinase type 2-beta	0	7	0	8
Phosphatidylinositol 4-kinase type 2-alpha	0	8	0	9
Phosphatidylinositol 4-kinase beta	0	9	10	20
Potassium voltage-gated channel subfamily H member 2	0	106	1	108
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	102	0	0	102
Chain A, Putative fructose-1,6-bisphosphate aldolase	56	0	0	56
Hsf1 protein	0	0	6	8
thioredoxin glutathione reductase	35	0	0	35
Smad3	77	0	0	77
apical membrane antigen 1, AMA1	39	0	0	39
hypothetical protein, conserved	24	0	0	24
pyruvate kinase	14	0	0	14
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase	0	5	0	5
glucose-6-phosphate 1-dehydrogenase isoform b	0	5	0	5
fructose-bisphosphate aldolase A	4	0	0	4
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	45	0	0	45
pyruvate kinase PKM isoform a	8	0	0	8
DNA polymerase beta	38	0	0	38
nuclear receptor ROR-gamma isoform 1	131	0	0	131
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	14	3	0	17
Estrogen receptor	2	49	12	68
Endothelin receptor type B	4	7	0	11
Endothelin-1 receptor	4	2	0	6
Disabled homolog 2-interacting protein	0	1	0	1
Estrogen receptor beta	2	26	11	40
Adenylate cyclase type 10	0	1	0	1
hypothetical protein CAALFM_CR05890CA	0	0	0	4
H3 histone acetyltransferase	0	0	0	4
large T antigen	0	7	0	7
PPM1D protein	73	0	0	73
interferon gamma precursor	0	0	0	5
atrial natriuretic peptide receptor 2 precursor	29	0	0	29
Tubulin alpha-1A chain	0	7	3	11
Tubulin beta chain	0	7	3	10
Cytochrome P450 1A1	0	5	0	5
Cytochrome P450 1B1	0	7	0	8
Tubulin beta-2B chain	0	7	1	11
Similar to alpha-tubulin isoform 1	0	6	1	10
Similar to alpha-tubulin isoform 1	0	6	0	9
Nitric oxide synthase, inducible	0	9	0	10
Adenosine kinase	0	0	24	25
peroxisome proliferator-activated receptor delta	169	0	0	169
heat shock protein beta-1	104	0	0	104
interleukin 8	44	0	0	44
peroxisome proliferator activated receptor gamma	178	0	0	178
thyroid hormone receptor beta isoform 2	240	0	0	240
Cellular tumor antigen p53	214	1	0	215
Nuclear receptor ROR-gamma	57	1	2	60
Peroxisome proliferator-activated receptor alpha	9	7	11	28
ATPase family AAA domain-containing protein 5	100	0	0	100
Glycogen synthase kinase-3 alpha	0	6	25	31
5-hydroxytryptamine receptor 2C	0	47	6	56
5-hydroxytryptamine receptor 2A	0	56	9	67
5-hydroxytryptamine receptor 1A	0	90	8	101
5-hydroxytryptamine receptor 1B	0	63	4	68
5-hydroxytryptamine receptor 1D	0	20	5	26
5-hydroxytryptamine receptor 1F	0	19	4	24
5-hydroxytryptamine receptor 2B	0	42	7	49
5-hydroxytryptamine receptor 6	0	8	3	11
5-hydroxytryptamine receptor 7	0	22	4	26
5-hydroxytryptamine receptor 5A	0	8	3	11
5-hydroxytryptamine receptor 5B	0	8	3	11
5-hydroxytryptamine receptor 3A	0	15	3	18
Sigma non-opioid intracellular receptor 1	0	18	3	21
5-hydroxytryptamine receptor 4	0	10	3	14
5-hydroxytryptamine receptor 3B	0	15	3	18
Chain A, Ferritin light chain	89	0	0	89
Poly [ADP-ribose] polymerase 2	0	2	0	2
Poly [ADP-ribose] polymerase 1	0	6	0	6
Poly [ADP-ribose] polymerase 1	0	1	0	1
Transporter	0	22	1	24
Protein skinhead-1	0	1	0	1
Monocarboxylate transporter 2	0	2	0	2
Solute carrier family 22 member 20	0	7	0	7
Solute carrier family 22 member 6	0	7	0	7
D(2) dopamine receptor	0	89	16	116
D(4) dopamine receptor	0	47	5	60
D(3) dopamine receptor	0	91	6	105
D(2) dopamine receptor	0	75	13	93
dopamine D1 receptor	22	0	0	22
lethal factor (plasmid)	90	0	0	90
POU domain, class 2, transcription factor 1	0	0	0	3
Chain A, Poly(adp-ribose) Polymerase	0	1	0	1
Chain A, Poly(adp-ribose) Polymerase	0	1	0	1
Chain A, Poly(adp-ribose) Polymerase	0	1	0	1
glycogen synthase kinase-3 beta isoform 1	0	0	3	3
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	108	0	0	108
Tyrosine-protein kinase Lck	0	21	26	48
Tyrosine-protein kinase Fyn	0	25	26	51
Aldo-keto reductase family 1 member B1	0	74	0	74
Acetylcholinesterase	0	35	3	39
Sodium-dependent noradrenaline transporter	0	90	8	99
Aryl hydrocarbon receptor	0	0	2	2
Glycoprotein hormones alpha chain	3	0	0	3
Tubulin--tyrosine ligase	0	2	0	2
Androgen receptor	2	27	9	44
Thyroid hormone receptor alpha	0	5	4	9
Thyroid hormone receptor beta	0	5	4	9
Proliferating cell nuclear antigen	0	3	0	3
Thyroid hormone receptor beta	0	5	0	5
Retinoic acid receptor RXR-alpha	0	6	16	25
Peroxisome proliferator-activated receptor gamma	0	12	20	35
Sodium/bile acid cotransporter	0	7	1	8
Solute carrier organic anion transporter family member 1C1	0	3	0	3
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Protocatechuate 3,4-dioxygenase	0	0	1	1
Chain M, Protocatechuate 3,4-dioxygenase	0	0	1	1
Olfactory receptor class A-like protein 1	0	0	1	1
endonuclease IV	41	0	0	41
RGS12	5	0	0	5
alkaline phosphatase, intestinal	0	2	2	4
Bloom syndrome protein isoform 1	110	0	0	110
peripheral myelin protein 22 isoform 1	71	0	0	71
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	3	1	4
intestinal alkaline phosphatase precursor	0	3	1	4
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	4	0	0	4
alkaline phosphatase, germ cell type preproprotein	0	2	2	4
POsterior Segregation	0	0	7	8
muscarinic acetylcholine receptor M1	83	0	0	83
Prolyl 4-hydroxylase subunit alpha-1	0	3	0	3
Zinc finger protein mex-5	0	0	6	7
Chain A, TGF-beta receptor type-1	0	1	0	1
tyrosine-protein kinase Yes	19	0	0	19
Serine/threonine-protein kinase 25	0	0	10	10
Citron Rho-interacting kinase	0	0	25	25
Serine/threonine-protein kinase RIO3	0	0	10	10
Serine/threonine-protein kinase Chk1	0	1	25	26
Aurora kinase A	0	6	25	31
Cyclin-G-associated kinase	0	1	25	26
Serine/threonine-protein kinase DCLK1	0	0	10	10
Muscle, skeletal receptor tyrosine-protein kinase	0	0	10	10
3-phosphoinositide-dependent protein kinase 1	0	2	10	12
Death-associated protein kinase 3	0	0	10	10
Receptor-interacting serine/threonine-protein kinase 2	0	4	25	29
NUAK family SNF1-like kinase 1	0	2	10	12
Tyrosine-protein kinase JAK2	0	3	15	18
Ribosomal protein S6 kinase alpha-5	0	1	26	27
Ribosomal protein S6 kinase alpha-4	0	0	26	26
Serine/threonine-protein kinase 16	0	0	25	25
Serine/threonine-protein kinase PAK 3	0	0	10	10
Serine/threonine-protein kinase 17B	0	0	10	10
Serine/threonine-protein kinase 10	0	0	25	25
Serine/threonine-protein kinase D3	0	7	26	35
Cyclin-dependent kinase 14	0	0	10	10
Mitogen-activated protein kinase kinase kinase kinase 4	0	0	25	25
Serine/threonine-protein kinase LATS1	0	0	25	25
Serine/threonine-protein kinase PAK 4	0	2	25	27
Tyrosine-protein kinase ABL1	0	23	29	54
Epidermal growth factor receptor	0	44	28	73
RAF proto-oncogene serine/threonine-protein kinase	0	10	11	23
Receptor tyrosine-protein kinase erbB-2	0	18	11	29
High affinity nerve growth factor receptor	0	1	22	23
Insulin receptor	0	10	25	36
Tyrosine-protein kinase Fes/Fps	0	0	26	26
Macrophage colony-stimulating factor 1 receptor	0	7	10	17
Tyrosine-protein kinase Yes	0	2	25	27
Tyrosine-protein kinase Lyn	0	5	25	30
Proto-oncogene tyrosine-protein kinase receptor Ret	0	7	25	32
Insulin-like growth factor 1 receptor	0	6	26	32
Hepatocyte growth factor receptor	0	7	23	30
Tyrosine-protein kinase HCK	0	6	25	31
Proto-oncogene tyrosine-protein kinase ROS	0	2	11	13
Platelet-derived growth factor receptor beta	0	10	25	36
Tyrosine-protein kinase Fgr	0	1	17	18
Mast/stem cell growth factor receptor Kit	0	13	11	24
Fibroblast growth factor receptor 1	0	9	26	36
Myosin light chain kinase, smooth muscle	0	3	8	11
Proto-oncogene tyrosine-protein kinase Src	0	15	25	41
Insulin receptor-related protein	0	0	10	10
Serine/threonine-protein kinase B-raf	0	8	28	38
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0	0	25	25
Platelet-derived growth factor receptor alpha	0	11	11	22
Tyrosine-protein kinase Fer	0	0	25	25
cAMP-dependent protein kinase catalytic subunit alpha	0	8	25	33
Vascular endothelial growth factor receptor 1	0	7	10	17
Interferon-induced, double-stranded RNA-activated protein kinase	0	1	10	11
Cyclin-dependent kinase 11B	0	0	10	10
Ephrin type-A receptor 1	0	0	24	24
Fibroblast growth factor receptor 2	0	4	10	15
Fibroblast growth factor receptor 4	0	3	10	14
Fibroblast growth factor receptor 3	0	3	11	15
cAMP-dependent protein kinase catalytic subunit beta	0	5	25	30
Tyrosine-protein kinase JAK1	0	2	25	27
Protein kinase C eta type	0	9	12	23
Activin receptor type-2A	0	0	10	10
MAP/microtubule affinity-regulating kinase 3	0	0	25	25
Mitogen-activated protein kinase 1	0	9	27	36
Ephrin type-A receptor 2	0	2	25	27
Ephrin type-A receptor 3	0	0	10	10
Ephrin type-A receptor 8	0	0	10	10
Ephrin type-B receptor 2	0	1	25	26
Leukocyte tyrosine kinase receptor	0	0	11	11
Non-receptor tyrosine-protein kinase TYK2	0	1	26	27
Wee1-like protein kinase	0	0	25	25
Tyrosine-protein kinase receptor UFO	0	2	10	12
Mitogen-activated protein kinase 4	0	0	10	10
RAC-beta serine/threonine-protein kinase	0	2	25	27
Dual specificity protein kinase TTK	0	1	19	20
Tyrosine-protein kinase receptor Tie-1	0	0	10	10
Vascular endothelial growth factor receptor 3	0	7	10	17
Vascular endothelial growth factor receptor 2	0	20	12	33
Dual specificity mitogen-activated protein kinase kinase 2	0	7	25	32
Receptor-type tyrosine-protein kinase FLT3	0	9	25	35
Bone morphogenetic protein receptor type-1A	0	0	25	25
Activin receptor type-1B	0	0	25	25
TGF-beta receptor type-1	0	3	26	29
Serine/threonine-protein kinase receptor R3	0	0	14	14
TGF-beta receptor type-2	0	1	22	23
Tyrosine-protein kinase CSK	0	4	25	29
Tyrosine-protein kinase Tec	0	1	25	26
Tyrosine-protein kinase TXK	0	1	10	11
Tyrosine-protein kinase ABL2	0	2	25	27
Tyrosine-protein kinase FRK	0	0	25	25
Tyrosine-protein kinase ZAP-70	0	4	10	14
Tyrosine-protein kinase SYK	0	5	25	30
Mitogen-activated protein kinase 8	0	0	25	25
Mitogen-activated protein kinase 9	0	0	25	25
Dual specificity mitogen-activated protein kinase kinase 4	0	1	17	18
Dual specificity mitogen-activated protein kinase kinase 3	0	0	25	25
Casein kinase I isoform delta	0	2	25	27
MAP kinase-activated protein kinase 2	0	3	25	28
Cyclin-dependent kinase 8	0	1	10	11
Casein kinase I isoform epsilon	0	2	25	27
Dual specificity protein kinase CLK1	0	1	23	24
Dual specificity protein kinase CLK2	0	0	24	24
Dual specificity protein kinase CLK3	0	0	17	17
Cyclin-dependent kinase 7	0	5	25	30
Cyclin-dependent kinase 9	0	6	25	31
Tyrosine-protein kinase Blk	0	2	10	12
Ribosomal protein S6 kinase alpha-3	0	2	25	27
Cytoplasmic tyrosine-protein kinase BMX	0	1	10	11
cAMP-dependent protein kinase catalytic subunit PRKX	0	0	10	10
Serine/threonine-protein kinase Nek2	0	1	25	26
Tyrosine-protein kinase JAK3	0	7	10	17
Dual specificity mitogen-activated protein kinase kinase 6	0	0	25	25
Death-associated protein kinase 1	0	2	10	12
LIM domain kinase 1	0	1	25	26
LIM domain kinase 2	0	1	25	26
Mitogen-activated protein kinase 10	0	1	24	25
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	1	11	13
Ephrin type-B receptor 3	0	0	25	25
Ephrin type-A receptor 5	0	0	25	25
Ephrin type-B receptor 4	0	5	25	30
Ephrin type-B receptor 1	0	0	10	10
Ephrin type-A receptor 4	0	1	25	26
Serine/threonine-protein kinase SIK1	0	2	10	12
Tubulin alpha-1A chain	0	0	8	8
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	0	0	10	10
SRSF protein kinase 2	0	0	10	10
Casein kinase I isoform gamma-2	0	1	22	23
Mitogen-activated protein kinase kinase kinase 9	0	0	10	10
Cyclin-dependent kinase 3	0	0	23	23
Cyclin-dependent-like kinase 5	0	3	25	28
Cyclin-dependent kinase 16	0	0	25	25
Cyclin-dependent kinase 17	0	0	23	23
Protein kinase C epsilon type	0	10	12	24
Angiopoietin-1 receptor	0	2	11	13
Mitogen-activated protein kinase kinase kinase 10	0	0	10	10
Protein kinase C theta type	0	9	27	38
Activin receptor type-1	0	1	25	26
Focal adhesion kinase 1	0	3	26	29
Protein kinase C delta type	0	13	27	42
Tyrosine-protein kinase BTK	0	4	25	29
Tyrosine-protein kinase receptor TYRO3	0	0	10	10
Cyclin-dependent kinase 18	0	0	14	14
Activated CDC42 kinase 1	0	1	25	26
Epithelial discoidin domain-containing receptor 1	0	5	25	30
Tyrosine-protein kinase ITK/TSK	0	2	10	12
Myotonin-protein kinase	0	0	10	10
Tyrosine-protein kinase Mer	0	2	17	19
Serine/threonine-protein kinase 4	0	0	25	25
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	1	28	30
Serine/threonine-protein kinase PAK 1	0	2	10	12
Mitogen-activated protein kinase 7	0	0	24	24
Serine/threonine-protein kinase PAK 2	0	1	24	25
Serine/threonine-protein kinase 3	0	0	25	25
cGMP-dependent protein kinase 2	0	0	10	10
Non-receptor tyrosine-protein kinase TNK1	0	0	25	25
Receptor-interacting serine/threonine-protein kinase 1	0	3	10	13
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	10	11
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	0	25	25
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	0	25	25
Activin receptor type-2B	0	0	24	24
Bone morphogenetic protein receptor type-2	0	0	25	25
Protein-tyrosine kinase 6	0	1	25	26
cGMP-dependent protein kinase 1	0	1	25	26
Calcium/calmodulin-dependent protein kinase type 1	0	0	10	10
Inhibitor of nuclear factor kappa-B kinase subunit epsilon	0	0	25	25
Protein-tyrosine kinase 2-beta	0	2	26	28
Maternal embryonic leucine zipper kinase	0	1	25	26
Serine/threonine-protein kinase D1	0	8	11	21
Ribosomal protein S6 kinase alpha-2	0	0	10	10
Ephrin type-A receptor 7	0	0	23	23
Ribosomal protein S6 kinase alpha-1	0	2	25	27
Dual specificity testis-specific protein kinase 1	0	0	23	23
Myosin light chain kinase, smooth muscle	0	4	25	29
Serine/threonine-protein kinase STK11	0	0	25	25
NT-3 growth factor receptor	0	0	10	10
Serine/threonine-protein kinase N1	0	0	25	25
Serine/threonine-protein kinase N2	0	0	25	25
Calcium/calmodulin-dependent protein kinase type IV	0	0	24	24
Mitogen-activated protein kinase kinase kinase 11	0	0	25	25
BDNF/NT-3 growth factors receptor	0	1	10	11
Mitogen-activated protein kinase 6	0	0	11	11
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	0	0	10	10
Discoidin domain-containing receptor 2	0	7	25	32
AP2-associated protein kinase 1	0	1	25	26
Serine/threonine-protein kinase TNNI3K	0	1	10	11
Serine/threonine-protein kinase MRCK alpha	0	0	25	25
Serine/threonine-protein kinase MRCK gamma	0	0	23	23
Serine/threonine-protein kinase Nek5	0	0	10	10
Serine/threonine-protein kinase MARK2	0	0	25	25
Serine/threonine-protein kinase tousled-like 2	0	0	10	10
Serine/threonine-protein kinase 32C	0	0	10	10
Myosin light chain kinase family member 4	0	0	10	10
Calcium/calmodulin-dependent protein kinase type 1D	0	0	10	10
Mitogen-activated protein kinase kinase kinase kinase 3	0	0	25	25
MAP kinase-activated protein kinase 5	0	4	24	28
Serine/threonine-protein kinase BRSK2	0	0	11	11
Serine/threonine-protein kinase DCLK2	0	0	10	10
Calcium/calmodulin-dependent protein kinase kinase 1	0	0	10	10
Casein kinase I isoform alpha-like	0	0	10	10
Myosin-IIIa	0	0	10	10
Ankyrin repeat and protein kinase domain-containing protein 1	0	0	10	10
Atypical kinase COQ8A, mitochondrial	0	0	25	25
Mitogen-activated protein kinase 15	0	0	25	25
Serine/threonine-protein kinase Nek9	0	0	25	25
Serine/threonine-protein kinase BRSK1	0	0	10	10
Serine/threonine-protein kinase Nek7	0	0	15	15
Myosin-IIIb	0	0	10	10
Mitogen-activated protein kinase kinase kinase kinase 1	0	0	24	24
Atypical kinase COQ8B, mitochondrial	0	0	10	10
Aurora kinase B	0	5	25	30
MAP/microtubule affinity-regulating kinase 4	0	0	23	23
Calcium/calmodulin-dependent protein kinase type 1G	0	0	12	12
Serine/threonine-protein kinase Nek1	0	0	25	25
Calcium/calmodulin-dependent protein kinase kinase 2	0	2	25	27
SRSF protein kinase 1	0	0	10	10
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	0	2	25	27
Mitogen-activated protein kinase kinase kinase 5	0	0	25	25
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	0	0	10	10
Serine/threonine-protein kinase RIO1	0	0	10	10
MAP kinase-interacting serine/threonine-protein kinase 1	0	0	10	10
Cyclin-dependent kinase 19	0	1	10	11
Testis-specific serine/threonine-protein kinase 1	0	1	10	11
Serine/threonine-protein kinase 33	0	0	10	10
Serine/threonine-protein kinase D2	0	0	25	25
Serine/threonine-protein kinase DCLK3	0	0	10	10
NUAK family SNF1-like kinase 2	0	0	23	23
Serine/threonine-protein kinase SIK2	0	1	25	26
Myosin light chain kinase 2, skeletal/cardiac muscle	0	0	10	10
STE20-like serine/threonine-protein kinase	0	0	25	25
Tyrosine-protein kinase Srms	0	0	10	10
Dual specificity protein kinase CLK4	0	0	22	22
MAP kinase-interacting serine/threonine-protein kinase 2	0	2	10	12
Serine/threonine-protein kinase Nek6	0	0	10	10
Casein kinase I isoform gamma-1	0	1	25	26
Serine/threonine-protein kinase PAK 6	0	1	17	18
Serine/threonine-protein kinase LATS2	0	0	10	10
Serine/threonine-protein kinase 36	0	0	10	10
BMP-2-inducible protein kinase	0	0	25	25
Serine/threonine-protein kinase 32B	0	0	10	10
Mitogen-activated protein kinase kinase kinase 20	0	1	25	26
Serine/threonine-protein kinase MARK1	0	0	10	10
Serine/threonine-protein kinase pim-2	0	0	18	18
Serine/threonine-protein kinase PAK 5	0	1	10	11
Serine/threonine-protein kinase 26	0	0	25	25
eIF-2-alpha kinase GCN2	0	0	10	10
Serine/threonine-protein kinase NLK	0	0	24	24
Serine/threonine-protein kinase 17A	0	0	10	10
Ephrin type-A receptor 6	0	0	10	10
Death-associated protein kinase 2	0	0	10	10
Ribosomal protein S6 kinase alpha-6	0	0	25	25
TRAF2 and NCK-interacting protein kinase	0	0	25	25
Serine/threonine-protein kinase tousled-like 1	0	0	10	10
ALK tyrosine kinase receptor	0	6	13	20
Cyclin-dependent kinase 11A	0	0	10	10
Aurora kinase C	0	0	10	10
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	0	10	10
RAC-gamma serine/threonine-protein kinase	0	2	25	27
Serine/threonine-protein kinase 38-like	0	0	17	17
Dual specificity tyrosine-phosphorylation-regulated kinase 1B	0	2	16	18
Mitogen-activated protein kinase kinase kinase kinase 5	0	0	25	25
Serine/threonine-protein kinase MRCK beta	0	0	25	25
Interleukin-1 receptor-associated kinase 3	0	0	25	25
Serine/threonine-protein kinase 24	0	0	19	19
Casein kinase I isoform gamma-3	0	0	25	25
Mitogen-activated protein kinase kinase kinase 4	0	0	25	25
cytochrome P450 family 3 subfamily A polypeptide 4	204	0	0	204
cytochrome P450 2D6	140	0	0	140
transcriptional regulator ERG isoform 3	27	0	0	27
peripheral myelin protein 22	146	0	0	146
Potassium channel subfamily K member 2	0	5	13	18
Rap guanine nucleotide exchange factor 3	28	0	0	28
Potassium voltage-gated channel subfamily A member 3	0	2	1	3
Acetylcholinesterase	0	4	0	4
Pteridine reductase 1	0	5	0	5
Potassium voltage-gated channel subfamily A member 1	0	4	1	5
[tau protein] kinase	0	1	0	1
Phospholipase A2	0	3	0	3
cAMP-dependent protein kinase catalytic subunit gamma	0	5	21	26
nonstructural protein 1	52	0	0	52
Cytochrome P450 2B1	0	4	0	5
Cytochrome P450 1A1	0	1	0	2
Polyunsaturated fatty acid 5-lipoxygenase	0	9	0	12
Steroid C26-monooxygenase	0	0	7	7
Steroid C26-monooxygenase	0	0	6	6
Lanosterol 14-alpha demethylase	0	0	2	2
Lanosterol 14-alpha demethylase	0	0	5	5
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
Chain A, Leukotriene A-4 hydrolase	0	2	0	2
90-kda heat shock protein beta HSP90 beta, partial	0	3	0	3
ubiquitin carboxyl-terminal hydrolase 2 isoform a	40	0	0	40
heat shock protein HSP 90-alpha isoform 2	0	3	0	15
neuropeptide S receptor isoform A	49	0	0	49
DNA repair and recombination protein RadA	0	0	2	2
Leukotriene A-4 hydrolase	0	9	2	11
Tyrosinase	0	6	0	6
Neuronal acetylcholine receptor subunit alpha-7	0	4	4	8
Sulfotransferase 1E1	0	0	0	1
Sulfotransferase 1A1	0	2	1	5
Disintegrin and metalloproteinase domain-containing protein 17	28	4	0	32
DNA repair protein RAD51 homolog 1	0	0	1	1
Chain A, ATP-DEPENDENT DNA HELICASE Q1	48	0	0	48
Mcl-1	0	5	0	5
Myeloid cell leukemia sequence 1 (BCL2-related)	0	1	0	1
envelope glycoprotein	0	1	0	1
core protein, partial	0	2	0	2
polyunsaturated fatty acid lipoxygenase ALOX12	18	0	0	18
glyceraldehyde-3-phosphate dehydrogenase isoform 1	3	1	0	4
eukaryotic translation initiation factor 4 gamma 1 isoform 4	0	2	0	2
eukaryotic translation initiation factor 4E isoform 1	0	2	0	2
Vif	0	3	0	3
Tat	0	2	0	2
dual specificity protein phosphatase 6	0	1	0	1
tyrosine-protein phosphatase non-receptor type 7 isoform 2	0	2	0	2
bcl-2-like protein 1 isoform Bcl-X(L)	0	1	0	1
Muscarinic acetylcholine receptor M1	0	31	9	45
Muscarinic acetylcholine receptor M3	0	28	9	41
Muscarinic acetylcholine receptor M4	0	29	8	41
Muscarinic acetylcholine receptor M5	0	29	8	41
Muscarinic acetylcholine receptor M2	0	30	9	44
Caspase-1	1	5	0	7
Solute carrier organic anion transporter family member 2A1	0	2	0	6
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	15	1	17
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	11	0	11
D(1A) dopamine receptor	76	0	0	76
Chain A, Avidin	0	0	2	2
Chain A, Avidin	0	0	2	2
Chain B, Avidin	0	0	2	2
Trypsin	0	5	0	6
Coagulation factor VII	0	9	0	9
Tissue factor	0	11	0	11
Oxoeicosanoid receptor 1	0	1	0	1
Adenosine deaminase	0	1	0	2
P53	6	0	0	6
Caspase-7	33	0	0	33
serine-protein kinase ATM isoform a	16	0	0	16
caspase-3	33	0	0	33
nuclear factor NF-kappa-B p105 subunit isoform 1	18	0	1	19
lethal(3)malignant brain tumor-like protein 1 isoform I	14	0	0	14
caspase-1 isoform alpha precursor	14	0	0	14
Caspase-7	11	0	0	11
atrial natriuretic peptide receptor 1 precursor	21	0	0	21
Beta-1 adrenergic receptor	0	10	2	16
D	0	37	1	42
Chain A, Apoptosis regulator Bcl-X	0	1	0	1
Bcl-2-like protein 11	0	2	0	2
Beta-casein	0	1	0	1
Apoptosis regulator Bcl-2	0	10	4	14
BH3-interacting domain death agonist	0	4	0	4
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog	0	0	1	1
Apoptosis regulator BAX	0	1	1	2
Bcl-2-like protein 1	0	11	4	15
Induced myeloid leukemia cell differentiation protein Mcl-1	0	7	1	8
Aspartyl/asparaginyl beta-hydroxylase	0	4	0	4
Bcl-2-related protein A1	0	2	1	3
Bcl-2 homologous antagonist/killer	0	2	1	3
Bcl-2-like protein 2	0	6	0	6
Bcl2-associated agonist of cell death	0	4	0	4
Bcl-2-binding component 3, isoforms 1/2	0	1	0	1
Bcl-2-like protein 10	0	2	0	2
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Class Iii Chitinase Chia1	0	1	0	1
Chain A, Carbonic anhydrase 13	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase	0	1	0	1
Chain B, Carbonic anhydrase	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Carbonic anhydrase	0	0	0	3
Carbonic anhydrase	0	10	0	10
GALC protein	33	0	0	33
Carbonic anhydrase	0	5	0	5
Carbonic anhydrase	0	5	0	5
Carbonic anhydrase	0	5	0	5
muscleblind-like protein 1 isoform 1	40	0	0	40
ATP-binding cassette sub-family C member 3	0	179	0	179
Multidrug resistance-associated protein 4	0	180	0	187
Carbonic anhydrase	0	3	0	3
Solute carrier family 22 member 6	0	15	0	16
Carbonic anhydrase 12	0	24	1	36
Prolyl endopeptidase	0	3	0	3
Carbonic anhydrase-related protein 11	0	1	0	3
Bile salt export pump	0	263	0	263
Glycogen phosphorylase, muscle form	0	4	0	4
Carbonic anhydrase 1	0	56	1	77
Carbonic anhydrase 2	0	64	4	88
Carbonic anhydrase 2	0	2	0	2
Carbonic anhydrase 3	0	18	1	27
Cathepsin B	0	2	0	2
Cytochrome P450 3A4	0	81	6	100
Steryl-sulfatase	0	5	0	6
Polyunsaturated fatty acid 5-lipoxygenase	0	16	0	18
Cytochrome P450 2C8	0	14	2	17
Cytochrome P450 2D6	0	45	4	51
Cytochrome P450 2A6	0	8	2	10
Cytochrome P450 2C9	0	71	5	79
Translocator protein	0	10	4	15
Arachidonate 5-lipoxygenase-activating protein	0	2	0	2
Cytochrome P450 2B6	0	13	2	17
Carbonic anhydrase 4	0	34	1	45
Carbonic anhydrase 6	0	21	1	32
Carbonic anhydrase 5A, mitochondrial	0	2	0	2
Serum paraoxonase/arylesterase 1	0	7	0	7
Dipeptidyl peptidase 4	0	8	1	10
Endochitinase	0	1	0	1
Delta-type opioid receptor	0	26	6	38
Cytochrome P450 2C19	0	42	1	45
Delta-type opioid receptor	0	24	6	32
Mu-type opioid receptor	0	32	9	44
Carbonic anhydrase 5A, mitochondrial	0	23	2	36
Carbonic anhydrase	0	17	0	23
Kappa-type opioid receptor	0	17	4	24
Carbonic anhydrase 7	0	21	1	32
Carbonic anhydrase	0	1	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	3	0	3
Carbonic anhydrase	0	4	0	11
Cholinesterase	0	16	0	17
Carbonic anhydrase	0	2	0	2
Fatty-acid amide hydrolase 1	0	10	0	11
Beta-carbonic anhydrase 1	0	5	0	5
Carbonic anhydrase 2	0	4	0	4
Squalene synthase	0	4	0	4
Neuronal acetylcholine receptor subunit alpha-7	0	7	3	11
Carbonic anhydrase 9	0	31	2	45
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase, alpha family	0	6	0	6
Carbonic anhydrase	0	4	0	11
Carbonic anhydrase 3	0	2	0	2
Carbonic anhydrase	0	3	0	11
Carbonic anhydrase	0	4	0	12
Carbonic anhydrase	0	5	0	5
Sigma intracellular receptor 2	0	10	0	10
Delta carbonic anhydrase	0	5	0	5
Renin	0	1	0	1
Carbonic anhydrase	0	3	0	10
Endochitinase A1	0	1	0	1
Multidrug resistance-associated protein 1	0	2	0	2
Carbonic anhydrase 13	0	7	1	12
Canalicular multispecific organic anion transporter 1	0	170	0	171
Carbonic anhydrase 4	0	5	0	9
Carbonic anhydrase 15	0	20	0	27
Acidic mammalian chitinase	0	1	0	1
Carbonic anhydrase 13	0	13	0	22
Carbonic anhydrase 7	0	1	0	1
Carbonic anhydrase	0	6	0	6
Carbonic anhydrase 14	0	18	1	30
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 2, isoform A	0	1	0	1
Carbonic anhydrase 5B, mitochondrial	0	20	1	32
Free fatty acid receptor 3	0	0	2	2
Free fatty acid receptor 2	0	1	1	2
Fibrinogen C domain-containing protein 1	0	1	0	1
Histone deacetylase 3	0	19	1	25
Histone deacetylase 4	0	16	2	24
Histone deacetylase 1	0	21	4	30
Histone deacetylase 7	0	16	2	23
Histone deacetylase 2	0	20	3	28
Polyamine deacetylase HDAC10	0	14	1	20
Histone deacetylase 11	0	15	1	21
Histone deacetylase 8	0	20	2	27
Histone deacetylase 6	0	19	3	27
Histone deacetylase 9	0	15	1	21
Histone deacetylase 5	0	17	1	23
Fumarate hydratase	90	0	0	90
polyprotein	90	0	0	90
Hydroxycarboxylic acid receptor 2	0	2	2	4
Telomerase reverse transcriptase	0	3	0	3
Amyloid-beta precursor protein	4	17	2	24
Reverse transcriptase/RNaseH	0	7	3	13
DNA topoisomerase 2-alpha	0	6	23	39
Chain E, Purine nucleoside phosphorylase	0	1	0	1
Thymidine kinase	0	4	0	5
hemoglobin subunit beta	10	0	0	10
Bile salt export pump	0	39	0	39
Purine nucleoside phosphorylase	0	4	0	5
Thymidine kinase, cytosolic	0	6	0	10
Cytochrome P450 2J2	0	30	0	31
Purine nucleoside phosphorylase	0	0	2	2
Solute carrier family 22 member 6	0	8	0	13
Thymidine kinase	0	1	0	1
Solute carrier family 22 member 8	0	9	0	14
Thymidine kinase	0	2	0	3
Chain A, MTA/SAH nucleosidase	0	1	0	1
Chain A, Ribosome-inactivating protein alpha-trichosanthin	0	0	1	1
Chain A, Ricin A chain	0	0	1	1
Chain A, Ribosome-inactivating protein 3	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
tumor susceptibility gene 101 protein	11	0	0	11
Cyclin-dependent kinase 1	0	11	24	36
Heat shock protein HSP 90-beta	0	3	1	5
Protein mono-ADP-ribosyltransferase PARP15	0	2	0	2
Leucine-rich repeat serine/threonine-protein kinase 2	0	3	9	12
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Membrane lipoprotein tmpC	0	0	2	2
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	2	0	0	2
NPYLR7B	0	0	7	7
high affinity choline transporter 1 isoform a	0	2	0	2
Sodium/nucleoside cotransporter 1	0	4	0	4
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	12	12
Sodium/nucleoside cotransporter 2	0	4	0	4
Phosphoglycerate kinase 1	0	1	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	1	0	2
Glyceraldehyde-3-phosphate dehydrogenase	0	2	0	2
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	4	5	10
Heat shock 70 kDa protein 1A	0	2	1	3
Heat shock cognate 71 kDa protein	0	0	2	2
Inosine-5'-monophosphate dehydrogenase 2	0	1	22	23
Endoplasmin	0	2	2	5
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Streptavidin	0	0	2	2
Adenosylhomocysteinase	0	3	0	5
Adenylate kinase 2, mitochondrial	0	2	0	3
Adenylate kinase isoenzyme 1	0	2	0	3
Adenosine receptor A1	0	3	1	4
Adenosine deaminase	0	1	0	3
Equilibrative nucleoside transporter 2	0	4	0	4
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	7	0	7
Solute carrier family 28 member 3	0	5	0	5
Adenosine kinase	0	1	0	2
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
Phospholipase C, gamma 1	0	1	0	1
Phospholipase C, beta 3 (phosphatidylinositol-specific)	0	1	0	1
5'-nucleotidase	0	3	0	3
5'-nucleotidase	0	2	1	4
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 1	0	1	0	1
Glycine--tRNA ligase	0	3	0	3
5'-nucleotidase	0	1	0	1
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	0	1	0	1
Chain A, Heat Shock Protein 90	0	0	1	1
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE	0	0	1	1
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE	0	0	1	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN	0	1	0	1
Chain A, Myosin Ie Heavy Chain	0	0	1	1
Chain A, Preprotein translocase secA	0	0	1	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Phosphoribosylformylglycinamidine synthase	0	1	0	1
Chain A, nucleoside diphosphate kinase A	0	0	1	1
Chain B, nucleoside diphosphate kinase A	0	0	1	1
Chain D, DNA polymerase III subunit gamma	0	0	1	1
Chain D, DNA polymerase III subunit gamma	0	0	1	1
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3	0	0	1	1
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3	0	0	1	1
Chain A, Kinesin-like protein KIF11	0	1	0	1
HPr kinase/phosphorylase	0	0	1	1
ATP-dependent molecular chaperone HSP82	0	0	0	1
2-dehydropantoate 2-reductase	0	2	4	6
Endoplasmic reticulum chaperone BiP	0	0	1	1
Pyruvate kinase PKM	0	0	0	1
Pyruvate kinase PKLR	0	0	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Mu-type opioid receptor	0	63	15	83
Delta-type opioid receptor	0	48	13	67
Kappa-type opioid receptor	0	52	10	68
Endoplasmin	0	1	1	2
P2Y purinoceptor 2	0	1	4	5
P2X purinoceptor 1	0	0	3	3
P2Y purinoceptor 1	0	0	2	2
P2Y purinoceptor 1	0	0	3	3
P2X purinoceptor 1	0	1	1	2
P2X purinoceptor 4	0	0	3	3
P2X purinoceptor 5	0	0	2	2
P2X purinoceptor 6	0	0	2	2
P2X purinoceptor 3	0	1	2	3
Heat shock protein 75 kDa, mitochondrial	0	1	0	1
P2Y purinoceptor 6	0	1	3	4
P2Y purinoceptor 11	0	1	3	4
P2Y purinoceptor 12	0	1	2	3
Sensor protein kinase WalK	0	2	0	2
P2X purinoceptor 2	0	0	2	2
Transient receptor potential cation channel subfamily M member 2	0	2	1	3
Chain A, Glycogen Phosphorylase B	0	0	1	1
Chain B, Glycogen Phosphorylase B	0	0	1	1
Chain A, ADP-dependent glucokinase	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, Ribonuclease pancreatic	0	1	0	1
Chain A, phosphodiesterase-nucleotide pyrophosphatase	0	1	0	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain B, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
Chain A, GLYCOGEN PHOSPHORYLASE B	0	0	1	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1	0	1	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	1	2
Alcohol dehydrogenase E chain	0	2	0	2
Alcohol dehydrogenase S chain	0	2	0	2
L-lactate dehydrogenase A chain	0	2	1	3
Adenylate kinase isoenzyme 1	0	0	0	1
Fructose-1,6-bisphosphatase 1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	5	0	6
Fructose-1,6-bisphosphatase 1	0	4	0	5
Inosine-5'-monophosphate dehydrogenase	0	1	0	1
Amine oxidase [flavin-containing] B	0	13	0	14
GTP:AMP phosphotransferase AK3, mitochondrial	0	0	0	1
5'-AMP-activated protein kinase subunit gamma-1	0	0	26	27
Adenylate kinase 2, mitochondrial	0	0	24	25
Adenosine deaminase-like protein	0	0	0	1
Protease	0	8	3	15
Histamine H3 receptor	1	1	0	2
5'-AMP-activated protein kinase subunit gamma-3	0	0	1	2
5'-AMP-activated protein kinase subunit gamma-2	0	0	25	26
5'-AMP-activated protein kinase subunit beta-1	0	0	2	3
Chain A, Carbamoyl-phosphate Synthase	0	1	0	1
Chain A, Potassium-transporting ATPase B chain	0	0	1	1
S-adenosylmethionine synthase isoform type-1	0	1	0	2
S-adenosylmethionine synthase isoform type-2	0	1	0	2
ubiquitin-conjugating enzyme E2 N	0	5	0	5
Phospholipase D2	0	1	0	1
Aromatase	0	34	0	41
Estrogen-related receptor gamma	0	3	2	5
Phospholipase D1	0	2	0	2
Acetylcholinesterase	0	6	0	6
Bifunctional purine biosynthesis protein ATIC	0	3	0	4
Histidine triad nucleotide-binding protein 1	0	0	1	1
Alanine racemase, biosynthetic	0	0	0	1
5-hydroxytryptamine receptor 1D	0	7	1	14
Adenosine deaminase	0	1	0	2
Mineralocorticoid receptor	2	11	5	20
Mineralocorticoid receptor	0	2	1	3
Solute carrier organic anion transporter family member 1A1	0	6	0	10
retinoic acid receptor alpha isoform 1	0	1	0	1
retinoic acid receptor RXR-alpha isoform a	0	1	0	1
Retinoic acid receptor alpha	0	5	6	15
Retinoic acid receptor beta	0	5	6	15
Retinoic acid receptor alpha	0	3	3	6
Retinoic acid receptor gamma	0	5	6	15
Retinoic acid receptor gamma	0	2	3	5
Retinoic acid receptor beta	0	2	3	5
Nuclear receptor subfamily 4 group A member 1	0	0	2	2
Cellular retinoic acid-binding protein 2	0	0	3	3
Retinoic acid receptor RXR-alpha	0	3	5	8
Retinoic acid receptor RXR-beta	0	5	6	11
Retinoic acid receptor RXR-beta	0	2	6	8
Retinoic acid receptor RXR-gamma	0	2	6	8
Cellular retinoic acid-binding protein 1	0	3	0	4
Retinoic acid receptor RXR-gamma	0	5	6	11
Type-2 angiotensin II receptor	0	7	2	9
Cellular retinoic acid-binding protein 1	0	0	3	3
Retinoic acid receptor RXR-alpha	0	0	2	2
Botulinum neurotoxin type A	0	2	0	2
Neutrophil cytosol factor 1	0	2	0	2
Nitric oxide synthase, endothelial	0	4	0	4
Nitric oxide synthase, brain	0	4	0	6
Nitric oxide synthase, inducible	0	4	1	8
Tyrosine-protein kinase	0	0	1	1
D(3) dopamine receptor isoform e	3	0	0	3
DNA dC->dU-editing enzyme APOBEC-3F isoform a	13	0	0	13
ATP-dependent translocase ABCB1	0	23	0	23
ATP-dependent translocase ABCB1	0	62	9	95
Beta-3 adrenergic receptor	0	29	7	36
ATP-dependent translocase ABCB1	0	25	1	27
D(1A) dopamine receptor	0	65	8	79
Alpha-1D adrenergic receptor	0	67	7	82
5-hydroxytryptamine receptor 6	0	68	1	71
WRN	5	0	0	5
phospholipase A2 precursor	0	1	0	1
cysteine protease ATG4B isoform a	0	1	0	1
Free fatty acid receptor 1	0	0	3	3
Prostaglandin G/H synthase 1	0	10	0	13
Nuclear receptor subfamily 1 group I member 2	0	1	18	19
Prostaglandin G/H synthase 1	0	27	0	28
Prostaglandin G/H synthase 2	0	12	0	13
Free fatty acid receptor 4	0	0	1	1
Beta-2 adrenergic receptor	0	19	8	28
Beta-1 adrenergic receptor	0	25	8	33
5-hydroxytryptamine receptor 1A	0	37	17	56
Beta-2 adrenergic receptor	0	9	1	13
Alpha-1A adrenergic receptor	0	22	9	42
Alpha-1B adrenergic receptor	0	17	8	33
Thromboxane-A synthase	0	17	0	17
Prostaglandin E2 receptor EP3 subtype	0	3	0	3
Prostaglandin E2 receptor EP4 subtype	0	3	1	4
Prostaglandin E2 receptor EP1 subtype	0	3	0	3
Prostacyclin receptor	0	3	2	5
Nuclear receptor subfamily 4 group A member 2	0	0	6	6
Nuclear receptor subfamily 4 group A member 2	0	0	1	1
Nuclear receptor subfamily 4 group A member 2	0	0	1	1
Prostaglandin E2 receptor EP2 subtype	0	3	1	4
Solute carrier organic anion transporter family member 2A1	0	3	0	6
Solute carrier organic anion transporter family member 2B1	0	1	0	2
Solute carrier organic anion transporter family member 3A1	0	0	0	1
Chain A, Protein (glycogen Phosphorylase)	0	1	0	1
Leukotriene C4 synthase	0	0	9	9
Glycogen synthase kinase-3 beta	0	2	0	2
[Tau protein] kinase	0	2	0	2
Bone morphogenetic protein receptor type-1B	0	0	24	24
ATP-dependent RNA helicase DDX3X	0	0	24	24
Pyridoxal kinase	0	0	24	25
Dual specificity mitogen-activated protein kinase kinase 7	0	0	9	9
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	2	9	12
Peripheral plasma membrane protein CASK	0	0	9	9
Inhibitor of nuclear factor kappa-B kinase subunit alpha	0	3	9	12
Ephrin type-B receptor 6	0	0	23	23
Peroxisomal acyl-coenzyme A oxidase 3	0	0	24	24
Mitogen-activated protein kinase kinase kinase 13	0	0	9	9
Mitotic checkpoint serine/threonine-protein kinase BUB1	0	0	23	23
Dynamin-like 120 kDa protein, mitochondrial	0	0	24	24
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	0	0	9	9
Cyclin-T1	0	6	0	6
UDP-glucuronosyltransferase 1A9	0	1	0	5
Eukaryotic translation initiation factor 5B	0	0	17	17
Rho-associated protein kinase 2	0	2	25	27
Serine/threonine-protein kinase ULK1	0	0	23	23
Serine/threonine-protein kinase/endoribonuclease IRE1	0	2	24	26
U5 small nuclear ribonucleoprotein 200 kDa helicase	0	0	24	24
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	0	0	9	9
Cyclin-K	0	2	0	2
Cyclin-dependent kinase-like 5	0	0	18	18
G2/mitotic-specific cyclin-B2	0	4	0	5
Structural maintenance of chromosomes protein 2	0	0	24	24
Mitogen-activated protein kinase kinase kinase 6	0	0	24	24
Serine/threonine-protein kinase OSR1	0	0	9	9
Serine/threonine-protein kinase Chk2	0	1	9	10
G1/S-specific cyclin-E2	0	2	0	2
Vitamin K-dependent protein C	0	2	0	2
Guanine nucleotide-binding protein G(i) subunit alpha-2	0	0	20	20
Protein kinase C gamma type	0	11	2	15
ADP/ATP translocase 2	0	0	24	24
Protein kinase C alpha type	0	4	0	4
Protein kinase C beta type	0	11	26	39
Glycogen phosphorylase, liver form	0	0	24	24
Adenine phosphoribosyltransferase	0	0	20	20
Signal recognition particle receptor subunit alpha	0	0	22	22
Cytochrome c1, heme protein, mitochondrial	0	0	24	24
Protein kinase C delta type	0	4	0	4
Protein kinase C epsilon type	0	4	0	4
Protein kinase C zeta type	0	4	0	4
Wee1-like protein kinase 2	0	0	9	9
Uncharacterized serine/threonine-protein kinase SBK3	0	0	9	9
Serine/threonine-protein kinase A-Raf	0	3	23	26
Glycogen phosphorylase, brain form	0	2	24	26
Breakpoint cluster region protein	0	7	27	36
Cyclin-dependent kinase 4	0	10	24	35
ADP/ATP translocase 3	0	0	24	24
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	0	24	24
G2/mitotic-specific cyclin-B1	0	9	0	10
G2/mitotic-specific cyclin-B	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	8	25	33
Protein kinase C alpha type	0	15	27	46
General transcription and DNA repair factor IIH helicase subunit XPD	0	0	24	24
Glycogen synthase kinase-3 beta	0	3	0	3
Ras-related protein Rab-6A	0	0	23	23
Serine/threonine-protein kinase MAK	0	0	9	9
Receptor tyrosine-protein kinase erbB-3	0	2	9	11
Multifunctional protein ADE2	0	0	24	24
Nucleoside diphosphate kinase B	0	0	3	3
Dual specificity protein kinase CLK1	0	2	0	2
Ferrochelatase, mitochondrial	0	0	26	26
Ribosomal protein S6 kinase beta-1	0	3	22	25
G1/S-specific cyclin-D1	0	8	0	9
G1/S-specific cyclin-E1	0	5	0	5
Beta-adrenergic receptor kinase 1	0	0	25	25
Probable ATP-dependent RNA helicase DDX6	0	0	24	24
Deoxycytidine kinase	0	0	24	30
UMP-CMP kinase	0	0	17	18
Phosphatidylethanolamine-binding protein 1	0	0	21	21
G1/S-specific cyclin-D2	0	2	0	3
G1/S-specific cyclin-D3	0	3	0	4
Heme oxygenase 2	0	0	24	24
S-adenosylmethionine synthase isoform type-2	0	0	23	23
DnaJ homolog subfamily A member 1	0	0	24	24
G protein-coupled receptor kinase 4	0	0	9	9
DNA replication licensing factor MCM4	0	0	24	24
Prostaglandin G/H synthase 2	0	26	11	39
Myosin-10	0	0	17	17
Electron transfer flavoprotein subunit beta	0	0	19	19
Glycine--tRNA ligase	0	0	24	24
Protein kinase C iota type	0	8	25	35
Exosome RNA helicase MTR4	0	0	24	24
Megakaryocyte-associated tyrosine-protein kinase	0	0	9	9
26S proteasome regulatory subunit 6B	0	1	24	25
Casein kinase I isoform alpha	0	5	24	29
Elongation factor Tu, mitochondrial	0	0	24	24
Choline-phosphate cytidylyltransferase A	0	0	14	14
Cysteine--tRNA ligase, cytoplasmic	0	0	22	22
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	0	0	24	24
Ras-related protein Rab-27A	0	0	23	23
Interleukin-1 receptor-associated kinase 1	0	0	24	24
Cyclin-H	0	5	0	5
CDK-activating kinase assembly factor MAT1	0	3	0	3
Serine/threonine-protein kinase Nek3	0	0	24	24
Serine/threonine-protein kinase Nek4	0	0	9	9
Tyrosine--tRNA ligase, cytoplasmic	0	0	24	24
Hormonally up-regulated neu tumor-associated kinase	0	0	9	9
Receptor-interacting serine/threonine-protein kinase 4	0	0	9	9
Ras-related protein Rab-10	0	0	24	24
Cell division control protein 2 homolog	0	0	9	9
Actin-related protein 3	0	1	24	25
Actin-related protein 2	0	0	23	23
Calcium-dependent protein kinase 1	0	1	9	10
GTP-binding nuclear protein Ran	0	0	24	24
Protein kinase C gamma type	0	4	0	4
Protein kinase C beta type	0	4	0	4
Cyclin-A1	0	7	0	8
Serine/threonine-protein kinase PknB	0	0	9	9
Cyclin-dependent kinase-like 1	0	0	9	9
Cyclin-dependent kinase 6	0	4	24	28
Cyclin homolog	0	1	0	1
ATP-dependent 6-phosphofructokinase, platelet type	0	0	23	23
DNA topoisomerase 2-beta	0	2	25	34
Macrophage-stimulating protein receptor	0	0	24	24
Protein kinase C zeta type	0	9	16	27
Mitogen-activated protein kinase kinase kinase kinase 2	0	0	24	24
Mitogen-activated protein kinase kinase kinase 12	0	0	9	9
Dual specificity mitogen-activated protein kinase kinase 5	0	0	24	24
Mitogen-activated protein kinase kinase kinase 1	0	0	24	24
Integrin-linked protein kinase	0	0	22	22
Rho-associated protein kinase 1	0	0	24	24
Serine/threonine-protein kinase PRP4 homolog	0	0	9	9
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	3	24	27
Cyclin-dependent kinase 13	0	0	23	23
Structural maintenance of chromosomes protein 1A	0	0	23	23
Chromodomain-helicase-DNA-binding protein 4	0	0	23	23
Peroxisomal acyl-coenzyme A oxidase 1	0	0	22	22
Cyclin-dependent kinase 5 activator 1	0	3	0	3
Cyclin-dependent kinase 10	0	0	9	9
Serine/threonine-protein kinase 38	0	0	15	15
Receptor tyrosine-protein kinase erbB-4	0	4	9	13
Delta(24)-sterol reductase	0	0	24	24
Rhodopsin kinase GRK1	0	0	9	9
Myosin light chain kinase 3	0	1	23	24
La-related protein 7	0	1	0	1
Serine/threonine-protein kinase SBK1	0	0	9	9
Mitogen-activated protein kinase kinase kinase 19	0	0	9	9
Putative heat shock protein HSP 90-beta 2	0	0	24	24
Rab-like protein 3	0	0	16	16
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	3	0	3
Protein kinase C eta type	0	4	0	4
Acyl-CoA dehydrogenase family member 10	0	0	21	21
Serine/threonine-protein kinase N3	0	0	21	21
Serine/threonine-protein kinase ULK3	0	0	24	24
Dual serine/threonine and tyrosine protein kinase	0	1	9	10
Mitogen-activated protein kinase kinase kinase 15	0	0	9	9
Uncharacterized protein FLJ45252	0	0	24	24
Acyl-CoA dehydrogenase family member 11	0	0	22	22
Serine/threonine-protein kinase/endoribonuclease IRE2	0	0	23	23
ATP-dependent RNA helicase DHX30	0	0	16	16
Serine/threonine-protein kinase TAO1	0	0	24	24
STE20-related kinase adapter protein alpha	0	0	24	24
Myosin-14	0	0	24	24
AarF domain-containing protein kinase 1	0	0	24	24
ATP-dependent RNA helicase DDX42	0	0	19	19
Serine/threonine-protein kinase VRK2	0	0	9	9
Homeodomain-interacting protein kinase 1	0	1	9	10
Cyclin-dependent kinase-like 3	0	0	9	9
Serine/threonine-protein kinase NIM1	0	0	9	9
Serine/threonine-protein kinase ULK2	0	0	9	9
Misshapen-like kinase 1	0	0	19	19
Homeodomain-interacting protein kinase 4	0	1	9	10
Serine/threonine-protein kinase Nek11	0	0	9	9
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	0	0	23	23
Serine/threonine-protein kinase 35	0	0	9	9
Rhodopsin kinase GRK7	0	0	9	9
Serine/threonine-protein kinase 32A	0	0	9	9
G2/mitotic-specific cyclin-B3	0	4	0	5
ATP-dependent RNA helicase DDX1	0	0	24	24
Dual specificity tyrosine-phosphorylation-regulated kinase 2	0	1	9	10
Cyclin-dependent kinase-like 2	0	0	9	9
Serine/threonine-protein kinase Sgk3	0	0	9	9
Cyclin-dependent kinase 15	0	0	9	9
PAS domain-containing serine/threonine-protein kinase	0	0	16	16
EKC/KEOPS complex subunit TP53RK	0	0	24	24
Dual specificity testis-specific protein kinase 2	0	0	14	14
Mitogen-activated protein kinase kinase kinase 3	0	0	24	24
Eukaryotic translation initiation factor 2-alpha kinase 1	0	0	24	24
Serine/threonine-protein kinase RIO2	0	0	9	9
Transient receptor potential cation channel subfamily M member 6	0	0	9	9
Nucleolar GTP-binding protein 1	0	0	24	24
Cyclin-dependent kinase 1	0	1	0	1
RNA cytidine acetyltransferase	0	0	24	24
Serine/threonine-protein kinase TAO3	0	0	24	24
Homeodomain-interacting protein kinase 2	0	1	9	10
Homeodomain-interacting protein kinase 3	0	1	9	10
dCTP pyrophosphatase 1	0	2	24	26
SNF-related serine/threonine-protein kinase	0	0	9	9
Phenylalanine--tRNA ligase beta subunit	0	0	24	24
Isoleucine--tRNA ligase, mitochondrial	0	0	18	18
Obg-like ATPase 1	0	0	20	20
Midasin	0	0	24	24
Interleukin-1 receptor-associated kinase 4	0	0	24	24
Cyclin-dependent kinase 12	0	1	24	25
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	0	0	22	22
STE20/SPS1-related proline-alanine-rich protein kinase	0	0	9	9
Serine/threonine-protein kinase TBK1	0	2	24	26
Septin-9	0	0	24	24
Serine/threonine-protein kinase TAO2	0	0	24	24
Long-chain-fatty-acid--CoA ligase 5	0	0	17	17
SRSF protein kinase 3	0	0	9	9
Serine/threonine-protein kinase ICK	0	0	23	23
Protein kinase C theta type	0	4	0	4
Microtubule-associated serine/threonine-protein kinase 1	0	0	9	9
Serine/threonine-protein kinase SIK3	0	1	24	25
Mitogen-activated protein kinase kinase kinase 2	0	0	24	24
Thyroid hormone receptor-associated protein 3	0	0	20	20
Receptor-interacting serine/threonine-protein kinase 3	0	2	24	26
putative alpha-glucosidase	1	0	0	1
Glutamate receptor ionotropic, NMDA 2D	0	5	1	6
Glutamate receptor ionotropic, NMDA 3B	0	5	1	6
Matrix protein 2	0	1	1	2
Matrix protein 2	0	1	2	3
Glutamate receptor ionotropic, NMDA 1	0	7	1	8
Glutamate receptor ionotropic, NMDA 2A	0	7	1	8
Glutamate receptor ionotropic, NMDA 2B	0	7	2	9
Glutamate receptor ionotropic, NMDA 2C	0	5	1	6
Glutamate receptor ionotropic, NMDA 3A	0	5	1	6
Multidrug and toxin extrusion protein 1	0	26	0	26
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR	0	1	0	1
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR	0	1	0	1
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR	0	1	0	1
Membrane primary amine oxidase	0	2	0	2
Prothrombin	0	5	3	9
Coagulation factor X	0	3	0	3
Plasminogen	0	2	0	2
Urokinase-type plasminogen activator	0	4	0	4
Tissue-type plasminogen activator	0	4	0	4
Cationic trypsin	0	2	0	2
Coagulation factor XI	0	1	0	1
Plasma kallikrein	0	4	0	11
Urokinase-type plasminogen activator	0	4	0	4
Trypsin-1	0	2	0	2
Trypsin-2	0	2	0	2
Sodium/hydrogen exchanger 1	0	1	0	1
Sodium/hydrogen exchanger 1	0	2	0	2
Sodium/hydrogen exchanger 3	0	2	0	2
Trypsin-3	0	2	0	2
Amiloride-sensitive sodium channel subunit alpha	0	1	0	1
5-hydroxytryptamine receptor 7	0	21	0	22
Sodium/hydrogen exchanger 2	0	2	0	2
Acid-sensing ion channel 1	0	2	0	2
Sodium channel protein type 5 subunit alpha	0	27	0	27
Sodium/hydrogen exchanger 5	0	2	0	2
Acid-sensing ion channel 3	0	1	0	1
Sodium/hydrogen exchanger	0	1	0	1
Snq2p	0	0	0	9
Pleiotropic ABC efflux transporter of multiple drugs	0	9	0	18
potassium voltage-gated channel subfamily H member 2 isoform d	103	0	0	103
Sterol O-acyltransferase 1	0	3	0	3
Cholesterol side-chain cleavage enzyme, mitochondrial	0	1	1	2
Triosephosphate isomerase	0	2	0	2
Steroid 17-alpha-hydroxylase/17,20 lyase	0	10	0	10
Cholesterol side-chain cleavage enzyme, mitochondrial	0	1	0	1
Aromatase	0	2	2	4
Cytochrome P450 11B2, mitochondrial	0	3	0	3
aryl hydrocarbon receptor nuclear translocator	0	0	0	2
transforming acidic coiled-coil-containing protein 3	0	0	0	2
Guanine deaminase	0	3	0	4
Gamma-aminobutyric acid receptor subunit rho-1	0	1	4	5
Glutamate receptor 1	0	3	1	4
Glutamate receptor 2	0	3	1	4
Glutamate receptor 3	0	2	1	3
Glutamate receptor ionotropic, kainate 3	0	4	0	4
Solute carrier family 15 member 1	0	8	0	8
Glutamate receptor 4	0	3	1	4
Solute carrier family 15 member 1	0	6	0	6
Solute carrier family 15 member 2	0	6	0	6
Dihydrofolate reductase	0	10	0	13
Dihydrofolate reductase	0	4	0	6
Dihydrofolate reductase	0	3	0	5
Dihydrofolate reductase	0	7	4	12
Folylpolyglutamate synthase, mitochondrial	0	2	0	6
Solute carrier organic anion transporter family member 1A3	0	3	0	7
Folylpolyglutamate synthase, mitochondrial	0	1	0	6
Nicotinate phosphoribosyltransferase	0	5	0	5
ORF73	0	0	5	5
Voltage-dependent L-type calcium channel subunit alpha-1C	0	15	0	15
Solute carrier organic anion transporter family member 1A4	0	4	0	9
Voltage-dependent L-type calcium channel subunit alpha-1F	0	30	1	31
Lysine-specific demethylase PHF2	0	1	0	1
Thyroid hormone receptor alpha	0	1	0	1
Muscarinic acetylcholine receptor M2	0	54	8	68
Muscarinic acetylcholine receptor M4	0	49	6	60
Muscarinic acetylcholine receptor M5	0	43	5	52
Muscarinic acetylcholine receptor M1	0	52	11	70
Lethal factor	0	3	0	3
Muscarinic acetylcholine receptor M3	0	53	7	65
Substance-K receptor	0	34	0	34
Carnitine O-palmitoyltransferase 2, mitochondrial	0	3	0	3
Histamine H2 receptor	0	44	2	47
Endothelin-1 receptor	0	5	1	7
Lysine-specific demethylase 5A	0	2	0	2
B2 bradykinin receptor	0	4	0	4
Melanocortin receptor 4	0	8	0	8
C-8 sterol isomerase	0	7	0	7
Melanocortin receptor 5	0	16	0	16
Sodium channel protein type 1 subunit alpha	0	11	0	11
Sodium channel protein type 4 subunit alpha	0	14	0	17
Squalene synthase	0	1	0	1
C-C chemokine receptor type 2	0	8	0	8
Melanocortin receptor 3	0	8	0	8
Carnitine O-palmitoyltransferase 1, liver isoform	0	3	0	3
C-C chemokine receptor type 4	0	5	0	5
Sodium channel protein type 7 subunit alpha	0	10	0	10
Voltage-dependent L-type calcium channel subunit alpha-1D	0	30	1	31
Voltage-dependent L-type calcium channel subunit alpha-1S	0	30	1	31
Squalene monooxygenase	0	1	0	1
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	8	1	9
Sodium channel protein type 9 subunit alpha	0	18	0	18
Lysine-specific demethylase 7A	0	1	0	1
Carnitine O-palmitoyltransferase 1, muscle isoform	0	2	0	2
Sodium channel protein type 2 subunit alpha	0	13	0	13
Sigma non-opioid intracellular receptor 1	0	56	1	57
NAD-dependent protein deacetylase sirtuin-3, mitochondrial	0	1	2	3
Sodium channel protein type 3 subunit alpha	0	14	0	14
Sodium channel protein type 11 subunit alpha	0	9	0	9
Histone lysine demethylase PHF8	0	1	0	1
Sodium channel protein type 8 subunit alpha	0	10	0	10
Sodium channel protein type 10 subunit alpha	0	10	0	10
Integrase	0	9	0	9
Beta-lactamase	0	1	0	3
Beta-lactamase	0	1	0	3
Beta-lactamase	0	0	0	3
Beta-lactamase	0	1	0	3
Beta-lactamase	0	0	0	2
Beta-lactamase SHV-1	0	1	0	3
Beta-lactamase SHV-1	0	2	0	5
Beta-lactamase	0	1	0	4
B2 metallo-beta-lactamase	0	0	0	3
Solute carrier family 15 member 2	0	3	0	3
Beta-lactamase	0	1	0	3
Beta-lactamase	0	1	0	3
Beta-lactamase	0	1	0	3
Beta-lactamase	0	0	0	2
Phenylethanolamine N-methyltransferase	0	3	0	3
Substance-P receptor	0	5	0	5
Cytochrome P450 2A5	0	2	0	2
Sodium-dependent dopamine transporter	0	28	2	30
Beta-2 adrenergic receptor	0	4	3	9
Sigma non-opioid intracellular receptor 1	0	13	3	16
tumor necrosis factor	2	0	0	2
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	33	4	40
Chain A, Mutant Al2 6e7p9g	0	0	1	1
Beta-lactamase	0	0	0	2
Beta-lactamase	0	1	0	3
Beta-lactamase	0	0	0	3
Metallo-beta-lactamase type 2	0	1	2	6
Metallo-beta-lactamase VIM-11	0	0	0	3
Metallo-beta-lactamase VIM-2	0	0	0	3
Beta-lactamase	0	0	0	3
Metallo-beta-lactamase	0	0	0	3
Beta-lactamase	0	1	0	3
60 kDa heat shock protein, mitochondrial	0	14	0	14
Beta-lactamase OXA-7	0	0	0	1
10 kDa heat shock protein, mitochondrial	0	14	0	14
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	2
Thiosulfate sulfurtransferase	0	13	0	13
Metallo-beta-lactamase VIM-13	0	1	0	4
Efflux transporter	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase Toho-1	0	0	0	2
Beta-lactamase	0	0	0	2
Class D beta-lactamase	0	1	0	3
60 kDa chaperonin	0	14	0	14
Metallo-beta-lactamase	0	0	0	2
Beta-lactamase	0	1	0	3
Beta-lactamase	0	0	1	4
10 kDa chaperonin	0	14	0	14
Metallo-b-lactamase	0	0	0	4
Carbapenem-hydrolyzing beta-lactamase KPC	0	2	0	5
Histamine H3 receptor	0	1	0	4
Beta-lactamase class B VIM-2	0	1	2	7
Beta-lactamase VIM-1	0	1	0	4
Fatty-acid amide hydrolase 1	0	10	0	11
Fatty-acid amide hydrolase 1	0	1	0	2
Potassium channel subfamily K member 3	0	4	0	4
Fatty acid-binding protein, liver	0	3	0	3
Glutamate receptor 1	5	3	3	13
Glutamate receptor 3	5	3	3	13
Glutamate receptor 4	5	3	3	13
Cannabinoid receptor 1	0	12	1	14
Cannabinoid receptor 2	0	4	1	6
Cannabinoid receptor 1	0	4	2	6
Cannabinoid receptor 2	0	2	3	5
Corticotropin-releasing factor receptor 2	0	2	0	2
Lanosterol 14-alpha demethylase	0	13	2	15
Potassium channel subfamily K member 2	0	2	0	2
Transient receptor potential cation channel subfamily V member 1	0	0	2	3
Cannabinoid receptor 2	0	2	0	2
Transient receptor potential cation channel subfamily V member 2	0	7	0	7
Amine oxidase [flavin-containing] A	0	12	0	13
UDP-glucuronosyltransferase 1A4	0	7	0	16
Beta-glucuronidase	0	2	0	2
Cholinesterase	0	18	1	19
Gastrin/cholecystokinin type B receptor	1	5	3	10
Testosterone 17-beta-dehydrogenase 3	0	4	0	4
Chain A, retinol dehydratase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	11	1	13
G-protein coupled bile acid receptor 1	0	0	7	7
Atrial natriuretic peptide receptor 3	0	2	0	2
Type-1A angiotensin II receptor	0	6	4	10
Type-1 angiotensin II receptor	0	0	1	1
Type-1B angiotensin II receptor	0	7	1	8
Type-1 angiotensin II receptor	0	9	5	16
Type-2 angiotensin II receptor	0	6	1	7
Aminopeptidase N	0	5	0	5
Interleukin-1 receptor antagonist protein	0	2	0	2
Endoplasmic reticulum aminopeptidase 2	0	2	0	2
Endoplasmic reticulum aminopeptidase 1	0	2	0	2
Leucyl-cystinyl aminopeptidase	0	1	0	1
M17 leucyl aminopeptidase	0	1	0	1
Cytochrome P450 130	0	0	2	2
Cytochrome P450 130	0	0	2	2
Tryptophan 5-hydroxylase 1	0	4	0	4
D(3) dopamine receptor	0	33	1	38
D(2) dopamine receptor	0	12	0	13
D(1B) dopamine receptor	0	12	1	17
D(1B) dopamine receptor	0	21	0	21
D(4) dopamine receptor	0	23	1	24
E3 ubiquitin-protein ligase Mdm2	0	4	0	4
D	0	3	0	3
D	0	9	0	9
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN	0	0	1	1
Chain A, SERUM ALBUMIN	0	0	2	2
Chain A, SERUM ALBUMIN	0	0	2	2
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	40	0	0	40
60 kDa chaperonin	0	10	0	10
Calmodulin	0	2	4	7
Solute carrier organic anion transporter family member 1B3	0	26	0	32
Cytosolic phospholipase A2 gamma	0	3	0	3
Solute carrier organic anion transporter family member 1B1	0	28	0	33
Cytosolic phospholipase A2	0	1	0	1
Cytosolic phospholipase A2 beta	0	1	0	1
Cytosolic phospholipase A2	0	1	0	1
Platelet-activating factor acetylhydrolase	0	5	0	6
Monoglyceride lipase	0	4	0	4
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	3	3
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	3	3
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	3	3
Nitric oxide synthase, endothelial	0	3	0	5
Cationic amino acid transporter 3	0	2	0	2
Vasopressin V2 receptor	0	10	3	14
Oxytocin receptor	0	3	4	7
Vasopressin V1a receptor	0	2	3	5
Vasopressin V1a receptor	0	15	4	19
Vasopressin V1b receptor	0	3	3	6
Vasopressin V2 receptor	0	0	1	1
Vasopressin V1b receptor	0	3	1	5
Translocator protein	0	3	0	5
Oxytocin receptor	0	3	1	4
Vasopressin V2 receptor	0	4	2	6
Integrin beta-1	0	3	0	3
Integrin alpha-V	0	3	0	3
Integrin alpha-5	0	2	0	2
Integrin beta-5	0	1	0	1
5-hydroxytryptamine receptor 3E	0	9	1	10
mu-type opioid receptor isoform MOR-1	0	0	6	6
5-hydroxytryptamine receptor 2A	0	0	6	6
5-hydroxytryptamine receptor 3A	0	3	1	4
5-hydroxytryptamine receptor 3B	0	9	1	10
Histamine H1 receptor	0	9	5	15
5-hydroxytryptamine receptor 7	0	26	1	30
Histamine H1 receptor	0	46	6	56
5-hydroxytryptamine receptor 3A	0	10	1	12
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	6	0	6
5-hydroxytryptamine receptor 3D	0	9	1	10
Multidrug and toxin extrusion protein 2	0	12	0	12
5-hydroxytryptamine receptor 3C	0	9	1	10
Histamine H3 receptor	0	9	2	11
Chain A, Hyaluronidase, phage associated	0	1	0	1
Polyphenol oxidase 2	0	10	0	14
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	1	0	2
Urease	0	4	0	5
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	4	0	4
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	0	0	1
Egl nine homolog 1	0	1	1	3
Prolyl hydroxylase EGLN3	0	0	0	1
Hypoxia-inducible factor 1-alpha inhibitor	0	0	0	1
Solute carrier family 23 member 1	0	1	0	1
Neutral amino acid transporter A	0	5	0	5
Neutral amino acid transporter B(0)	0	5	0	5
Carbonic anhydrase-like protein, putative	0	0	0	10
Amino acid transporter	0	5	0	5
Metabotropic glutamate receptor 6	0	2	2	5
Excitatory amino acid transporter 4	0	2	0	2
Glutamate transporter homolog	0	0	1	1
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	2	0	2
Excitatory amino acid transporter 1	0	3	0	4
Excitatory amino acid transporter 2	0	3	0	4
Excitatory amino acid transporter 3	0	3	0	4
Metabotropic glutamate receptor 1	0	1	2	4
Metabotropic glutamate receptor 2	0	1	2	4
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	1	1
ras protein, partial	0	0	1	1
Rac1 protein	0	0	1	1
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	1	1
Prostaglandin-H2 D-isomerase	0	2	0	2
Prostaglandin G/H synthase 2	0	4	0	6
Fatty acid-binding protein, liver	0	9	2	11
Myeloperoxidase	0	8	0	8
Prostaglandin G/H synthase 1	0	17	2	20
Seed linoleate 13S-lipoxygenase-1	0	3	0	3
Glutathione hydrolase 1 proenzyme	0	1	0	1
Substance-P receptor	0	9	0	9
Urotensin-2 receptor	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Ras-related protein Rab-2A	0	0	1	1
Rho-associated protein kinase 2	0	3	0	3
Atrial natriuretic peptide receptor 1	0	1	1	2
Atrial natriuretic peptide receptor 1	0	0	1	1
cystic fibrosis transmembrane conductance regulator	0	3	0	3
short transient receptor potential channel 6 isoform 1	0	0	2	2
Muscarinic acetylcholine receptor M1	0	2	4	8
Muscarinic acetylcholine receptor M4	0	3	1	5
Muscarinic acetylcholine receptor	0	6	1	8
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	2	0	2
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	2	0	2
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	2	0	2
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	2	0	2
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2	0	2	0	2
Cell division cycle 7-related protein kinase	0	0	15	15
G protein-coupled receptor kinase 6	0	1	16	17
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	0	0	21	21
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	0	0	10	10
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial	0	0	21	21
DNA (cytosine-5)-methyltransferase 1	0	5	0	5
Protein-arginine deiminase type-4	0	6	0	6
Chain A, Diaminopimelate decarboxylase	0	1	0	1
Chain B, Diaminopimelate decarboxylase	0	1	0	1
Potassium voltage-gated channel subfamily H member 2	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 1	0	1	0	1
Gamma-aminobutyric acid type B receptor subunit 2	0	3	2	5
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	3	2	5
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
V-type proton ATPase subunit S1	0	1	0	1
Vacuolar proton pump subunit B	0	1	0	1
Interstitial collagenase	0	3	0	3
Low affinity immunoglobulin epsilon Fc receptor	0	1	0	1
72 kDa type IV collagenase	0	9	0	9
Stromelysin-1	0	4	1	5
Matrilysin	0	4	0	4
Matrix metalloproteinase-9	0	6	0	6
Neutrophil collagenase	0	3	0	3
Metabotropic glutamate receptor 5	0	3	2	5
Collagenase 3	0	3	0	3
Matrix metalloproteinase-14	0	3	0	3
Snake venom metalloproteinase BaP1	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	12	0	13
Voltage-dependent L-type calcium channel subunit alpha-1D	0	8	0	9
Voltage-dependent L-type calcium channel subunit alpha-1S	0	7	0	8
Transient receptor potential cation channel subfamily A member 1	0	0	6	6
Rap guanine nucleotide exchange factor 4	23	0	0	23
Zinc finger protein mex-5	0	0	1	1
Genome polyprotein	0	1	0	1
Hexokinase-2	0	1	0	1
Nrf2	7	0	0	7
ClpP	10	0	0	10
Nicotinamide N-methyltransferase	0	1	0	1
Poly(ADP-ribose) glycohydrolase	0	1	0	1
Chain A, Integrase	0	1	0	1
Chain A, Integrase	0	1	0	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, GCN4P1	0	0	1	1
Chain B, GCN4P1	0	0	1	1
Chain C, GCN4P1	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, T4 LYSOZYME	0	0	1	1
Chain A, Replicase polyprotein 1ab	0	1	0	1
Chain A, 3C-like proteinase	0	1	0	1
Endolysin	0	0	2	2
Proteasome subunit beta type-11	0	3	0	4
Calpain-9	0	1	0	1
Proteasome subunit alpha type-7	0	3	0	4
Cathepsin B	0	6	0	6
Replicase polyprotein 1ab	0	16	14	30
Calpain-2 catalytic subunit	0	1	0	1
Proteasome subunit beta type-1	0	4	0	6
Proteasome subunit alpha type-1	0	3	0	4
Proteasome subunit alpha type-2	0	3	0	4
Proteasome subunit alpha type-3	0	3	0	4
Proteasome subunit alpha type-4	0	3	0	4
NF-kappa-B inhibitor alpha	0	0	1	1
Proteasome subunit beta type-8	0	3	0	4
Proteasome subunit beta type-9	0	3	0	4
Proteasome subunit alpha type-5	0	3	0	4
Proteasome subunit beta type-4	0	3	0	4
Proteasome subunit beta type-6	0	3	0	4
Proteasome subunit beta type-5	0	12	0	14
Proteasome subunit beta type-10	0	3	0	4
Cathepsin K	0	2	0	2
Proteasome subunit beta type-3	0	3	0	4
Proteasome subunit beta type-2	0	4	0	6
Proteasome subunit alpha type-6	0	3	3	7
Proteasome subunit alpha-type 8	0	3	0	4
Proteasome subunit beta type-7	0	3	0	4
Gamma-secretase subunit PEN-2	0	1	0	1
Chain A, D-MALTODEXTRIN BINDING PROTEIN	0	0	1	1
Chain A, Limit Dextrinase	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain A, Solute-binding protein	0	0	1	1
Chain B, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, SusD	0	0	1	1
Chain A, Alpha-hemolysin	0	0	1	1
Chain B, Alpha-hemolysin	0	0	1	1
Chain C, Alpha-hemolysin	0	0	1	1
Chain D, Alpha-hemolysin	0	0	1	1
Chain E, Alpha-hemolysin	0	0	1	1
Chain F, Alpha-hemolysin	0	0	1	1
Chain G, Alpha-hemolysin	0	0	1	1
galanin receptor type 3	0	2	0	2
Cytochrome P450 26A1	0	2	0	2
Cytochrome P450 26B1	0	1	0	1
Gamma-aminobutyric acid receptor subunit pi	0	12	0	12
Gamma-aminobutyric acid receptor subunit delta	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-1	0	17	7	24
Gamma-aminobutyric acid receptor subunit beta-1	0	12	3	15
Gamma-aminobutyric acid receptor subunit gamma-2	0	16	6	22
Gamma-aminobutyric acid receptor subunit beta-3	0	16	4	20
Gamma-aminobutyric acid receptor subunit alpha-5	0	14	6	20
Gamma-aminobutyric acid receptor subunit alpha-3	0	14	4	18
Gamma-aminobutyric acid receptor subunit alpha-2	0	14	6	20
Gamma-aminobutyric acid receptor subunit beta-2	0	13	6	19
Gamma-aminobutyric acid receptor subunit alpha-4	0	12	3	15
Gamma-aminobutyric acid receptor subunit epsilon	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-6	0	13	3	16
Gamma-aminobutyric acid receptor subunit gamma-1	0	12	0	12
Gamma-aminobutyric acid receptor subunit gamma-3	0	12	0	12
Gamma-aminobutyric acid receptor subunit theta	0	12	0	12
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1	0	1	0	1
Membrane-associated progesterone receptor component 1	0	0	18	18
MAP kinase-activated protein kinase 3	0	0	8	8
Uncharacterized aarF domain-containing protein kinase 5	0	0	13	13
Chain A, Avidin	0	0	1	1
Chain A, Protein (streptavidin)	0	0	1	1
Chain B, Protein (streptavidin)	0	0	1	1
Chain A, Streptavidin	0	0	1	1
Chain D, Streptavidin	0	0	1	1
Chain A, Streptavidin	0	0	1	1
Chain D, Streptavidin	0	0	1	1
Chain A, Streptavidin	0	0	1	1
Chain D, Streptavidin	0	0	1	1
Chain A, Streptavidin Complex With Biotin	0	0	1	1
Chain D, Circularly Permuted Core-streptavidin E51/a46	0	0	1	1
Chain A, Core-streptavidin	0	0	1	1
Chain D, Core-streptavidin	0	0	1	1
Chain A, Core-streptavidin	0	0	1	1
Chain D, Core-streptavidin	0	0	1	1
Chain A, Core-streptavidin	0	0	1	1
Chain D, Core-streptavidin	0	0	1	1
Chain A, Core-streptavidin	0	0	1	1
Chain D, Core-streptavidin	0	0	1	1
Chain A, Avidin	0	0	1	1
Chain A, Streptavidin	0	0	1	1
Chain B, Streptavidin	0	0	1	1
Chain A, Streptavidin	0	0	1	1
Chain B, Streptavidin	0	0	1	1
nonstructural protein 1	0	2	0	2
green fluorescent protein, partial	0	1	0	1
insulin-degrading enzyme isoform 1	0	0	1	1
Receptor-type tyrosine-protein phosphatase beta	0	0	0	2
Chain A, Protein kinase C, iota	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	4	0	4
Insulin receptor	0	2	0	2
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
MO15-related protein kinase Pfmrk	0	5	0	5
NAD-dependent protein deacetylase sirtuin-2	0	6	1	7
NAD-dependent protein deacetylase sirtuin-1	0	4	1	7
Serine/threonine-protein kinase LMTK3	0	1	0	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
Chain A, Estrogen-related receptor gamma	0	0	1	1
GTPase KRas	0	2	1	3
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	14	1	15
Polyunsaturated fatty acid lipoxygenase ALOX15	0	23	0	23
GTP-binding protein Rheb	0	0	1	1
Chain H, Proteasome component PUP1	0	1	0	1
Chain I, Proteasome component PUP3	0	1	0	1
Chain K, Proteasome component PRE2	0	1	0	1
Chain L, Proteasome component C5	0	1	0	1
Chain K, Proteasome component PRE2	0	1	0	1
Chain L, Proteasome component C5	0	1	0	1
26S proteasome non-ATPase regulatory subunit 11	0	1	0	1
26S proteasome non-ATPase regulatory subunit 12	0	1	0	1
26S proteasome non-ATPase regulatory subunit 14	0	1	0	1
26S proteasome non-ATPase regulatory subunit 3	0	1	0	1
Chymotrypsinogen A	0	10	0	11
Neutrophil elastase	0	4	0	4
Cathepsin G	0	2	0	2
Lysosomal protective protein	0	2	0	2
Chymotrypsinogen B	0	3	0	3
26S proteasome regulatory subunit 6A	0	1	0	1
Nuclear factor NF-kappa-B p105 subunit	0	3	0	3
Chymase	0	1	0	1
Proteasome subunit beta type-8	0	1	0	1
26S proteasome regulatory subunit 7	0	1	0	1
Lon protease homolog, mitochondrial	0	1	0	1
26S proteasome non-ATPase regulatory subunit 8	0	1	0	1
26S proteasome non-ATPase regulatory subunit 7	0	1	0	1
26S proteasome non-ATPase regulatory subunit 4	0	1	0	1
26S proteasome complex subunit SEM1	0	1	0	1
26S proteasome regulatory subunit 4	0	1	0	1
26S proteasome regulatory subunit 8	0	1	0	1
26S proteasome regulatory subunit 10B	0	1	0	1
Nuclear factor NF-kappa-B p100 subunit	0	3	0	3
Transcription factor p65	0	4	0	5
26S proteasome non-ATPase regulatory subunit 2	0	1	0	1
26S proteasome non-ATPase regulatory subunit 6	0	1	0	1
Proteasomal ubiquitin receptor ADRM1	0	1	0	1
ATP-dependent Clp protease proteolytic subunit	0	1	1	2
NACHT, LRR and PYD domains-containing protein 3	0	3	0	3
26S proteasome non-ATPase regulatory subunit 1	0	1	0	1
26S proteasome non-ATPase regulatory subunit 13	0	1	0	1
Signal transducer and activator of transcription 3	0	3	1	4
Signal transducer and activator of transcription 3	0	1	0	2
Multidrug resistance-associated protein 6	0	0	0	1
Solute carrier organic anion transporter family member 1A5	0	0	0	6
Endothelin receptor type B	0	8	0	8
Endothelin-1 receptor	0	3	0	3
Canalicular multispecific organic anion transporter 1	0	3	0	6
Solute carrier organic anion transporter family member 1B2	0	0	0	4
PAX8	0	0	0	7
NPC intracellular cholesterol transporter 1 precursor	38	0	0	38
major prion protein preproprotein Prp precursor	0	2	0	2
nuclear receptor subfamily 0 group B member 1	0	6	0	6
steroidogenic factor 1	0	6	0	6
Genome polyprotein	0	4	2	6
Nuclear hormone receptor family member daf-12	0	0	1	1
oxysterols receptor LXR-beta isoform 1	0	0	1	1
Thymidine phosphorylase	0	0	1	4
Thymidylate kinase	0	2	0	2
Thymidine kinase	0	0	0	3
Thymidylate kinase	0	2	0	2
Nuclear factor erythroid 2-related factor 2	0	1	2	5
vasopressin V1b receptor	2	0	0	2
cAMP-dependent protein kinase type I-alpha regulatory subunit	0	0	1	1
cAMP-dependent protein kinase type II-beta regulatory subunit	0	0	1	1
cAMP-dependent protein kinase catalytic subunit beta isoform 1	0	0	1	1
relaxin receptor 1 isoform 1	4	0	0	4
relaxin receptor 2 isoform 1	3	0	0	3
cAMP-dependent protein kinase catalytic subunit beta isoform 3	0	0	1	1
Chain A, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	2	0	2
Aldo-keto reductase family 1 member C3	0	8	0	8
Phosphatidylinositol 3-kinase catalytic subunit type 3	0	3	1	4
Serine/threonine-protein kinase mTOR	0	2	0	2
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	3	0	3
Potassium channel subfamily K member 3	0	1	0	1
Potassium channel subfamily K member 9	0	1	0	1
Acetylcholine receptor subunit alpha	0	3	1	4
Acetylcholine receptor subunit gamma	0	3	1	4
Acetylcholine receptor subunit beta	0	3	1	4
UDP-glucuronosyltransferase 2B7	0	8	0	16
Neuronal acetylcholine receptor subunit beta-2	0	4	1	6
UDP-glucuronosyltransferase 1-6	0	7	0	8
UDP-glucuronosyltransferase 1A1	0	12	0	17
Neuronal acetylcholine receptor subunit beta-4	0	3	1	5
Neuronal acetylcholine receptor subunit alpha-3	0	3	1	4
UDP-glucuronosyltransferase 2B10	0	6	0	6
Neuronal acetylcholine receptor subunit alpha-4	0	3	1	5
Acetylcholine receptor subunit delta	0	3	1	4
Chain A, Nitrile Hydratase alpha subunit	0	1	0	1
Chain B, Nitrile Hydratase beta subunit	0	1	0	1
Lysine-specific demethylase 4E	0	4	0	4
Methyl-accepting chemotaxis protein NahY	0	0	2	2
Aldo-keto reductase family 1 member B10	0	3	0	3
Pancreatic triacylglycerol lipase	0	5	0	6
Aldo-keto reductase family 1 member A1	0	2	0	2
Aldo-keto reductase family 1 member B1	0	7	0	7
Polyunsaturated fatty acid lipoxygenase ALOX15	0	4	0	5
Aldo-keto reductase family 1 member C4	0	3	0	3
Aldo-keto reductase family 1 member C2	0	5	0	5
Aldo-keto reductase family 1 member C1	0	4	0	4
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
Vasopressin V2 receptor	0	1	0	3
Adenylate cyclase type 1	0	1	2	5
Chitotriosidase-1	0	2	0	2
Adenosine receptor A2b	0	1	0	3
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	3	5
Endochitinase B1	0	2	0	2
electroneutral potassium-chloride cotransporter KCC2	0	0	1	1
TSHR protein	2	0	0	2
LacZ protein (plasmid)	0	0	2	2
XBP1	0	3	0	3
hexokinase-4 isoform 1	16	0	0	16
type-1 angiotensin II receptor	0	2	0	2
glucokinase regulatory protein	16	0	0	16
apelin receptor	0	2	0	2
DNA damage-inducible transcript 3 protein	0	3	0	3
Vpr	19	0	0	19
streptokinase A precursor	0	0	9	9
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	5
heat shock protein 90, putative	0	0	0	12
Chain A, Vitamin D Nuclear Receptor	0	0	1	1
Vitamin D3 receptor	0	0	1	1
Vitamin D-binding protein	0	0	1	1
Vitamin D3 receptor	0	4	4	12
Vitamin D3 receptor	0	1	1	3
Vitamin D3 receptor	0	0	2	2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	2	1	3
Vitamin D3 receptor	0	1	1	2
Transporter	0	9	0	9
Vitamin D3 receptor A	0	0	2	2
Tyrosine-protein phosphatase non-receptor type 1	0	14	1	17
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	0	1	0	1
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B	0	1	0	1
Sodium/glucose cotransporter 1	0	4	2	6
Sodium/glucose cotransporter 2	0	3	2	5
Liver carboxylesterase 1	0	2	0	7
Chain A, Beta-lactoglobulin	0	0	1	1
Chain A, Beta-lactoglobulin	0	0	1	1
UDP-3-O-acyl-N-acetylglucosamine deacetylase	0	0	1	1
Replicase polyprotein 1ab	0	9	13	22
histone-lysine N-methyltransferase 2A isoform 2 precursor	34	0	0	34
Chain A, angiotensin converting enzyme	0	1	0	1
Chain A, angiotensin converting enzyme	0	1	0	1
transient receptor potential cation channel subfamily V member 1	5	0	0	5
Neprilysin	0	1	0	1
Neprilysin	0	2	0	2
EEF1AKMT4-ECE2 readthrough transcript protein	0	1	0	1
Angiotensin-converting enzyme	0	7	1	8
Angiotensin-converting enzyme	0	33	0	34
Leukotriene A-4 hydrolase	0	1	0	1
Endothelin-converting enzyme 1	0	1	0	1
Succinyl-diaminopimelate desuccinylase	0	2	0	2
Angiotensin-converting enzyme	0	5	1	6
Beta-lactamase TEM	0	6	0	9
Beta-lactamase	0	3	0	4
Beta-lactamase	0	3	0	3
Angiotensin-converting enzyme 2	0	5	13	18
Neuronal acetylcholine receptor subunit alpha-3	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-2	0	4	2	7
Neuronal acetylcholine receptor subunit beta-3	0	4	2	7
Neuronal acetylcholine receptor subunit beta-4	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-5	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-6	0	4	2	7
Neuronal acetylcholine receptor subunit alpha-9	0	4	2	7
Muscarinic acetylcholine receptor M3	0	1	2	6
Muscarinic acetylcholine receptor M2	0	1	1	6
Neuronal acetylcholine receptor subunit alpha-10	0	4	2	7
Albumin	0	0	12	12
Major prion protein	0	0	6	6
Sodium channel protein type 1 subunit alpha	0	4	0	4
Sodium channel protein type 2 subunit alpha	0	9	0	9
Sodium channel protein type 3 subunit alpha	0	5	0	5
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	2	0	2
Lactoperoxidase	0	2	0	2
Chain A, PAPAIN	1	0	0	1
CDGSH iron-sulfur domain-containing protein 1	0	12	0	12
Hypoxia-inducible factor 1-alpha	0	6	2	9
Endothelial PAS domain-containing protein 1	0	3	1	5
Chain A, serum paraoxonase	0	1	0	1
Poly [ADP-ribose] polymerase tankyrase-2	0	1	2	3
Glutathione reductase, mitochondrial	0	10	0	12
Glutathione reductase	0	2	0	2
Solute carrier family 22 member 5	0	0	0	2
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 16	0	0	0	1
Solute carrier family 22 member 21	0	0	0	1
Solute carrier family 22 member 5	0	0	0	2
Arginase	0	2	0	2
Melatonin receptor type 1A	0	2	2	4
Melatonin receptor type 1B	0	2	2	4
Beta-secretase 1	0	7	1	8
Dihydroorotate dehydrogenase	0	2	0	2
Solute carrier family 22 member 11	0	4	0	8
Solute carrier family 22 member 8	0	4	0	6
L-ornithine N(5)-monooxygenase	0	1	1	2
Ubiquitin carboxyl-terminal hydrolase 2	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase isozyme L1	0	2	0	2
Ubiquitin carboxyl-terminal hydrolase isozyme L3	0	2	0	2
Tyrosine-protein phosphatase non-receptor type 2	0	3	0	3
Receptor-type tyrosine-protein phosphatase epsilon	0	1	0	1
Tyrosine-protein phosphatase non-receptor type 6	0	2	0	2
Tyrosine-protein phosphatase non-receptor type 7	0	1	0	1
Tryptophan 2,3-dioxygenase	0	3	0	4
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	0	1	0	1
Heat shock factor protein 1	0	2	1	3
Tyrosine-protein phosphatase non-receptor type 11	0	3	0	4
Receptor-type tyrosine-protein phosphatase eta	0	3	0	3
Regulator of G-protein signaling 17	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 15	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase isozyme L5	0	1	0	1
Nucleophosmin	0	1	0	1
Transcription factor ETV6	0	1	0	1
Echinoderm microtubule-associated protein-like 4	0	1	2	4
Caspase-2	0	0	2	2
DNA polymerase III, partial	12	0	0	12
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	2	0	2
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aromatic-L-amino-acid decarboxylase	0	1	0	1
Single-stranded DNA cytosine deaminase	6	0	0	6
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	6	0	0	6
FAD-linked sulfhydryl oxidase ALR	0	0	0	3
Dihydroxyacetone phosphate acyltransferase	0	0	0	2
30S ribosomal protein S6	0	3	0	4
30S ribosomal protein S7	0	3	0	4
50S ribosomal protein L15	0	3	0	4
50S ribosomal protein L10	0	3	0	4
50S ribosomal protein L11	0	3	0	4
50S ribosomal protein L7/L12	0	3	0	4
50S ribosomal protein L19	0	3	0	4
50S ribosomal protein L1	0	3	0	4
50S ribosomal protein L20	0	3	0	4
50S ribosomal protein L27	0	3	0	4
50S ribosomal protein L28	0	3	0	4
50S ribosomal protein L29	0	3	0	4
50S ribosomal protein L31	0	3	0	4
50S ribosomal protein L31 type B	0	3	0	4
50S ribosomal protein L32	0	3	0	4
50S ribosomal protein L33	0	3	0	4
50S ribosomal protein L34	0	3	0	4
50S ribosomal protein L35	0	3	0	4
50S ribosomal protein L36	0	3	0	4
30S ribosomal protein S10	0	3	0	4
30S ribosomal protein S11	0	3	0	4
30S ribosomal protein S12	0	3	0	4
30S ribosomal protein S13	0	3	0	4
30S ribosomal protein S16	0	3	0	4
30S ribosomal protein S18	0	3	0	4
30S ribosomal protein S19	0	3	0	4
30S ribosomal protein S20	0	3	0	4
30S ribosomal protein S2	0	3	0	4
30S ribosomal protein S3	0	3	0	4
30S ribosomal protein S4	0	3	0	4
30S ribosomal protein S5	0	3	0	4
30S ribosomal protein S8	0	3	0	4
30S ribosomal protein S9	0	3	0	4
50S ribosomal protein L13	0	3	0	4
50S ribosomal protein L14	0	3	0	4
50S ribosomal protein L16	0	3	0	4
50S ribosomal protein L23	0	3	0	4
30S ribosomal protein S15	0	3	0	4
50S ribosomal protein L17	0	3	0	4
50S ribosomal protein L21	0	3	0	4
50S ribosomal protein L30	0	3	0	4
50S ribosomal protein L6	0	3	0	4
30S ribosomal protein S14	0	3	0	4
30S ribosomal protein S17	0	3	0	4
30S ribosomal protein S1	0	3	0	4
50S ribosomal protein L18	0	3	0	4
50S ribosomal protein L2	0	3	0	4
50S ribosomal protein L3	0	3	0	4
50S ribosomal protein L24	0	3	0	4
50S ribosomal protein L4	0	3	0	4
50S ribosomal protein L22	0	3	0	4
50S ribosomal protein L5	0	3	0	4
30S ribosomal protein S21	0	3	0	4
50S ribosomal protein L25	0	3	0	4
50S ribosomal protein L36 2	0	3	0	4
Methionine--tRNA ligase, mitochondrial	0	0	1	1
Estrogen receptor	0	0	2	2
Estrogen receptor beta	0	0	2	2
Gamma-aminobutyric acid receptor subunit alpha-1	0	4	0	6
Gamma-aminobutyric acid receptor subunit beta-1	0	4	0	6
Gamma-aminobutyric acid receptor subunit alpha-2	0	4	0	6
Gamma-aminobutyric acid receptor subunit alpha-3	0	4	0	6
Gamma-aminobutyric acid receptor subunit alpha-4	0	4	0	6
Gamma-aminobutyric acid receptor subunit gamma-2	0	4	0	6
Cholecystokinin receptor type A	1	7	0	8
Spike glycoprotein	0	4	13	17
Transmembrane protease serine 2	0	4	13	17
Dihydrofolate reductase	0	4	0	4
DNA ligase	0	1	0	1
Riboflavin-binding protein	0	1	2	3
Histidine-rich protein PFHRP-II	0	4	0	5
Procathepsin L	0	7	13	20
Replicase polyprotein 1a	0	4	13	17
Replicase polyprotein 1ab	0	4	13	17
Spike glycoprotein	0	1	0	1
DNA ligase 1	0	1	0	1
Calcium-dependent protein kinase 1	0	0	1	1
DNA ligase A	0	1	0	1
Sigma intracellular receptor 2	0	4	0	4
Phosphoethanolamine N-methyltransferase	0	1	0	1
Cysteine proteinase falcipain 2a	0	2	0	2
Cysteine proteinase falcipain 2a	0	1	0	1
NADPH oxidase 1	0	5	0	5
Adenylate cyclase type 1	0	4	0	4
Transient receptor potential cation channel subfamily V member 1	0	3	0	3
Albumin	0	10	11	26
Major prion protein	0	1	1	2
Cys-loop ligand-gated ion channel	0	1	0	1
Calmodulin-1	0	3	2	5
Sphingomyelin phosphodiesterase	0	2	0	2
Adenylate cyclase type 3	0	4	0	4
Adenylate cyclase type 2	0	4	1	5
Adenylate cyclase type 4	0	4	0	4
Trypanothione reductase	0	11	0	13
Adenylate cyclase type 8	0	4	0	4
Gastrin/cholecystokinin type B receptor	0	5	0	5
Aldehyde oxidase 1	0	3	0	3
Adenylate cyclase type 6	0	4	0	4
Adenylate cyclase type 5	0	4	0	4
Aldehyde oxidase	0	11	0	13
Nuclear receptor subfamily 3 group C member 3	0	29	0	29
Adenylyl cyclase 7	0	4	0	4
P2Y purinoceptor 12	0	3	0	3
Glycine receptor subunit alpha-1	0	0	5	5
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Acetylcholinesterase	0	0	2	2
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Choline O-acetyltransferase	0	2	0	3
High affinity choline transporter 1	0	1	0	1
Isocitrate dehydrogenase [NADP] cytoplasmic	0	1	0	1
Lysine-specific demethylase 4B	0	1	0	1
Deoxyhypusine hydroxylase	0	2	0	2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]	0	1	0	1
Peroxisome proliferator-activated receptor gamma	0	1	7	8
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Potassium-transporting ATPase subunit beta	0	1	0	1
Histamine H4 receptor	0	4	3	8
Solute carrier family 22 member 4	0	2	0	2
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit A	0	3	0	6
DNA gyrase subunit B	0	3	0	6
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	2
DNA topoisomerase 4 subunit A	0	1	0	2
DNA gyrase subunit A	0	1	0	2
Multidrug resistance protein MdtK	0	0	1	1
DNA gyrase subunit B	0	5	0	6
DNA gyrase subunit A	0	5	0	6
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	2	0	5
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	1
Sodium-dependent noradrenaline transporter	0	3	0	3
Aldo-keto reductase family 1 member B1	0	3	0	3
Sodium-dependent serotonin transporter	0	3	0	3
Sodium-dependent dopamine transporter	0	4	0	4
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	3	0	3
General amino-acid permease GAP1	0	0	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	2
Beta-lactamase	0	3	0	6
Beta-lactamase OXA-1	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	2
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	1
Beta-lactamase	0	1	0	3
Type IV secretion-like conjugative transfer relaxase protein TraI	0	1	0	1
Macrophage metalloelastase	0	1	0	1
Peroxisome proliferator-activated receptor alpha	0	3	4	7
Histamine H1 receptor	0	10	1	11
Trypanothione reductase	0	1	0	1
Voltage-dependent N-type calcium channel subunit alpha-1B	0	4	0	4
Envelope glycoprotein	0	0	3	3
Translocator protein	0	2	0	2
Translocator protein	0	3	1	5
Beta-1 adrenergic receptor	0	2	3	7
Alpha-1B adrenergic receptor	0	0	3	3
Alpha-1A adrenergic receptor	0	7	3	10
Alpha-2B adrenergic receptor	0	2	0	4
Alpha-2C adrenergic receptor	0	2	0	4
Alpha-2A adrenergic receptor	0	2	0	4
Alpha-2A adrenergic receptor	0	2	0	2
Nischarin	0	2	0	2
isocitrate dehydrogenase 1, partial	4	0	0	4
heat shock protein 90	0	0	2	2
calcineurin A1, putative	0	0	1	1
beta-2 adrenergic receptor	10	0	1	11
Intermediate conductance calcium-activated potassium channel protein 4	0	1	0	1
Estrogen receptor	0	2	5	8
Heme oxygenase 1	0	5	0	5
Potassium-transporting ATPase subunit beta	0	1	0	1
Potassium-transporting ATPase alpha chain 1	0	1	0	1
Heme oxygenase 2	0	5	0	5
C-X-C chemokine receptor type 1	0	1	0	1
Substance-P receptor	0	11	1	12
Indoleamine 2,3-dioxygenase 1	0	6	0	6
Malate dehydrogenase, cytoplasmic	0	6	0	6
Transitional endoplasmic reticulum ATPase	0	2	0	2
Mycocyclosin synthase	0	0	3	3
Nuclear receptor subfamily 1 group I member 3	0	3	0	3
Sterol 14-alpha demethylase	0	0	3	3
Estrogen receptor beta	0	1	5	7
Indoleamine 2,3-dioxygenase 2	0	5	0	5
Bile acid receptor	0	4	1	5
14-alpha sterol demethylase	0	0	3	3
Cysteinyl leukotriene receptor 1	0	9	1	10
5-hydroxytryptamine receptor 3A	0	3	0	3
Beta-3 adrenergic receptor	0	5	2	7
5-hydroxytryptamine receptor 2C	0	6	0	6
5-hydroxytryptamine receptor 2A	0	4	0	4
5-hydroxytryptamine receptor 5A	0	8	0	9
D(2) dopamine receptor	0	3	0	3
D(3) dopamine receptor	0	3	0	3
D(2) dopamine receptor	0	7	0	7
5-hydroxytryptamine receptor 2B	0	4	0	4
5-hydroxytryptamine receptor 4	0	2	1	4
Cholecystokinin receptor type A	0	6	0	6
5-hydroxytryptamine receptor 1A	0	4	0	4
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	1	2
Lysosomal Pro-X carboxypeptidase	0	2	0	2
Leukotriene B4 receptor 1	0	2	0	3
Leukotriene B4 receptor 2	0	1	0	2
Cytochrome P450 2D1	0	2	0	2
Cytochrome P450 2D26	0	2	0	2
Cytochrome P450 2D3	0	2	0	2
Kappa-type opioid receptor	0	10	2	15
Mu-type opioid receptor	0	11	2	18
Cytochrome P450 2D4	0	2	0	2
Mas-related G-protein coupled receptor member X2	0	0	6	6
Tubulin beta-4A chain	0	5	5	13
Tubulin beta chain	0	5	5	13
Tubulin alpha-3C chain	0	5	5	13
Tubulin alpha-1B chain	0	5	5	13
Tubulin alpha-4A chain	0	5	5	13
Tubulin beta-4B chain	0	5	5	13
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	6	5	14
Tubulin beta-2A chain	0	5	5	13
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	5	5	13
Tubulin alpha-3E chain	0	5	5	13
Tubulin alpha-1A chain	0	5	5	13
CREB-binding protein	3	3	0	6
Tubulin alpha-1C chain	0	5	5	13
Tubulin beta-6 chain	0	5	5	13
Tubulin beta-2B chain	0	5	5	13
Tubulin beta-1 chain	0	5	5	13
Solute carrier family 2, facilitated glucose transporter member 1	0	8	1	9
Adenylate cyclase type 8	0	0	2	2
Relaxin receptor 1	0	0	1	1
Nuclear receptor subfamily 1 group I member 2	0	0	4	4
B2 bradykinin receptor	0	3	0	3
Dihydrofolate reductase	0	2	0	2
Beta-galactosidase	0	2	0	3
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	2	0	2
PH domain leucine-rich repeat-containing protein phosphatase 2	0	1	0	1
Chymotrypsin-C	0	2	0	2
PINK1	8	0	0	8
TPA: protein transporter TIM23	0	1	0	1
Sterol 14-alpha demethylase	0	2	1	3
RNA-directed RNA polymerase	0	1	1	3
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Chain A, Breast cancer type 1 susceptibility protein	4	0	0	4
toll-like receptor 9	0	2	0	2
TPA: protein transporter TIM10	0	2	0	2
perilipin-5	0	4	0	4
perilipin-1	0	4	0	4
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	4	0	4
hypothetical protein SA1422	0	1	0	1
Prostaglandin E synthase	0	3	0	3
Acetylcholinesterase	0	20	0	21
Lysine-specific histone demethylase 1A	0	4	0	4
D-amino-acid oxidase	0	2	0	2
Neuronal proto-oncogene tyrosine-protein kinase Src	0	1	0	2
Glutathione S-transferase P	0	2	0	2
Microtubule-associated protein tau	0	3	1	5
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	1	0	1
Aminopeptidase N	0	5	0	5
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	0	3	0	3
17-beta-hydroxysteroid dehydrogenase type 2	0	2	0	2
Lactoylglutathione lyase	0	3	0	3
Histone acetyltransferase p300	0	3	0	3
Thioredoxin reductase 1, cytoplasmic	0	2	0	3
Thioredoxin reductase 3	0	1	0	1
Sortase A	0	1	0	1
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	0	3	0	3
Cysteine protease	0	1	0	1
NACHT, LRR and PYD domains-containing protein 3	0	2	0	2
Thioredoxin reductase 2, mitochondrial	0	1	0	1
Lymphocyte antigen 96	0	0	1	1
Beta lactamase (plasmid)	0	2	0	2
Multidrug resistance-associated protein 5	0	1	0	2
RPL19A	0	0	1	1
transactivating tegument protein VP16 [Human herpesvirus 1]	0	5	0	5
COUP transcription factor 2 isoform a	0	1	0	1
Glucose transporter	0	4	0	4
Hexose transporter 1	0	4	0	4
Eukaryotic initiation factor 4A-I	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	6	2	8
Peptidyl-prolyl cis-trans isomerase FKBP3	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP4	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP14	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	0	1	0	1
chaperonin GroEL	1	0	0	1
Glycogen phosphorylase, muscle form	0	2	0	2
UDP-glucuronosyltransferase 1A3	0	0	0	5
Histone-lysine N-methyltransferase SETD7	0	2	0	2
Progesterone receptor	0	19	9	31
Glutaminyl-peptide cyclotransferase	0	2	0	2
LMP1 [Human herpesvirus 4]	0	0	0	4
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	0	3	0	3
nuclear receptor coactivator 3 isoform a	0	3	0	3
Thymidine kinase 2, mitochondrial	0	1	0	1
Thymidine kinase	0	2	0	3
Thymidylate synthase	0	4	0	6
Thymidine kinase	0	1	0	1
Probable deoxycytidylate deaminase	0	0	0	2
Cytidine deaminase	0	3	0	7
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	3	0	3
Deoxynucleoside kinase	0	1	0	1
Cdk-related protein kinase 6	0	1	0	1
Protein kinase domain-containing protein	0	1	0	1
Mitogen-activated protein kinase	0	1	0	1
Proline--tRNA ligase	0	1	0	1
Calcium-dependent protein kinase 4	0	2	0	2
Lysine--tRNA ligase	0	1	0	1
Uridine-cytidine kinase 1	0	0	0	2
Ribonucleoside-diphosphate reductase large subunit	0	0	0	1
Ribonucleoside-diphosphate reductase subunit M2	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	1	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	2	2
Ribonucleoside-diphosphate reductase subunit M2 B	0	0	0	1
Orotidine 5'-phosphate decarboxylase	0	1	0	1
Seminal ribonuclease	0	1	0	1
Uridine 5'-monophosphate synthase	0	1	0	1
Beta-galactoside alpha-2,6-sialyltransferase 1	0	1	0	1
Ribonuclease pancreatic	0	1	0	1
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	0	1	0	1
Orotidine 5'-phosphate decarboxylase	0	1	0	1
Chain A, Glucose-1-phosphate cytidylyltransferase	0	1	0	1
Chain B, CTP synthase	0	1	0	1
Glucose-1-phosphate cytidylyltransferase	0	1	0	1
neutrophil cytosol factor 1	0	2	0	2
Solute carrier family 2, facilitated glucose transporter member 3	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 4	0	1	0	1
Deoxycytidine kinase	0	0	0	1
Cruzipain	0	6	0	6
Phosphatidylcholine:ceramide cholinephosphotransferase 2	0	1	0	1
Alpha-tocopherol transfer protein	0	0	1	1
Pirin	0	2	0	2
Isocitrate lyase	0	2	0	2
RAD51	0	1	0	1
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	0	1	0	1
Growth factor receptor-bound protein 2	0	1	0	2
Pantothenate synthetase	0	3	0	3
Growth factor receptor-bound protein 2	0	1	0	1
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase	0	0	1	1
Regulatory-associated protein of mTOR	0	3	0	3
Target of rapamycin complex subunit LST8	0	3	0	3
Neuraminidase	0	5	0	6
rac GTPase-activating protein 1 isoform a	0	4	0	4
pyruvate kinase PKM isoform b	7	0	0	7
Aldehyde dehydrogenase, mitochondrial	0	3	0	3
Ornithine decarboxylase	7	2	0	10
Urease subunit alpha	0	3	0	3
Polyunsaturated fatty acid lipoxygenase ALOX12	0	3	0	4
Urease subunit beta	0	3	0	3
Substance-K receptor	0	3	0	3
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	3	0	3
Prenyltransferase homolog	0	0	0	3
Sodium/glucose cotransporter 2	0	0	1	1
Sodium/myo-inositol cotransporter 2	0	2	0	2
Solute carrier family 5 member 4	0	1	0	1
Prothrombin	0	2	0	2
Glandular kallikrein	0	1	0	1
Cell division protein FtsZ	0	0	1	2
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase	0	1	0	1
Dihydrofolate reductase	0	5	0	5
Tyrosine-protein kinase ABL1	0	2	0	2
Proto-oncogene tyrosine-protein kinase Src	0	3	2	5
Proto-oncogene tyrosine-protein kinase LCK	0	2	0	2
Quinolone resistance protein NorA	0	4	0	5
Potassium voltage-gated channel subfamily E member 1	0	8	0	8
Tyrosine-protein kinase Blk	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 1	0	8	0	8
Myelin transcription factor 1	0	1	0	1
Breakpoint cluster region protein	0	1	0	1
Protein cereblon	0	10	2	14
Potassium voltage-gated channel subfamily D member 3	0	5	0	5
NF-kappa-B essential modulator	0	1	0	1
runt-related transcription factor 1 isoform AML1b	7	0	0	7
core-binding factor subunit beta isoform 2	7	0	0	7
NADH-ubiquinone oxidoreductase chain 4	0	0	0	1
Carbonyl reductase [NADPH] 1	0	2	0	4
Multidrug resistance-associated protein 1	0	6	1	11
exodeoxyribonuclease V subunit RecD	0	1	0	1
exodeoxyribonuclease V subunit RecB	0	1	0	1
exodeoxyribonuclease V subunit RecC	0	1	0	1
Lysine-specific demethylase 4A	0	1	0	1
Methylcytosine dioxygenase TET2	0	1	0	1
Beta-glucuronidase	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
NPC1-like intracellular cholesterol transporter 1	0	1	1	2
Solute carrier organic anion transporter family member 1A2	0	1	0	5
ATP-binding cassette sub-family C member 11	0	0	0	2
Solute carrier organic anion transporter family member 1A1	0	0	0	1
Chain A, STEROID DELTA-ISOMERASE	0	0	1	1
Steroid Delta-isomerase	0	0	1	1
Ileal sodium/bile acid cotransporter	0	1	0	1
Thymidine kinase 2	0	1	0	1
AAA family ATPase	0	0	0	2
AAA family ATPase	0	0	0	1
Sterol O-acyltransferase 1	0	2	0	2
Nociceptin receptor	0	3	0	3
Amine oxidase [flavin-containing] B	0	4	0	4
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	1	1
Gamma-aminobutyric acid	0	2	1	3
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit delta	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	3	1	4
Gamma-aminobutyric acid receptor subunit beta-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	1	3
Gamma-aminobutyric acid receptor subunit pi	0	2	1	3
Sphingosine-1-phosphate lyase 1	0	1	0	1
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	1	3
Gamma-aminobutyric acid receptor subunit theta	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	1	3
Nicotinamide phosphoribosyltransferase	0	0	1	1
ATP-binding cassette sub-family C member 8	0	4	1	5
ATP-sensitive inward rectifier potassium channel 11	0	4	1	5
Chain A, Cell division protein kinase 9	0	1	0	1
Chain A, Cell division protein kinase 2	0	1	0	1
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	3
Casein kinase II subunit beta	0	1	0	1
Casein kinase II subunit alpha	0	1	0	1
NAD	0	1	0	1
NAD	0	1	0	4
ATP phosphoribosyltransferase	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	2	0	2
G-protein coupled receptor 35	0	2	2	4
UDP-glucose 4-epimerase	0	1	0	1
Chain A, DigA16	0	0	1	1
Chain A, DigA16	0	0	1	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	3	0	4
Sodium/potassium-transporting ATPase subunit beta-1	0	3	0	4
Sodium/potassium-transporting ATPase subunit alpha-2	0	3	0	4
Solute carrier organic anion transporter family member 4C1	0	2	0	4
Beta-2 adrenergic receptor	0	1	2	3
fatty acid synthase	0	1	0	1
Chain A, Sex Hormone-Binding Globulin	0	0	1	1
Progesterone receptor	0	1	0	1
Glucocorticoid receptor	0	3	2	6
Sex hormone-binding globulin	0	2	0	2
Androgen receptor	0	2	3	5
Neuropeptide FF receptor 2	0	0	0	2
Cereblon isoform 4	0	4	0	4
Insulin-like growth factor-binding protein 5	0	0	1	1
Glutathione S-transferase omega-1	0	2	0	2
prostaglandin E2 receptor EP2 subtype	1	0	0	2
Prostaglandin E2 receptor EP1 subtype	0	2	1	3
Prostaglandin E2 receptor EP4 subtype	0	2	1	4
Prostaglandin F2-alpha receptor	0	0	1	1
Prostaglandin E2 receptor EP4 subtype	0	1	1	2
Prostaglandin E2 receptor EP3 subtype	0	2	1	4
Prostaglandin E2 receptor EP2 subtype	0	2	1	3
Solute carrier family 22 member 7	0	1	0	4
Prostaglandin E2 receptor EP2 subtype	0	1	1	2
Solute carrier family 22 member 7	0	0	0	1
Solute carrier family 22 member 7	0	0	0	2
Kappa-type opioid receptor	0	10	6	18
LANA	0	0	0	1
eyes absent homolog 2 isoform a	7	0	0	7
kelch-like ECH-associated protein 1	0	0	0	2
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	0	1	0	1
3',5'-cyclic-AMP phosphodiesterase	0	6	0	6
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	0	1	0	1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	0	1	0	1
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	0	1	0	1
Exopolyphosphatase PRUNE1	0	1	0	1
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	0	2	0	2
Phosphodiesterase	0	4	0	4
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	3	0	4
polypyrimidine tract-binding protein 1 isoform a	1	0	0	1
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase	0	2	0	2
Transient receptor potential cation channel subfamily A member 1	0	1	3	4
Carbamate kinase	0	1	0	1
Retinal dehydrogenase 1	0	3	0	3
C-X-C chemokine receptor type 2	0	2	0	2
C-C chemokine receptor type 5	0	2	0	2
Gasdermin-D	0	2	0	2
Lysyl oxidase homolog 3	0	2	0	2
Lysyl oxidase homolog 4	0	2	0	2
Gasdermin-D	0	2	0	2
Lysyl oxidase homolog 2	0	2	0	2
Kinesin-like protein KIF11	0	2	0	2
Nucleotide-binding oligomerization domain-containing protein 2	0	2	0	2
Acetylcholinesterase	0	2	1	3
Amine oxidase [flavin-containing] A	0	4	0	4
Acetylcholinesterase	0	5	0	5
Cholinesterase	0	3	0	3
Acetylcholine receptor subunit epsilon	0	1	1	2
Acyl-CoA:cholesterol acyltransferase	0	2	0	2
Carboxylic ester hydrolase	0	3	0	4
Carboxylic ester hydrolase	0	4	0	4
Alpha-1A adrenergic receptor	0	3	2	5
Platelet-activating factor receptor	0	2	0	2
Eyes absent homolog 2	0	2	0	2
Somatostatin receptor type 1	0	4	0	4
Somatostatin receptor type 2	0	4	0	4
Somatostatin receptor type 4	0	4	0	4
Somatostatin receptor type 3	0	4	0	4
Somatostatin receptor type 5	0	4	0	4
Mitochondrial 2-oxodicarboxylate carrier	0	1	0	1
Chain A, FATTY ACID-BINDING PROTEIN, BRAIN	0	0	1	1
Chain A, Fatty Acid-binding Protein, Brain	0	0	1	1
Chain A, Liver Fatty Acid Binding Protein	0	0	1	1
NS5	0	0	1	1
Serine hydrolase RBBP9	0	1	0	1
chaperonin-containing TCP-1 beta subunit homolog	4	0	0	4
protein AF-9 isoform a	0	0	0	5
Cytosol aminopeptidase	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	5	6	11
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Mu-type opioid receptor	0	2	0	2
Capsid protein	0	1	2	3
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	0	1	1
Chain A, POLYMERASE PA	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
galactokinase	3	0	0	3
Polycomb protein EED	0	1	2	3
NAD kinase	0	2	1	3
Polymerase acidic protein	0	1	1	2
Plasminogen activator inhibitor 1	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Alpha-amylase 1A	0	1	0	1
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
Fatty acid synthase	0	1	0	1
CPG DNA methylase	0	1	0	1
Phosphoglycerate mutase 1	0	1	0	1
Signal transducer and activator of transcription 1-alpha/beta	0	0	1	1
DNA repair protein RAD52 homolog	0	2	0	2
Fatty acid synthase	0	2	0	2
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6	0	3	0	3
Squalene monooxygenase	0	2	0	2
6-phosphogluconate dehydrogenase, decarboxylating	0	4	0	4
Lactoperoxidase	0	2	0	4
Alpha-(1,3)-fucosyltransferase 7	0	3	0	3
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	0	3	0	3
3-oxoacyl-[acyl-carrier-protein] reductase	0	1	0	1
Histone acetyltransferase KAT2B	0	1	0	1
Histone acetyltransferase KAT5	0	1	0	1
Enoyl-acyl-carrier protein reductase	0	2	0	2
3-oxoacyl-acyl-carrier protein reductase	0	1	0	1
Adenylate cyclase	0	1	0	1
5-hydroxytryptamine receptor 1B	0	9	2	12
Flavin reductase (NADPH)	0	0	1	1
Olfactory receptor 51E2	0	1	5	6
UDP-glucuronosyltransferase 1A10	0	0	0	2
17-beta-hydroxysteroid dehydrogenase type 1	0	3	0	4
Ghrelin O-acyltransferase	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	2	0	2
14 kDa phosphohistidine phosphatase	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)	0	1	0	1
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)	0	1	0	1
Acetylcholine receptor subunit alpha	0	3	1	4
Acetylcholine receptor subunit beta	0	3	1	4
Acetylcholine receptor subunit gamma	0	3	1	4
Acetylcholine receptor subunit delta	0	1	0	1
Acetylcholine receptor subunit delta	0	3	1	4
Acetylcholine receptor subunit alpha	0	1	0	1
Acetylcholine receptor subunit gamma	0	1	0	1
Acetylcholine receptor subunit beta	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	7	0	7
Cytochrome P450 11B2, mitochondrial	0	7	0	7
Regulatory protein E2	0	0	2	2
DNA topoisomerase 2	0	0	0	1
Caspase-3	0	1	0	1
DNA topoisomerase 2-alpha	0	0	0	1
NPC1-like intracellular cholesterol transporter 1	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	2	0	2
Fatty acid-binding protein, liver	0	1	1	2
Peroxisome proliferator-activated receptor alpha	0	0	2	2
Chain A, BCL-2-RELATED PROTEIN A1	0	0	2	3
unnamed protein product	0	1	0	1
bcl-2-like protein 11 isoform 1	0	0	2	2
Lanosterol 14-alpha demethylase	0	1	2	3
likely tRNA 2'-phosphotransferase	0	1	0	1
Chain A, Uracil Phosphoribosyltransferase	0	1	0	1
Skn7p	0	0	0	2
Solute carrier family 22 member 8	0	2	0	4
Acid-sensing ion channel 3	0	1	0	1
Prostaglandin G/H synthase 2	0	3	0	4
Prostaglandin G/H synthase 1	0	9	0	9
alternatively spliced Trp4	0	0	2	2
replicative DNA helicase	0	0	0	2
recombinase A	0	0	2	2
Cocaine esterase	0	3	0	4
Arylacetamide deacetylase	0	1	0	3
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Neuropeptide FF receptor 2	0	1	1	2
Chain A, Dihydrofolate reductase	0	0	1	1
Thymidylate synthase	0	4	0	4
Multidrug resistance associated protein	0	1	0	3
Sialin	0	1	0	1
Fucose-binding lectin PA-IIL	0	2	0	2
CD209 antigen	0	3	0	3
Steroid hormone receptor ERR1	0	3	0	3
Bifunctional epoxide hydrolase 2	0	7	0	7
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	5	0	5
Methionine aminopeptidase	0	1	0	1
Methionine aminopeptidase 2	0	3	0	3
Methionine aminopeptidase 1	0	1	0	1
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	1	0	1
Holo-[acyl-carrier-protein] synthase	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	2
Lipopolysaccharide heptosyltransferase 1	0	1	0	1
PA-I galactophilic lectin	0	0	1	1
Jacalin	0	0	1	1
L-selectin	0	1	0	1
P-selectin	0	1	0	1
E-selectin	0	1	0	1
Autoinducer 2-binding periplasmic protein LuxP	0	1	0	1
Anthrax toxin receptor 2	0	1	0	1
Polypeptide N-acetylgalactosaminyltransferase 2	0	1	1	2
Toll-like receptor 2	0	1	0	1
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	1
Sodium- and chloride-dependent GABA transporter 1	0	8	0	8
Gamma-aminobutyric acid receptor subunit rho-2	0	0	2	2
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	8	0	8
Sodium- and chloride-dependent GABA transporter 3	0	8	0	8
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	2	0	2
Sodium- and chloride-dependent GABA transporter 3	0	2	0	2
Sodium- and chloride-dependent betaine transporter	0	8	0	8
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	2
Sterol O-acyltransferase 1	0	0	1	1
Platelet glycoprotein VI	0	1	2	4
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Gonadotropin-releasing hormone receptor	0	2	1	3
Cholecystokinin receptor type A	0	6	4	10
Ras-related C3 botulinum toxin substrate 1	0	0	2	2
epidermal growth factor receptor isoform a precursor	1	1	0	2
Cytochrome P450 2E1	0	1	0	1
Mitogen-activated protein kinase kinase kinase 8	0	2	0	2
Synaptic vesicular amine transporter	0	4	1	5
Serine/threonine-protein kinase ULK3	0	0	2	2
Chain A, DEOXYNUCLEOSIDE KINASE	0	1	0	1
Chain A, Estrogen receptor 1 (alpha)	0	1	0	1
Chain A, Transthyretin	0	0	1	1
Chain A, Transthyretin	0	0	1	1
BRCA1	3	0	0	3
Steroid hormone receptor ERR2	0	1	0	1
Sialidase	0	1	0	1
Ornithine decarboxylase	0	2	0	2
Cystic fibrosis transmembrane conductance regulator	0	1	1	2
Solute carrier family 2, facilitated glucose transporter member 4	0	2	0	2
Dipeptidyl peptidase 4	0	2	0	2
Cystic fibrosis transmembrane conductance regulator	0	0	1	1
Quinone oxidoreductase	0	0	0	1
Xanthine dehydrogenase/oxidase	0	3	0	3
Tissue alpha-L-fucosidase	0	1	0	1
Dipeptidyl peptidase 3	0	1	0	1
DNA (cytosine-5)-methyltransferase 3-like	0	1	0	1
Sialidase-2	0	2	0	2
DNA (cytosine-5)-methyltransferase 3A	0	1	0	1
Glucagon-like peptide 1 receptor	0	0	1	1
Glucagon-like peptide 1 receptor	0	3	3	6
Glucagon receptor	0	0	1	1
Glucagon receptor	0	0	1	1
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
Metabotropic glutamate receptor 8	0	2	0	2
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
ATP-citrate synthase	0	1	0	1
Glutamate receptor ionotropic, kainate 1	0	3	1	4
Metabotropic glutamate receptor 1	0	4	1	5
Metabotropic glutamate receptor 2	0	1	1	2
Metabotropic glutamate receptor 3	0	1	1	2
Metabotropic glutamate receptor 4	0	2	1	3
Metabotropic glutamate receptor 6	0	1	1	2
Metabotropic glutamate receptor 7	0	1	1	2
Glutamate receptor ionotropic, kainate 1	0	1	1	2
Metabotropic glutamate receptor 5	0	1	2	4
Glutamate receptor ionotropic, kainate 2	0	3	1	4
Metabotropic glutamate receptor 8	0	0	1	1
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	2	1	3
Glutamate receptor ionotropic, kainate 4	0	3	0	3
Glutamate carboxypeptidase 2	0	1	0	1
Glutamate receptor ionotropic, kainate 2	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	1	0	1
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	1	1	3
Glutamate receptor ionotropic, kainate 5	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	3	0	3
Glutamate racemase	0	0	0	1
Prolyl 4-hydroxylase	0	2	0	2
Alpha-ketoglutarate-dependent dioxygenase FTO	0	1	0	1
Chain A, Glutamine Binding Protein	0	0	1	1
Asc-type amino acid transporter 1	0	2	0	2
ATP-binding cassette sub-family C member 9	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	6	0	7
ATP synthase subunit beta, mitochondrial	0	1	0	1
ATP synthase subunit delta, mitochondrial	0	1	0	1
ATP synthase subunit gamma, mitochondrial	0	1	0	1
ATP synthase subunit epsilon, mitochondrial	0	1	0	1
Cholesteryl ester transfer protein	0	1	0	1
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E	0	0	1	1
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	9	0	10
Serine racemase	0	1	0	1
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Estrogen receptor 1	0	1	0	1
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase	1	0	0	1
Malate dehydrogenase, mitochondrial	0	1	0	1
L-lactate dehydrogenase B chain	0	1	0	1
Malate dehydrogenase, cytoplasmic	0	1	0	1
L-lactate dehydrogenase B chain	0	1	0	1
DNA-3-methyladenine glycosylase	0	1	0	1
Type 1 InsP3 receptor isoform S2	1	0	0	1
L-lactate dehydrogenase	0	1	0	1
L-lactate dehydrogenase	0	1	0	1
L-lactate dehydrogenase B chain	0	1	0	1
L-lactate dehydrogenase	0	1	0	1
Inosine-5'-monophosphate dehydrogenase	0	1	0	1
phosphoglycerate kinase	6	0	0	6
Valosin-containing protein	0	1	0	1
estrogen receptor beta isoform 1	0	4	0	4
Polycomb protein SUZ12	0	1	0	1
Histone-lysine N-methyltransferase EZH2	0	2	0	2
Hypoxanthine-guanine phosphoribosyltransferase	0	0	0	2
Ricin	0	1	0	1
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	0	0	2	2
Purine nucleoside phosphorylase	0	0	1	2
Shiga toxin subunit A	0	1	0	1
Chain A, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain B, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain A, ELONGATION FACTOR TU (EF-TU)	0	0	1	1
Chain A, Elongation Factor G	0	0	1	1
Chain A, ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 3	0	0	1	1
Chain A, Eukaryotic peptide chain release factor GTP-binding subunit	0	0	1	1
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b	0	0	2	2
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b	0	0	2	2
Chain A, interferon-inducible GTPase	0	0	1	1
Chain A, interferon-inducible GTPase	0	0	1	1
Chain A, Elongation factor 2	0	0	1	1
Chain A, Guanine nucleotide-binding protein G(i), alpha-1 subunit	0	0	1	1
Ras-related protein Rab-7a	0	0	2	2
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5	0	1	0	1
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9	0	4	0	4
Chain A, Uracil Phosphoribosyltransferase	0	0	1	1
Chain B, Uracil Phosphoribosyltransferase	0	0	1	1
Chain C, Uracil Phosphoribosyltransferase	0	0	1	1
Protein-glutamine gamma-glutamyltransferase 2	0	3	0	3
Chain E, C-amp-dependent Protein Kinase	0	1	0	1
Chain I, Protein Kinase Inhibitor Peptide	0	1	0	1
Chain E, C-amp-dependent Protein Kinase	0	1	0	1
Chain E, C-amp-dependent Protein Kinase	0	1	0	1
Chain I, Protein Kinase Inhibitor Peptide	0	1	0	1
cAMP-dependent protein kinase type II-alpha regulatory subunit	0	2	0	2
cAMP-dependent protein kinase catalytic subunit beta	0	2	0	2
cAMP-dependent protein kinase catalytic subunit alpha	0	1	1	2
cAMP-dependent protein kinase type II-beta regulatory subunit	0	2	0	2
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	4	4
Integrin alpha-4	0	2	0	2
5-hydroxytryptamine receptor 2A	0	2	1	3
AP-2 complex subunit sigma	0	1	0	1
N-acetyltransferase Eis	0	2	0	2
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Zinc finger protein 664	0	1	0	1
Vesicular acetylcholine transporter	0	3	0	3
Transient receptor potential cation channel subfamily V member 4	0	1	0	1
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
CDC-like kinase 1, isoform CRA_c	0	0	0	1
dual specificity protein kinase CLK4	1	0	0	1
Dual specificity protein kinase CLK2	0	1	0	1
Dual specificity protein kinase CLK3	0	1	0	1
Dual specificity protein kinase CLK4	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 3	0	1	0	1
Sodium-dependent dopamine transporter	0	1	0	1
Neuromedin-B receptor	0	1	0	1
Mitogen-activated protein kinase 1	0	1	0	1
Serine/threonine-protein kinase haspin	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 4	0	1	0	1
Chain E, Fibrin beta chain	0	2	0	2
MPI protein	0	1	0	1
Cyclin-dependent kinase 5, regulatory subunit 1 (p35)	0	0	0	1
luciferase	3	0	0	3
CDK5	0	0	0	1
endoribonuclease toxin MazF	0	0	2	2
Pyruvate kinase PKM	0	3	1	4
Aurora kinase B-A	0	1	0	1
Platelet glycoprotein 4	0	1	0	1
Growth hormone secretagogue receptor type 1	0	3	1	4
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
Macrophage migration inhibitory factor	0	3	0	3
Histamine H3 receptor	0	1	0	1
Histamine N-methyltransferase	0	1	0	1
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	0	1
Chain A, HISTIDINE-BINDING PROTEIN	0	0	1	1
Histidine-binding periplasmic protein	0	0	1	1
Histidinol dehydrogenase	0	0	0	1
Phosphatidylcholine-sterol acyltransferase	0	0	1	1
G-protein coupled receptor 1	0	0	1	1
N-glycosylase/DNA lyase	0	2	0	2
Aspartate aminotransferase, cytoplasmic	0	2	0	2
Transient receptor potential cation channel subfamily A member 1	0	1	1	2
Cyclic GMP-AMP synthase	0	2	0	2
Toll-like receptor 9	0	1	0	1
Toll-like receptor 7	0	1	0	1
Uracil nucleotide/cysteinyl leukotriene receptor	0	3	0	3
Thioredoxin reductase 1, cytoplasmic	0	1	0	1
Dopamine beta-hydroxylase	0	1	0	1
Corticotropin-releasing factor receptor 1	0	1	0	1
Cystathionine beta-synthase	0	1	0	1
5-lipoxygenase	0	1	0	1
Cysteine protease ATG4B	0	1	0	1
Thioredoxin reductase 2, mitochondrial	0	1	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	4
Cytochrome P450 3A5	0	5	1	7
Peptidyl-prolyl cis-trans isomerase FKBP5	0	2	1	3
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, CELL DIVISION PROTEIN KINASE 2	0	1	0	1
Chain A, Cell Division Protein Kinase 2	0	1	0	1
Peptide deformylase 1A, chloroplastic/mitochondrial	0	1	0	1
Peptide deformylase	0	1	0	1
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Phospholipase A2, major isoenzyme	0	2	0	3
Interleukin-8	0	1	0	1
Prostaglandin G/H synthase 1	0	1	0	1
Prostaglandin G/H synthase 2	0	8	0	8
C-X-C chemokine receptor type 3	0	3	0	3
Prostaglandin D2 receptor	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
Chain B, Pulmonary surfactant-associated protein D	0	1	0	1
Chain A, Pulmonary surfactant-associated protein D	0	1	0	1
Beta-adrenergic receptor kinase 1	0	3	0	3
Chain A, BETA-SPECTRIN	0	0	1	1
Chain A, Phospholipase C Delta-1	0	0	1	1
Chain A, Inositol 1,4,5-trisphosphate receptor type 1	0	0	1	1
Inositol-trisphosphate 3-kinase A	0	2	0	2
Inositol 1,4,5-trisphosphate receptor type 1	0	0	3	3
Inositol 1,4,5-trisphosphate receptor type 2	0	1	0	1
Inositol 1,4,5-trisphosphate receptor type 3	0	1	1	2
Inositol polyphosphate-5-phosphatase A	0	1	0	1
Inositol 1,4,5-trisphosphate receptor type 1	0	1	1	2
Chain A, Tyrosine-protein Kinase Btk	0	0	1	1
Chain A, Bruton's Tyrosine Kinase	0	0	1	1
Chain A, DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES	0	0	1	1
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	0	1	0	1
Cytohesin-3	0	0	1	1
Fatty acid synthase	0	1	0	1
Liver carboxylesterase	0	1	0	1
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
Formamidopyrimidine-DNA glycosylase	0	1	0	1
Endonuclease III-like protein 1	0	1	0	1
Putative FAD-containing monooxygenase MymA	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Endonuclease 8-like 1	0	1	0	1
Chain A, beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Chain A, Beta-galactosidase	0	1	0	1
Beta-galactosidase	0	1	0	1
Beta-2 adrenergic receptor	0	0	1	1
Beta-3 adrenergic receptor	0	0	1	1
Beta-1 adrenergic receptor	0	2	1	3
Beta-2 adrenergic receptor	0	2	0	2
Taste receptor type 2 member 38	0	0	3	5
Taste receptor type 2 member 39	0	0	1	1
Taste receptor type 2 member 40	0	0	1	1
Taste receptor type 2 member 41	0	0	1	1
Taste receptor type 2 member 43	0	0	1	1
Taste receptor type 2 member 31	0	0	3	3
Taste receptor type 2 member 45	0	0	1	1
Taste receptor type 2 member 46	0	0	1	1
Taste receptor type 2 member 30	0	0	1	1
Taste receptor type 2 member 19	0	0	1	1
Taste receptor type 2 member 20	0	0	1	1
Taste receptor type 2 member 50	0	0	1	1
Taste receptor type 2 member 60	0	0	2	2
Taste receptor type 2 member 42	0	0	1	1
Taste receptor type 2 member 16	0	0	1	1
Taste receptor type 2 member 14	0	0	2	3
Taste receptor type 2 member 13	0	0	2	2
Taste receptor type 2 member 10	0	0	1	1
Taste receptor type 2 member 9	0	0	2	2
Taste receptor type 2 member 8	0	0	1	1
Taste receptor type 2 member 7	0	0	1	1
Taste receptor type 2 member 5	0	0	1	1
Taste receptor type 2 member 4	0	0	2	2
Taste receptor type 2 member 3	0	0	1	1
Taste receptor type 2 member 1	0	0	1	1
Ornithine decarboxylase	0	0	0	2
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	0	0	2	2
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	0	0	2	2
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	0	0	2	2
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
Gap junction alpha-1 protein	0	1	0	1
Gap junction beta-2 protein	0	1	0	1
Acyl-protein thioesterase 1	0	1	0	1
Synaptic vesicular amine transporter	0	5	1	6
Estrogen receptor beta	0	2	1	4
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	0	1	0	1
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	0	2	0	2
Camphor 5-monooxygenase	0	0	0	1
Cytochrome P450 2C11	0	2	0	2
Steroid 21-hydroxylase	0	1	0	1
Steroid 17-alpha-hydroxylase/17,20 lyase	0	2	0	2
Cholesterol side-chain cleavage enzyme, mitochondrial	0	1	0	1
Cytochrome P450 2A2	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	3	0	3
Cytochrome P450 7A1	0	1	0	1
Estrogen receptor	0	2	1	4
Gonadotropin-releasing hormone receptor	0	3	1	4
Cytochrome P450 4F2	0	1	0	1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	0	1	0	1
Cytochrome P450 7A1	0	1	0	1
Lanosterol 14-alpha demethylase	0	2	0	2
Calcium/calmodulin-dependent protein kinase type II subunit beta	0	1	0	1
Calcium/calmodulin-dependent protein kinase type II subunit alpha	0	1	0	1
Calcium/calmodulin-dependent protein kinase type II subunit gamma	0	1	0	1
Calcium/calmodulin-dependent protein kinase type II subunit delta	0	1	0	1
Growth hormone secretagogue receptor type 1	0	1	1	2
Growth hormone secretagogue receptor type 1	0	1	0	1
Sodium channel protein type 10 subunit alpha	0	1	0	1
Splicing factor 3B subunit 3	0	3	0	3
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, Lectin	0	0	1	1
Chain A, ERYTHRINA CRISTA-GALLI LECTIN	0	0	1	1
Chain A, ERYTHRINA CRISTA-GALLI LECTIN	0	0	1	1
Chain A, cellulase	0	0	1	1
Chain A, cellulase	0	0	1	1
Chain A, Galectin-3	0	0	1	1
Chain A, Anti-tumor lectin	0	1	0	1
Galectin-3	0	1	0	1
Galectin-9	0	0	1	1
Galectin-8	0	0	1	1
Beta-galactoside-binding lectin	0	1	0	1
Galectin-1	0	1	1	3
Galectin-3	0	1	1	2
Galectin-3	0	1	1	3
Galectin-7	0	0	1	1
Alpha 1,4 galactosyltransferase	0	0	0	1
Chain A, Epidermal growth factor receptor	0	1	0	1
Alpha-1A adrenergic receptor	0	1	0	1
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, Leucine Aminopeptidase	0	1	0	1
Intestinal-type alkaline phosphatase	0	4	0	4
Phospholipase A-2-activating protein	0	4	0	4
Cysteinyl leukotriene receptor 2	0	2	1	3
Cathepsin B	0	1	0	1
Serine protease hepsin	0	1	0	1
Plasminogen	0	1	0	1
Pro-cathepsin H	0	2	0	2
Calpain-1 catalytic subunit	0	1	0	1
Hepatocyte growth factor activator	0	1	0	1
Transmembrane protease serine 6	0	1	0	1
Cysteine protease	0	2	0	2
Cysteine protease falcipain-3	0	1	0	1
Suppressor of tumorigenicity 14 protein	0	2	0	2
integrase, partial	0	2	0	2
lens epithelium-derived growth factor p75	0	2	0	2
SLC16A10 protein	0	0	0	4
Monocarboxylate transporter 10	0	0	0	4
Potassium voltage-gated channel subfamily A member 5	0	3	0	3
Potassium voltage-gated channel subfamily D member 2	0	2	0	2
Potassium channel subfamily K member 18	0	1	0	1
Prolyl 4-hydroxylase, beta polypeptide	0	0	0	2
inositol monophosphatase 1	1	0	0	1
Thromboxane A2 receptor	0	1	0	2
Type-1 angiotensin II receptor	0	2	1	3
Cysteinyl leukotriene receptor 1	0	1	0	2
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast	0	1	0	1
Alpha-mannosidase 2C1	0	2	1	3
Phosphatidylcholine 2-acylhydrolase	0	1	0	1
Acidic phospholipase A2 beta	0	1	0	1
Phospholipase A2	0	1	0	1
Phospholipase A2, membrane associated	0	2	0	2
Phospholipase A2, membrane associated	0	3	0	4
Acidic phospholipase A2 2	0	2	0	2
DNA polymerase kappa	0	1	0	1
bioA	0	0	0	1
Cytochrome P450 1A2	0	2	0	2
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	1	1	2
Melatonin receptor type 1C	0	1	1	2
Melatonin receptor type 1B	0	1	1	2
Metallo-beta-lactamase VIM-19	0	0	0	2
Metallo-beta-lactamase VIM-2	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase	0	0	0	2
Beta-lactamase IMP-1	0	0	0	2
BlaVIM-1	0	0	0	2
Beta-lactamase	0	0	0	2
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7	0	0	0	2
5-hydroxytryptamine receptor 1E	0	1	0	2
Heparanase	0	0	1	1
Aldehyde oxidase 1	0	5	0	5
Dopamine beta-hydroxylase	0	2	0	2
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	0	1	3
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Chain B, DIHYDROFOLATE REDUCTASE	0	0	1	1
Thymidylate synthase	0	1	0	1
Thymidylate synthase	0	1	0	1
Toll-like receptor 4	0	1	0	1
ATP-binding cassette sub-family C member 3	0	1	0	2
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
High mobility group protein B1	0	0	2	2
Dihydrofolate reductase	0	1	0	1
Thymidylate synthase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	3	0	3
Folate receptor beta	0	1	0	1
Folate receptor alpha	0	1	0	1
Histidine decarboxylase	0	1	3	4
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Reduced folate transporter	0	2	0	2
Bifunctional dihydrofolate reductase-thymidylate synthase	0	2	0	2
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trifunctional purine biosynthetic protein adenosine-3	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Proton-coupled folate transporter	0	1	0	1
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	3
Cystathionine gamma-lyase	0	2	0	2
T cell receptor, partial	1	0	0	1
luteinizing hormone receptor	1	0	0	1
Apoptotic peptidase activating factor 1	0	1	0	1
caspase-9 isoform alpha precursor	0	1	0	1
caspase-3 isoform a preproprotein	0	1	0	1
Glutathione reductase	0	1	0	2
Dihydrolipoyl dehydrogenase, mitochondrial	0	1	0	3
Dihydrolipoyl dehydrogenase	0	1	0	2
5-hydroxytryptamine receptor 3B	0	1	0	1
Chain A, androgen receptor	0	0	1	1
Chain A, androgen receptor	0	0	1	1
Thioredoxin reductase	0	1	0	1
Flavodoxin	0	0	0	1
Cytochrome P450 11B1, mitochondrial	0	5	0	5
Voltage-dependent T-type calcium channel subunit alpha-1G	0	2	1	3
Voltage-dependent T-type calcium channel subunit alpha-1H	0	2	0	2
Sodium channel protein type 4 subunit alpha	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-3	0	1	0	1
Voltage-dependent N-type calcium channel subunit alpha-1B	0	1	0	1
Calcium release-activated calcium channel protein 1	0	2	0	2
Voltage-dependent T-type calcium channel subunit alpha-1I	0	2	0	2
Cytochrome P450 1A2	0	1	0	1
methionyl-tRNA synthetase, putative	0	1	0	1
Chain A, PROGESTERONE RECEPTOR	0	1	0	1
Glucocorticoid receptor	0	1	0	1
Tegument protein VP16	0	0	1	1
Glucocorticoid receptor	0	1	1	2
Progesterone receptor	0	0	1	1
Glucocorticoid receptor	0	1	0	1
cGMP-specific 3',5'-cyclic phosphodiesterase	0	2	0	2
Inner centromere protein	0	1	0	1
Nuclear receptor corepressor 1	0	3	0	3
Nuclear receptor corepressor 2	0	5	0	5
Iodotyrosine deiodinase	0	0	1	1
fMet-Leu-Phe receptor	0	1	0	1
Tyrosine 3-monooxygenase	0	1	0	1
Tyrosine 3-monooxygenase	0	1	0	1
Iodotyrosine deiodinase 1	0	0	1	1
Acyl-CoA desaturase 1	0	1	0	1
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
5-hydroxytryptamine receptor 1B	0	2	0	2
Toll-like receptor 2	0	2	0	2
Peroxisome proliferator-activated receptor delta	0	2	3	7
G-protein coupled receptor 84	0	2	2	4
Sialidase-4	0	1	0	1
Sialidase-1	0	1	0	1
Sialidase-3	0	1	0	1
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)	0	0	0	1
Acid ceramidase	0	2	0	2
Glucose-dependent insulinotropic receptor	0	0	1	1
Glucose-dependent insulinotropic receptor	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
Chain B, Exotoxin A	0	0	1	1
UDP-glucuronosyltransferase 1A8	0	0	0	3
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	0	1	0	1
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	0	1	0	1
Chain A, Cholix toxin	0	1	0	1
Beta-hexosaminidase subunit alpha	0	2	0	3
Chain A, ASPARTYLPROTEASE	0	1	0	1
Chain B, ASPARTYLPROTEASE	0	1	0	1
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Protease	0	6	2	9
Microsomal glutathione S-transferase 1	0	1	0	1
Adenosylhomocysteinase	0	1	0	1
Adenosylhomocysteinase	0	2	0	2
Neuromedin-K receptor	0	0	2	2
Substance-K receptor	0	2	3	5
Neuromedin-K receptor	0	3	2	5
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	2	0	2
Substance-K receptor	0	2	0	2
Neuropeptide Y receptor type 1	0	2	0	2
Neuropeptide Y receptor type 2	0	2	0	2
Neurotensin receptor type 1	0	0	1	1
Neurotensin receptor type 2	0	1	1	3
Myelin basic protein	0	0	1	1
Neurotensin receptor type 1	0	1	1	2
Neurotensin receptor type 1	0	2	2	5
Neurotensin receptor type 2	0	2	1	3
Sortilin	0	1	0	1
Cholesteryl ester transfer protein	0	1	0	1
D-amino-acid oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 3	0	0	1	1
Nicotinamidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	0	1	1
D-aspartate oxidase	0	1	0	1
Hydroxycarboxylic acid receptor 2	0	1	1	2
Chain A, NAD-dependent deacetylase	0	1	0	1
NAD-dependent histone deacetylase SIR2	0	1	0	1
NAD-dependent protein deacetylase HST2	0	2	0	2
NAD(+) hydrolase SARM1	0	1	0	1
NAD-dependent protein deacetylase sirtuin-6	0	2	1	3
NAD-dependent protein deacetylase	0	1	0	1
Equilibrative nucleoside transporter 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-7	0	2	0	2
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-2	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	2	2	4
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	2	0	0	2
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-4	0	1	0	1
Voltage-dependent P/Q-type calcium channel subunit alpha-1A	0	1	0	1
Voltage-dependent calcium channel gamma-3 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-3	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Voltage-dependent calcium channel gamma-7 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-1	0	1	0	1
Voltage-dependent calcium channel gamma-1 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-2	0	1	0	1
Voltage-dependent R-type calcium channel subunit alpha-1E	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-4	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-3	0	1	0	1
Voltage-dependent calcium channel gamma-8 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-6 subunit	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	1	0	1
Voltage-dependent calcium channel gamma-4 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-5 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-2 subunit	0	1	0	1
G-protein coupled receptor 55	0	1	0	1
Nitric oxide synthase, inducible	0	1	0	1
Nitric oxide synthase, brain	0	1	0	1
Chain A, Glutathione-requiring prostaglandin D synthase	0	1	0	1
Extracellular calcium-sensing receptor	0	0	1	1
STE24	0	0	0	1
CAAX prenyl protease	0	0	0	1
Chain A, Adipocyte Lipid-binding Protein	0	0	1	1
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	2	2
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	2	2
Chain A, MUSCLE FATTY ACID BINDING PROTEIN	0	0	2	2
putative potassium channel subunit	0	0	1	1
Sterol O-acyltransferase 1	0	2	0	2
Glutathione hydrolase 1 proenzyme	0	0	1	1
Chain A, ARGINASE 1	0	1	0	1
Chain A, Arginase 1	0	1	0	1
Chain A, ARGINASE 1	0	1	0	1
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	2	2	4
Putative nucleoside diphosphate kinase	0	0	1	1
von Hippel-Lindau disease tumor suppressor	0	1	0	1
Dipeptidyl peptidase 1	0	1	0	1
Epidermal growth factor receptor	0	2	0	2
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain)	0	1	0	1
Chain L, Igg2b-kappa 40-50 Fab (light Chain)	0	1	0	1
Chain A, Na, K-ATPase alpha subunit	0	0	1	1
STAT3, partial	0	1	0	1
Kruppel-like factor 5	0	1	0	1
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	2
Sodium/potassium-transporting ATPase subunit beta-2	0	1	0	2
Sodium/potassium-transporting ATPase subunit beta-3	0	1	0	2
Sodium/potassium-transporting ATPase subunit gamma	0	1	0	2
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	2
Sodium/potassium-transporting ATPase subunit beta-3	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
polyadenylate-binding protein 1	0	2	0	2
bcl-2-related protein A1	0	2	0	2
MCOLN3 protein	0	0	1	1
transient receptor potential cation channel, subfamily N, member 1	0	0	1	1
Muscarinic acetylcholine receptor DM1	0	3	0	3
Oxytocin receptor	0	0	1	1
Genome polyprotein	0	2	0	2
Beta-tubulin	0	1	0	1
Chain B, Cell division protein kinase 6	0	1	0	1
Chain B, Cell division protein kinase 6	0	1	0	1
Chain A, Fatty acid-binding protein, adipocyte	0	1	0	1
Geranylgeranyl pyrophosphate synthase	0	3	0	4
Farnesyl pyrophosphate synthase	0	4	0	4
Hypoxanthine-guanine phosphoribosyltransferase	0	1	0	1
Farnesyl pyrophosphate synthase	0	3	0	3
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	1	0	1
Serine hydroxymethyltransferase, mitochondrial	0	1	0	1
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	0	2	0	2
Pyrroline-5-carboxylate reductase 1, mitochondrial	0	1	0	1
Renin	0	1	0	1
Transcriptional activator Myb	0	1	0	1
UDP-N-acetylglucosamine 1-carboxyvinyltransferase	0	1	0	1
UDP-N-acetylglucosamine 1-carboxyvinyltransferase	0	1	0	1
BZLF2	0	1	0	1
Receptor protein-tyrosine kinase	0	3	0	3
Chain A, Protein (fibroblast Growth Factor (fgf) Receptor 1)	0	1	0	1
Platelet-derived growth factor receptor beta	0	3	0	3
Platelet-derived growth factor receptor alpha	0	1	0	1
Platelet-derived growth factor receptor beta	0	1	0	1
Luciferin 4-monooxygenase	0	2	1	3
Dual specificity mitogen-activated protein kinase kinase 2	0	1	0	1
Dual specificity mitogen-activated protein kinase kinase 1	0	1	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase 1	0	0	0	1
Beta-lactamase OXA-10	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Beta-lactamase	0	0	0	1
Chain A, CATHEPSIN D	0	1	0	1
Chain B, CATHEPSIN D	0	1	0	1
Chain A, PLASMEPSIN II	0	1	0	1
Chain E, ENDOTHIAPEPSIN	0	1	0	1
Chain E, RHIZOPUSPEPSIN	0	1	0	1
Chain E, ENDOTHIAPEPSIN	0	1	0	1
Chain E, ENDOTHIAPEPSIN	0	1	0	1
Chain E, RHIZOPUSPEPSIN	0	1	0	1
Chain E, RHIZOPUSPEPSIN	0	1	0	1
Pepsin A	0	2	0	2
Cathepsin D	0	3	0	4
Candidapepsin-2	0	1	0	1
Pepsin A-5	0	1	0	1
Gag-Pro polyprotein	0	1	0	1
Gag-Pol polyprotein	0	2	0	2
Cathepsin E	0	1	0	1
Plasmepsin-1	0	1	0	1
Plasmepsin-2	0	1	0	1
Cathepsin D	0	3	0	3
Disintegrin and metalloproteinase domain-containing protein 9	0	1	0	1
Plasmepsin 4	0	1	0	1
Aldehyde oxidase 1	0	2	0	2
Aldehyde oxidase 1	0	2	0	2
Focal adhesion kinase 1	0	0	0	1
Chain A, Immunoglobulin	0	0	1	1
Chain B, Immunoglobulin	0	0	1	1
Muscarinic acetylcholine receptor M5	0	1	1	3
Alpha-1B adrenergic receptor	0	3	0	3
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	1	0	1
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
Chain A, Hth-type Transcriptional Regulator Ttgr	0	0	1	1
serine/threonine-protein kinase 33 isoform a	0	0	2	2
Monocarboxylate transporter 1	0	1	0	1
Sodium/hydrogen exchanger 9B2	0	1	0	1
Protein kinase C alpha type	0	1	0	1
Proto-oncogene vav	0	0	1	1
Protein kinase C delta type	0	1	1	2
Transient receptor potential cation channel subfamily V member 4	0	0	1	1
Chain A, phosphoenolpyruvate carboxykinase, cytosolic	0	1	0	1
Chain A, Phosphoenolpyruvate Carboxykinase, Cytosolic	0	1	0	1
Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	0	1	0	1
Acetylcholinesterase	0	1	0	1
Chain D, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)	0	1	0	1
Chain A, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)	0	1	0	1
Chain A, Beta-arrestin 1	0	0	1	1
Ubiquitin carboxyl-terminal hydrolase 1	0	3	0	3
WD repeat-containing protein 48	0	3	0	3
CDGSH iron-sulfur domain-containing protein 1	0	2	0	2
Peroxisome proliferator-activated receptor gamma	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	2	0	2
CDGSH iron-sulfur domain-containing protein 2	0	2	0	2
Synaptic vesicle glycoprotein 2A	0	1	0	1
Chloride channel isoform 1	0	0	1	1
C-X-C chemokine receptor type 4	0	1	0	1
Atypical chemokine receptor 3	0	0	1	1
C-X-C chemokine receptor type 4	0	2	0	4
Chain A, AKAP9-BRAF fusion protein	0	1	0	1
Serine/threonine-protein kinase B-raf	0	2	0	2
Dual specificity mitogen-activated protein kinase kinase 4	0	0	1	1
Regulatory protein E2	0	0	1	1
Regulatory protein E2	0	0	1	1
Calcium-activated potassium channel subunit alpha-1	0	1	0	1
Sodium/potassium/calcium exchanger 4	0	1	1	2
Sodium/potassium/calcium exchanger 2	0	1	1	2
Beta-casein	0	2	0	2
Alpha-2A adrenergic receptor	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	2	0	2
luciferase	0	0	0	1
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Glutamate 5-kinase	0	0	0	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Chain A, Ferritin light chain	0	0	1	1
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
NADH-cytochrome b5 reductase 3	0	1	0	1
Thyroid peroxidase	0	1	0	1
Solute carrier organic anion transporter family member 2A1	0	1	0	1
Puromycin-sensitive aminopeptidase	0	2	0	2
Tyrosyl-DNA phosphodiesterase 1	0	1	0	1
Chain A, PUTRESCINE-BINDING PROTEIN	0	0	1	1
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN	0	1	0	1
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN	0	1	0	1
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN	0	1	0	1
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN	0	1	0	1
S-adenosylmethionine decarboxylase proenzyme	0	0	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	2	0	2
Trans-sialidase	0	1	0	1
Trans-sialidase	0	1	0	1
dual specificity protein phosphatase 3	0	1	0	1
low molecular weight phosphotyrosine protein phosphatase isoform c	0	1	0	1
tyrosine-protein phosphatase non-receptor type 22 isoform 1	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Beta-hexosaminidase subunit beta	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	1	0	1
Trace amine-associated receptor 5	0	0	1	1
Bifunctional dihydrofolate reductase-thymidylate synthase	0	2	0	2
Multidrug and toxin extrusion protein 1	0	1	0	1
Cytidine deaminase	0	1	0	1
Thyrotropin releasing hormone degrading enzyme	0	1	0	1
N	0	1	0	1
DNA-directed RNA polymerase subunit alpha	0	1	0	1
DNA-directed RNA polymerase subunit omega	0	1	0	1
DNA-directed RNA polymerase subunit beta'	0	1	0	1
DNA-directed RNA polymerase subunit beta	0	1	0	1
Multidrug resistance protein 1a	0	0	0	1
Dipeptidyl peptidase 4	0	0	1	1
Gastric inhibitory polypeptide receptor	0	1	0	1
Voltage-gated sodium channel Nav1.5 cardiac isoform	0	1	0	1
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	2	0	2
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
M18 aspartyl aminopeptidase	0	1	0	1
cathepsin L1	0	1	0	1
transcription factor p65 isoform 1	0	0	1	1
Aryl hydrocarbon receptor	0	1	0	1
Myc proto-oncogene protein	0	1	0	2
DNA polymerase alpha catalytic subunit	0	1	0	1
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	1	0	1
N1L	0	1	0	1
NAD(P)H dehydrogenase [quinone] 1	0	0	0	3
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR	0	0	1	1
Retinol-binding protein 4	0	0	1	1
Beta-lactoglobulin	0	0	1	1
DNA-directed RNA polymerase subunit beta	0	1	0	1
NH(3)-dependent NAD(+) synthetase	0	1	0	1
DNA-directed RNA polymerase subunit beta	0	1	0	1
Diacylglycerol kinase alpha	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, POL polyprotein	0	1	0	1
Chain B, POL polyprotein	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Gag-Pol polyprotein	0	1	0	1
Thromboxane-A synthase	0	0	0	1
Plasmepsin V	0	1	0	1
Chain A, Activated Factor Xa Heavy Chain	0	1	0	1
Coagulation factor XII	0	1	0	1
Retina-specific copper amine oxidase	0	1	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	0	1	0	1
Tumor necrosis factor	0	1	0	1
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
Phosphodiesterase	0	1	0	1
Catechol O-methyltransferase	0	0	1	1
Thrombin	0	0	1	1
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase (fumarate)	0	1	0	1
Acyl carrier protein, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase	0	1	0	1
Eukaryotic elongation factor 2 kinase	0	1	0	1
Malate dehydrogenase	0	2	0	2
M-phase inducer phosphatase 1	0	2	0	2
RuvB-like 1	0	2	0	2
Low-density lipoprotein receptor	0	1	0	1
Fibronectin	0	1	0	1
Macrophage colony-stimulating factor 1 receptor	0	1	0	1
Proprotein convertase subtilisin/kexin type 9	0	1	0	1
RmtA	0	2	0	2
Protein arginine N-methyltransferase 1	0	2	0	2
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, Lysr-type Regulatory Protein	0	0	1	1
Chain A, 146aa long hypothetical transcriptional regulator	0	0	1	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain B, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain C, Anthranilate phosphoribosyltransferase	0	1	0	1
Chain A, Anthranilate phosphoribosyltransferase	0	1	0	1
Anthranilate phosphoribosyltransferase	0	1	0	1
Tyrosine-protein phosphatase YopH	0	1	0	1
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
glycogen synthase kinase-3 alpha	0	0	0	1
Type-1 angiotensin II receptor	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Amine oxidase [flavin-containing] B	0	0	0	1
Transcriptional activator protein LuxR	0	2	0	2
Programmed cell death protein 1	0	1	0	1
Programmed cell death 1 ligand 1	0	1	0	1
photoreceptor-specific nuclear receptor	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	3	0	3
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	1	0	1
Cholecystokinin receptor type A	0	1	0	1
Eukaryotic translation initiation factor 4E	0	0	1	1
Peptidyl-prolyl cis-trans isomerase FKBP1A	0	1	0	1
Peptidyl-prolyl cis-trans isomerase FKBP1B	0	0	2	2
Programmed cell death protein 4	0	0	1	1
Adenylate cyclase type 6	0	0	1	1
Adenylate cyclase type 3	0	0	1	1
Adenylate cyclase type 9	0	0	1	1
D(1) dopamine receptor	0	0	1	1
Adenylate cyclase type 7	0	0	1	1
Adenylate cyclase type 2	0	0	1	1
Adenylate cyclase type 4	0	0	1	1
Laccase	0	1	0	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
Chain A, Mitogen-activated protein kinase 14	0	0	1	1
melanocortin receptor 4	0	1	1	2
Cyclin-C	0	1	1	2
Vascular endothelial growth factor receptor 3	0	1	0	1
Vascular endothelial growth factor receptor 2	0	1	0	1
Protein delta homolog 1	0	1	2	3
Vascular endothelial growth factor receptor 2	0	1	0	1
RuvB-like 2	0	1	1	2
Sulfate anion transporter 1	0	0	0	1
5-hydroxytryptamine receptor 1E	0	1	0	1
sphingosine 1-phosphate receptor 3	0	1	0	1
D(3) dopamine receptor	0	1	0	1
5-hydroxytryptamine receptor 7	0	1	0	1
D(4) dopamine receptor	0	1	0	1
D(1B) dopamine receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Mineralocorticoid receptor	0	1	0	1
Chain A, Ribosomal protein S6 kinase alpha-1	0	1	0	1
Chain X, Tyrosine-protein kinase Lyn	0	1	0	1
Chain A, Dual specificity protein kinase TTK	0	0	1	1
Chain A, Dual specificity protein kinase TTK	0	0	1	1
Mast/stem cell growth factor receptor Kit	0	1	0	1
Platelet-derived growth factor receptor alpha	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
Bromodomain-containing protein 9	0	0	1	1
Serine/threonine-protein kinase 3	0	0	1	1
Bromodomain-containing protein 7	0	0	1	1
Chain A, Protein (aspartate Aminotransferase)	0	0	1	1
Chain A, Aspartate Aminotransferase	0	0	1	1
Delta-aminolevulinic acid dehydratase	0	1	0	1
NADP-dependent malic enzyme, mitochondrial	0	0	0	1
Solute carrier family 13 member 3	0	1	0	1
Chain A, MALTOPORIN	0	0	1	1
Chain B, MALTOPORIN	0	0	1	1
D(2) dopamine receptor	0	1	0	1
Carboxypeptidase M	0	1	0	1
5-hydroxytryptamine receptor 1F	0	2	1	3
5-hydroxytryptamine receptor 1D	0	1	0	1
5-hydroxytryptamine receptor 1B	0	1	0	1
ATP-dependent 6-phosphofructokinase	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 2	0	1	0	1
P2X purinoceptor 2	0	1	1	2
P2Y purinoceptor 4	0	0	1	1
Ectonucleoside triphosphate diphosphohydrolase 1	0	1	0	1
DNA primase	0	1	0	1
Dual specificity protein phosphatase 5	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 8	0	1	0	1
Ectonucleoside triphosphate diphosphohydrolase 3	0	1	0	1
P2X purinoceptor 7	0	0	1	1
Chain A, Alpha-mannosidase Ii	0	1	0	1
Chain A, ALPHA-MANNOSIDASE II	0	1	0	1
Chain A, Alpha-mannosidase Ii	0	1	0	1
Lysosomal alpha-mannosidase	0	1	0	1
Mannosyl-oligosaccharide alpha-1,2-mannosidase IA	0	2	0	2
Alpha-mannosidase 2	0	1	0	1
Alpha-1,2-mannosidase family protein	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase, putative	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Glycoside hydrolase family 92	0	1	0	1
Glycoside hydrolase family 92	0	1	0	1
Alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase, putative	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase, putative	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Putative alpha-1,2-mannosidase	0	1	0	1
Alpha-1,2-mannosidase family protein	0	1	0	1
alpha-1,2-Mannosidase	0	1	0	1
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	0	2	0	2
Chain A, CES1 protein	0	1	0	1
Phospholipase D1	0	1	0	1
Emopamil-binding protein-like	0	2	0	2
7-dehydrocholesterol reductase	0	1	1	2
Chain A, Peroxisome proliferator-activated receptor gamma	0	1	0	1
Chain A, Peroxisome proliferator-activated receptor gamma	0	1	0	1
cGMP-gated cation channel alpha-1	0	0	1	1
Tetracycline resistance protein, class B	0	0	0	1
Multidrug transporter MdfA	0	1	0	1
Ras guanyl-releasing protein 3	0	0	1	1
Solute carrier family 22 member 4	0	0	0	1
Solute carrier family 22 member 3	0	0	0	1
Solute carrier family 22 member 4	0	0	0	1
Chain A, Multidrug-efflux Transporter 1 Regulator Bmrr	0	0	1	1
DNA-binding protein Ikaros	0	0	0	1
DNA damage-binding protein 1	0	1	1	2
Chain A, Pyridoxal kinase	0	1	0	1
Chain A, Pyridoxal Kinase	0	1	0	1
Adenosine receptor A1	0	3	0	3
Adenosine receptor A1	0	1	0	1
caspase recruitment domain family, member 15	0	1	0	1
neurotensin receptor type 1	0	0	1	1
receptor-interacting serine/threonine-protein kinase 2 isoform 1	0	1	0	1
Mucosa-associated lymphoid tissue lymphoma translocation protein 1	0	1	0	1
Urease subunit alpha	0	1	0	1
Urease subunit beta	0	1	0	1
Janus kinase 2 (a protein tyrosine kinase)	0	1	0	1
E3 ubiquitin-protein ligase Mdm2 isoform a	0	0	1	1
Gamma-butyrobetaine dioxygenase	0	1	1	2
Thymidine phosphorylase	0	0	0	1
Thymidine kinase, cytosolic	0	0	0	2
Thymidine kinase	0	1	0	2
Thymidine kinase	0	0	0	1
Chain A, ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE LARGE CHAIN	0	0	1	1
Chain A, ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE LARGE CHAIN	0	0	1	1
Chain A, Deoxynucleoside kinase	0	1	0	1
DNA polymerase beta	0	1	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Malate dehydrogenase, mitochondrial	0	1	0	1
Monocarboxylate transporter 8	0	0	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
DNA topoisomerase 1	0	1	0	1
Chain A, Nuclear Receptor ROR-beta	0	1	0	1
Nuclear receptor ROR-alpha	0	1	0	1
Nuclear receptor ROR-beta	0	1	0	1
procathepsin L isoform 1 preproprotein	0	1	0	1
Chain A, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)	0	1	0	1
Chain B, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)	0	1	0	1
Chain A, Histone deacetylase 7a	0	1	0	1
Chain A, Histone deacetylase 7a	0	1	0	1
Histone deacetylase 8	0	2	0	2
Histone deacetylase	0	2	0	2
unnamed protein product	0	0	0	1
Histone deacetylase 1	0	4	0	4
Histone deacetylase 3	0	1	0	1
Histone deacetylase 2	0	1	0	1
Histone deacetylase 1	0	2	0	2
Adenosine receptor A1	0	1	0	1
Histone deacetylase	0	2	0	2
Histone deacetylase 4	0	1	0	1
Polyamine deacetylase HDAC10	0	1	0	1
Histone deacetylase 3	0	2	0	2
Histone deacetylase-like amidohydrolase	0	4	1	5
Histone deacetylase 7	0	1	0	1
Histone deacetylase 8	0	1	0	1
Histone deacetylase 11	0	1	0	1
HD2 type histone deacetylase HDA106	0	4	0	4
Histone deacetylase 9	0	1	0	1
Histone deacetylase 7	0	2	0	2
Histone deacetylase 6	0	2	0	2
Histone deacetylase 4	0	2	0	2
Histone deacetylase	0	2	0	2
Histone deacetylase 6	0	2	0	2
Histone deacetylase 5	0	1	0	1
Histone deacetylase	0	2	0	2
Lysozyme C-1	0	1	0	1
Beta-glucuronidase	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	0	0	1
Solute carrier organic anion transporter family member 4A1	0	0	0	1
Proteinase-activated receptor 2	0	1	0	1
Forkhead box protein M1	0	2	0	2
Chain A, CARBONIC ANHYDRASE II	0	1	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryprostatin B synthase	0	0	0	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
jumonji domain containing 2C, partial	0	0	0	1
Chain A, Bacterial leucyl aminopeptidase	0	1	0	1
Aminopeptidase B	0	2	0	2
M1 family aminopeptidase	0	2	0	2
Cytosol aminopeptidase	0	2	0	2
Aminopeptidase N	0	1	0	1
Cytosol aminopeptidase	0	2	0	2
Aminopeptidase N	0	2	0	2
Leucyl-cystinyl aminopeptidase	0	1	0	1
Bacterial leucyl aminopeptidase	0	2	0	2
Aminopeptidase B	0	1	0	1
Cadherin-1	0	1	0	1
Adenomatous polyposis coli protein	0	1	0	1
Catenin beta-1	0	2	0	2
Transcription factor 7-like 2	0	1	0	1
Chain A, Cytidine Deaminase	0	1	0	1
Stimulator of interferon genes protein	0	1	2	3
Stimulator of interferon genes protein	0	1	1	2
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
Receptor-type tyrosine-protein phosphatase F	0	1	0	1
D-alanyl-D-alanine dipeptidase	0	1	0	1
Glycoprotein	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Chloroquine resistance transporter	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
M-phase inducer phosphatase 3	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase isozyme L3	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase isozyme L1	0	1	0	1
Sterol 14-alpha-demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
14-alpha sterol demethylase	0	0	1	1
Cholesterol 24-hydroxylase	0	2	1	3
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Chain A, Histone deacetylase-like amidohydrolase	0	1	0	1
Gli1	0	1	0	1
protein Wnt-3a precursor	0	1	0	1
Protein Tat	0	0	1	1
Leukotriene A-4 hydrolase	0	1	0	1
Renin	0	1	0	1
Histone deacetylase	0	1	0	1
Carboxypeptidase B2	0	1	0	1
REST corepressor 3	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
shiga toxin 1 variant A subunit	1	0	0	1
shiga toxin 1 B subunit	1	0	0	1
Arachidonate 5-lipoxygenase	0	1	0	1
Telomere resolvase ResT	0	1	0	1
Genome polyprotein	0	1	0	1
Butyrophilin subfamily 3 member A1	0	0	1	2
Farnesyl diphosphate synthase	0	1	0	1
Geranylgeranyl pyrophosphate synthase	0	2	0	2
Farnesyl pyrophosphate synthase	0	1	0	1
H	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(6)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (7,782)

Protein Targets (3,905)

Cancer of Pituitary

Synonyms(6)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (7,782)

Drugs Studied (1,465)

Protein Targets (3,905)